{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The Drug Abuse Warning Network (DAWN) is a public health surveillance system that monitors drug abuse related visits to emergency departments in hospitals in large metro areas across the US. The Drug Abuse Warning Network (DAWN) is a public health surveillance system that monitors drug abuse related visits to emergency departments in hospitals in large metro areas across the US. This data set is the DAWN data from 2011. In this part of the project, the data will be 'wrangled', which is the process of taking raw data and tranforming it into a format that is suitable for analysis.\n",
    "\n",
    "Import libraries that will be needed in this exercise\n",
    "Import DAWN dataset with Pandas as a dataframe"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "        METRO  STRATA  PSU  REPLICATE   CASEWGT  PSUFRAME  AGECAT  SEX  RACE  \\\n",
      "CASEID                                                                         \n",
      "1           2      25  108          2  0.942635         3       4    1     2   \n",
      "2           2      29  129          2  5.992011         9      11    1     3   \n",
      "3           7       7   25          1  4.723172         6      11    2     2   \n",
      "4          10       8   29          2  4.080147         6       2    1     3   \n",
      "5           1      22   94          2  5.177709        10       6    1     3   \n",
      "\n",
      "        YEAR  ...  sdled_4_22  sdled_5_22  sdled_6_22  CASETYPE  DISPOSITION  \\\n",
      "CASEID        ...                                                              \n",
      "1       2011  ...        -7.0        -7.0          -7         8            6   \n",
      "2       2011  ...        -7.0        -7.0          -7         4            7   \n",
      "3       2011  ...        -7.0        -7.0          -7         4            1   \n",
      "4       2011  ...        -7.0        -7.0          -7         4            7   \n",
      "5       2011  ...        -7.0        -7.0          -7         8            8   \n",
      "\n",
      "        ALCOHOL  NONALCILL  PHARMA  NONMEDPHARMA  ALLABUSE  \n",
      "CASEID                                                      \n",
      "1             1          1       0             0         1  \n",
      "2             0          0       1             0         0  \n",
      "3             0          0       1             0         0  \n",
      "4             0          0       1             0         0  \n",
      "5             1          1       0             0         1  \n",
      "\n",
      "[5 rows x 284 columns]\n",
      "        METRO  STRATA  PSU  REPLICATE   CASEWGT  PSUFRAME  AGECAT  SEX  RACE  \\\n",
      "CASEID                                                                         \n",
      "1           2      25  108          2  0.942635         3       4    1     2   \n",
      "2           2      29  129          2  5.992011         9      11    1     3   \n",
      "3           7       7   25          1  4.723172         6      11    2     2   \n",
      "4          10       8   29          2  4.080147         6       2    1     3   \n",
      "5           1      22   94          2  5.177709        10       6    1     3   \n",
      "\n",
      "        YEAR  ...  sdled_4_22  sdled_5_22  sdled_6_22  CASETYPE  DISPOSITION  \\\n",
      "CASEID        ...                                                              \n",
      "1       2011  ...        -7.0        -7.0          -7         8            6   \n",
      "2       2011  ...        -7.0        -7.0          -7         4            7   \n",
      "3       2011  ...        -7.0        -7.0          -7         4            1   \n",
      "4       2011  ...        -7.0        -7.0          -7         4            7   \n",
      "5       2011  ...        -7.0        -7.0          -7         8            8   \n",
      "\n",
      "        ALCOHOL  NONALCILL  PHARMA  NONMEDPHARMA  ALLABUSE  \n",
      "CASEID                                                      \n",
      "1             1          1       0             0         1  \n",
      "2             0          0       1             0         0  \n",
      "3             0          0       1             0         0  \n",
      "4             0          0       1             0         0  \n",
      "5             1          1       0             0         1  \n",
      "\n",
      "[5 rows x 284 columns]\n"
     ]
    }
   ],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "\n",
    "\n",
    "df = pd.read_csv (r\"C:\\Users\\Laura-Black\\Documents\\PhD\\Data Scientist\\Springboard\\Capstone Projects\\Drug Abuse ED Visits\\DAWN-2011-DS0001-data-excel.csv\", \n",
    "                     index_col=0, dtype={\"Buyer_Part_Number\": str}, low_memory=False)\n",
    "\n",
    "drugnames = pd.read_csv (r\"C:\\Users\\Laura-Black\\Documents\\PhD\\Data Scientist\\Springboard\\Capstone Projects\\Drug Abuse ED Visits\\DAWN-2011-Drug_Name_List.csv\", \n",
    "                     index_col=0, dtype={\"Buyer_Part_Number\": str}, low_memory=False)\n",
    "\n",
    "print(df.head())\n",
    "print(df.head())\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Look at dataframe to see its size and column names"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 229211 entries, 1 to 229211\n",
      "Columns: 284 entries, METRO to ALLABUSE\n",
      "dtypes: float64(100), int64(184)\n",
      "memory usage: 498.4 MB\n",
      "None\n",
      "['METRO', 'STRATA', 'PSU', 'REPLICATE', 'CASEWGT', 'PSUFRAME', 'AGECAT', 'SEX', 'RACE', 'YEAR', 'QUARTER', 'DAYPART', 'NUMSUBS', 'DRUGID_1', 'CATID_1_1', 'CATID_2_1', 'CATID_3_1', 'ROUTE_1', 'TOXTEST_1', 'sdled_1_1', 'sdled_2_1', 'sdled_3_1', 'sdled_4_1', 'sdled_5_1', 'sdled_6_1', 'DRUGID_2', 'CATID_1_2', 'CATID_2_2', 'CATID_3_2', 'ROUTE_2', 'TOXTEST_2', 'sdled_1_2', 'sdled_2_2', 'sdled_3_2', 'sdled_4_2', 'sdled_5_2', 'sdled_6_2', 'DRUGID_3', 'CATID_1_3', 'CATID_2_3', 'CATID_3_3', 'ROUTE_3', 'TOXTEST_3', 'sdled_1_3', 'sdled_2_3', 'sdled_3_3', 'sdled_4_3', 'sdled_5_3', 'sdled_6_3', 'DRUGID_4', 'CATID_1_4', 'CATID_2_4', 'CATID_3_4', 'ROUTE_4', 'TOXTEST_4', 'sdled_1_4', 'sdled_2_4', 'sdled_3_4', 'sdled_4_4', 'sdled_5_4', 'sdled_6_4', 'DRUGID_5', 'CATID_1_5', 'CATID_2_5', 'CATID_3_5', 'ROUTE_5', 'TOXTEST_5', 'sdled_1_5', 'sdled_2_5', 'sdled_3_5', 'sdled_4_5', 'sdled_5_5', 'sdled_6_5', 'DRUGID_6', 'CATID_1_6', 'CATID_2_6', 'CATID_3_6', 'ROUTE_6', 'TOXTEST_6', 'sdled_1_6', 'sdled_2_6', 'sdled_3_6', 'sdled_4_6', 'sdled_5_6', 'sdled_6_6', 'DRUGID_7', 'CATID_1_7', 'CATID_2_7', 'CATID_3_7', 'ROUTE_7', 'TOXTEST_7', 'sdled_1_7', 'sdled_2_7', 'sdled_3_7', 'sdled_4_7', 'sdled_5_7', 'sdled_6_7', 'DRUGID_8', 'CATID_1_8', 'CATID_2_8', 'CATID_3_8', 'ROUTE_8', 'TOXTEST_8', 'sdled_1_8', 'sdled_2_8', 'sdled_3_8', 'sdled_4_8', 'sdled_5_8', 'sdled_6_8', 'DRUGID_9', 'CATID_1_9', 'CATID_2_9', 'CATID_3_9', 'ROUTE_9', 'TOXTEST_9', 'sdled_1_9', 'sdled_2_9', 'sdled_3_9', 'sdled_4_9', 'sdled_5_9', 'sdled_6_9', 'DRUGID_10', 'CATID_1_10', 'CATID_2_10', 'CATID_3_10', 'ROUTE_10', 'TOXTEST_10', 'sdled_1_10', 'sdled_2_10', 'sdled_3_10', 'sdled_4_10', 'sdled_5_10', 'sdled_6_10', 'DRUGID_11', 'CATID_1_11', 'CATID_2_11', 'CATID_3_11', 'ROUTE_11', 'TOXTEST_11', 'sdled_1_11', 'sdled_2_11', 'sdled_3_11', 'sdled_4_11', 'sdled_5_11', 'sdled_6_11', 'DRUGID_12', 'CATID_1_12', 'CATID_2_12', 'CATID_3_12', 'ROUTE_12', 'TOXTEST_12', 'sdled_1_12', 'sdled_2_12', 'sdled_3_12', 'sdled_4_12', 'sdled_5_12', 'sdled_6_12', 'DRUGID_13', 'CATID_1_13', 'CATID_2_13', 'CATID_3_13', 'ROUTE_13', 'TOXTEST_13', 'sdled_1_13', 'sdled_2_13', 'sdled_3_13', 'sdled_4_13', 'sdled_5_13', 'sdled_6_13', 'DRUGID_14', 'CATID_1_14', 'CATID_2_14', 'CATID_3_14', 'ROUTE_14', 'TOXTEST_14', 'sdled_1_14', 'sdled_2_14', 'sdled_3_14', 'sdled_4_14', 'sdled_5_14', 'sdled_6_14', 'DRUGID_15', 'CATID_1_15', 'CATID_2_15', 'CATID_3_15', 'ROUTE_15', 'TOXTEST_15', 'sdled_1_15', 'sdled_2_15', 'sdled_3_15', 'sdled_4_15', 'sdled_5_15', 'sdled_6_15', 'DRUGID_16', 'CATID_1_16', 'CATID_2_16', 'CATID_3_16', 'ROUTE_16', 'TOXTEST_16', 'sdled_1_16', 'sdled_2_16', 'sdled_3_16', 'sdled_4_16', 'sdled_5_16', 'sdled_6_16', 'DRUGID_17', 'CATID_1_17', 'CATID_2_17', 'CATID_3_17', 'ROUTE_17', 'TOXTEST_17', 'sdled_1_17', 'sdled_2_17', 'sdled_3_17', 'sdled_4_17', 'sdled_5_17', 'sdled_6_17', 'DRUGID_18', 'CATID_1_18', 'CATID_2_18', 'CATID_3_18', 'ROUTE_18', 'TOXTEST_18', 'sdled_1_18', 'sdled_2_18', 'sdled_3_18', 'sdled_4_18', 'sdled_5_18', 'sdled_6_18', 'DRUGID_19', 'CATID_1_19', 'CATID_2_19', 'CATID_3_19', 'ROUTE_19', 'TOXTEST_19', 'sdled_1_19', 'sdled_2_19', 'sdled_3_19', 'sdled_4_19', 'sdled_5_19', 'sdled_6_19', 'DRUGID_20', 'CATID_1_20', 'CATID_2_20', 'CATID_3_20', 'ROUTE_20', 'TOXTEST_20', 'sdled_1_20', 'sdled_2_20', 'sdled_3_20', 'sdled_4_20', 'sdled_5_20', 'sdled_6_20', 'DRUGID_21', 'CATID_1_21', 'CATID_2_21', 'CATID_3_21', 'ROUTE_21', 'TOXTEST_21', 'sdled_1_21', 'sdled_2_21', 'sdled_3_21', 'sdled_4_21', 'sdled_5_21', 'sdled_6_21', 'DRUGID_22', 'CATID_1_22', 'CATID_2_22', 'CATID_3_22', 'ROUTE_22', 'TOXTEST_22', 'sdled_1_22', 'sdled_2_22', 'sdled_3_22', 'sdled_4_22', 'sdled_5_22', 'sdled_6_22', 'CASETYPE', 'DISPOSITION', 'ALCOHOL', 'NONALCILL', 'PHARMA', 'NONMEDPHARMA', 'ALLABUSE']\n"
     ]
    }
   ],
   "source": [
    "print(df.info())\n",
    "print(list(df.columns.values))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The dataframe is very large and somewhat unwieldy the decision was made to remove the 'sdled' and 'CATID' columns. These columns won't be used in the analysis because their inclusion is beyond the scope of this project."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 229211 entries, 1 to 229211\n",
      "Data columns (total 86 columns):\n",
      "METRO           229211 non-null int64\n",
      "STRATA          229211 non-null int64\n",
      "PSU             229211 non-null int64\n",
      "REPLICATE       229211 non-null int64\n",
      "CASEWGT         229211 non-null float64\n",
      "PSUFRAME        229211 non-null int64\n",
      "AGECAT          229211 non-null int64\n",
      "SEX             229211 non-null int64\n",
      "RACE            229211 non-null int64\n",
      "YEAR            229211 non-null int64\n",
      "QUARTER         229211 non-null int64\n",
      "DAYPART         229211 non-null int64\n",
      "NUMSUBS         229211 non-null int64\n",
      "DRUGID_1        229211 non-null int64\n",
      "ROUTE_1         229211 non-null int64\n",
      "TOXTEST_1       229211 non-null int64\n",
      "DRUGID_2        229211 non-null int64\n",
      "ROUTE_2         229211 non-null int64\n",
      "TOXTEST_2       229211 non-null int64\n",
      "DRUGID_3        229211 non-null int64\n",
      "ROUTE_3         229211 non-null int64\n",
      "TOXTEST_3       229211 non-null int64\n",
      "DRUGID_4        229211 non-null int64\n",
      "ROUTE_4         229211 non-null int64\n",
      "TOXTEST_4       229211 non-null int64\n",
      "DRUGID_5        229211 non-null int64\n",
      "ROUTE_5         229211 non-null int64\n",
      "TOXTEST_5       229211 non-null int64\n",
      "DRUGID_6        229211 non-null int64\n",
      "ROUTE_6         229211 non-null int64\n",
      "TOXTEST_6       229211 non-null int64\n",
      "DRUGID_7        229211 non-null int64\n",
      "ROUTE_7         229211 non-null int64\n",
      "TOXTEST_7       229211 non-null int64\n",
      "DRUGID_8        229211 non-null int64\n",
      "ROUTE_8         229211 non-null int64\n",
      "TOXTEST_8       229211 non-null int64\n",
      "DRUGID_9        229211 non-null int64\n",
      "ROUTE_9         229211 non-null int64\n",
      "TOXTEST_9       229211 non-null int64\n",
      "DRUGID_10       229211 non-null int64\n",
      "ROUTE_10        229211 non-null int64\n",
      "TOXTEST_10      229211 non-null int64\n",
      "DRUGID_11       229211 non-null int64\n",
      "ROUTE_11        229211 non-null int64\n",
      "TOXTEST_11      229211 non-null int64\n",
      "DRUGID_12       229211 non-null int64\n",
      "ROUTE_12        229211 non-null int64\n",
      "TOXTEST_12      229211 non-null int64\n",
      "DRUGID_13       229211 non-null int64\n",
      "ROUTE_13        229211 non-null int64\n",
      "TOXTEST_13      229211 non-null int64\n",
      "DRUGID_14       229211 non-null int64\n",
      "ROUTE_14        229211 non-null int64\n",
      "TOXTEST_14      229211 non-null int64\n",
      "DRUGID_15       229211 non-null int64\n",
      "ROUTE_15        229211 non-null int64\n",
      "TOXTEST_15      229211 non-null int64\n",
      "DRUGID_16       229211 non-null int64\n",
      "ROUTE_16        229211 non-null int64\n",
      "TOXTEST_16      229211 non-null int64\n",
      "DRUGID_17       229211 non-null int64\n",
      "ROUTE_17        229211 non-null int64\n",
      "TOXTEST_17      229211 non-null int64\n",
      "DRUGID_18       229211 non-null int64\n",
      "ROUTE_18        229211 non-null int64\n",
      "TOXTEST_18      229211 non-null int64\n",
      "DRUGID_19       229211 non-null int64\n",
      "ROUTE_19        229211 non-null int64\n",
      "TOXTEST_19      229211 non-null int64\n",
      "DRUGID_20       229211 non-null int64\n",
      "ROUTE_20        229211 non-null int64\n",
      "TOXTEST_20      229211 non-null int64\n",
      "DRUGID_21       229211 non-null int64\n",
      "ROUTE_21        229211 non-null int64\n",
      "TOXTEST_21      229211 non-null int64\n",
      "DRUGID_22       229211 non-null int64\n",
      "ROUTE_22        229211 non-null int64\n",
      "TOXTEST_22      229211 non-null int64\n",
      "CASETYPE        229211 non-null int64\n",
      "DISPOSITION     229211 non-null int64\n",
      "ALCOHOL         229211 non-null int64\n",
      "NONALCILL       229211 non-null int64\n",
      "PHARMA          229211 non-null int64\n",
      "NONMEDPHARMA    229211 non-null int64\n",
      "ALLABUSE        229211 non-null int64\n",
      "dtypes: float64(1), int64(85)\n",
      "memory usage: 152.1 MB\n",
      "None\n",
      "['METRO', 'STRATA', 'PSU', 'REPLICATE', 'CASEWGT', 'PSUFRAME', 'AGECAT', 'SEX', 'RACE', 'YEAR', 'QUARTER', 'DAYPART', 'NUMSUBS', 'DRUGID_1', 'ROUTE_1', 'TOXTEST_1', 'DRUGID_2', 'ROUTE_2', 'TOXTEST_2', 'DRUGID_3', 'ROUTE_3', 'TOXTEST_3', 'DRUGID_4', 'ROUTE_4', 'TOXTEST_4', 'DRUGID_5', 'ROUTE_5', 'TOXTEST_5', 'DRUGID_6', 'ROUTE_6', 'TOXTEST_6', 'DRUGID_7', 'ROUTE_7', 'TOXTEST_7', 'DRUGID_8', 'ROUTE_8', 'TOXTEST_8', 'DRUGID_9', 'ROUTE_9', 'TOXTEST_9', 'DRUGID_10', 'ROUTE_10', 'TOXTEST_10', 'DRUGID_11', 'ROUTE_11', 'TOXTEST_11', 'DRUGID_12', 'ROUTE_12', 'TOXTEST_12', 'DRUGID_13', 'ROUTE_13', 'TOXTEST_13', 'DRUGID_14', 'ROUTE_14', 'TOXTEST_14', 'DRUGID_15', 'ROUTE_15', 'TOXTEST_15', 'DRUGID_16', 'ROUTE_16', 'TOXTEST_16', 'DRUGID_17', 'ROUTE_17', 'TOXTEST_17', 'DRUGID_18', 'ROUTE_18', 'TOXTEST_18', 'DRUGID_19', 'ROUTE_19', 'TOXTEST_19', 'DRUGID_20', 'ROUTE_20', 'TOXTEST_20', 'DRUGID_21', 'ROUTE_21', 'TOXTEST_21', 'DRUGID_22', 'ROUTE_22', 'TOXTEST_22', 'CASETYPE', 'DISPOSITION', 'ALCOHOL', 'NONALCILL', 'PHARMA', 'NONMEDPHARMA', 'ALLABUSE']\n"
     ]
    }
   ],
   "source": [
    "for col in df.columns:\n",
    "    if 'sdled' in col:\n",
    "        del df[col]\n",
    "        \n",
    "for col in df.columns:\n",
    "    if 'CATID' in col:\n",
    "        del df[col]\n",
    "        \n",
    "print(df.info())\n",
    "print(list(df.columns.values))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Get summary data for all columns."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>METRO</th>\n",
       "      <th>STRATA</th>\n",
       "      <th>PSU</th>\n",
       "      <th>REPLICATE</th>\n",
       "      <th>CASEWGT</th>\n",
       "      <th>PSUFRAME</th>\n",
       "      <th>AGECAT</th>\n",
       "      <th>SEX</th>\n",
       "      <th>RACE</th>\n",
       "      <th>YEAR</th>\n",
       "      <th>...</th>\n",
       "      <th>DRUGID_22</th>\n",
       "      <th>ROUTE_22</th>\n",
       "      <th>TOXTEST_22</th>\n",
       "      <th>CASETYPE</th>\n",
       "      <th>DISPOSITION</th>\n",
       "      <th>ALCOHOL</th>\n",
       "      <th>NONALCILL</th>\n",
       "      <th>PHARMA</th>\n",
       "      <th>NONMEDPHARMA</th>\n",
       "      <th>ALLABUSE</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <td>count</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.0</td>\n",
       "      <td>...</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.00000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "      <td>229211.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>mean</td>\n",
       "      <td>6.670090</td>\n",
       "      <td>24.681551</td>\n",
       "      <td>109.610839</td>\n",
       "      <td>1.500028</td>\n",
       "      <td>22.107901</td>\n",
       "      <td>73.348304</td>\n",
       "      <td>7.352370</td>\n",
       "      <td>1.477289</td>\n",
       "      <td>0.278656</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-6.977012</td>\n",
       "      <td>-6.999808</td>\n",
       "      <td>-7.000052</td>\n",
       "      <td>5.377774</td>\n",
       "      <td>4.103743</td>\n",
       "      <td>0.19739</td>\n",
       "      <td>0.344613</td>\n",
       "      <td>0.687716</td>\n",
       "      <td>0.226477</td>\n",
       "      <td>0.574571</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>std</td>\n",
       "      <td>4.719905</td>\n",
       "      <td>13.331152</td>\n",
       "      <td>64.444097</td>\n",
       "      <td>0.500001</td>\n",
       "      <td>68.403862</td>\n",
       "      <td>211.852785</td>\n",
       "      <td>2.691575</td>\n",
       "      <td>0.526280</td>\n",
       "      <td>3.463027</td>\n",
       "      <td>0.0</td>\n",
       "      <td>...</td>\n",
       "      <td>5.912475</td>\n",
       "      <td>0.044111</td>\n",
       "      <td>0.010233</td>\n",
       "      <td>2.255081</td>\n",
       "      <td>10.315115</td>\n",
       "      <td>0.39803</td>\n",
       "      <td>0.475243</td>\n",
       "      <td>0.463426</td>\n",
       "      <td>0.418552</td>\n",
       "      <td>0.494409</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>min</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.938440</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-9.000000</td>\n",
       "      <td>-9.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>-8.000000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>25%</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>13.000000</td>\n",
       "      <td>53.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>2.714999</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>0.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>50%</td>\n",
       "      <td>5.000000</td>\n",
       "      <td>25.000000</td>\n",
       "      <td>109.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>4.190787</td>\n",
       "      <td>10.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>75%</td>\n",
       "      <td>12.000000</td>\n",
       "      <td>35.000000</td>\n",
       "      <td>165.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>7.148615</td>\n",
       "      <td>17.000000</td>\n",
       "      <td>9.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>7.000000</td>\n",
       "      <td>0.00000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>0.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <td>max</td>\n",
       "      <td>14.000000</td>\n",
       "      <td>51.000000</td>\n",
       "      <td>233.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>862.824350</td>\n",
       "      <td>1215.000000</td>\n",
       "      <td>11.000000</td>\n",
       "      <td>2.000000</td>\n",
       "      <td>4.000000</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>...</td>\n",
       "      <td>1878.000000</td>\n",
       "      <td>6.000000</td>\n",
       "      <td>-7.000000</td>\n",
       "      <td>8.000000</td>\n",
       "      <td>96.000000</td>\n",
       "      <td>1.00000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "      <td>1.000000</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>8 rows × 86 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "               METRO         STRATA            PSU      REPLICATE  \\\n",
       "count  229211.000000  229211.000000  229211.000000  229211.000000   \n",
       "mean        6.670090      24.681551     109.610839       1.500028   \n",
       "std         4.719905      13.331152      64.444097       0.500001   \n",
       "min         1.000000       1.000000       1.000000       1.000000   \n",
       "25%         2.000000      13.000000      53.000000       1.000000   \n",
       "50%         5.000000      25.000000     109.000000       2.000000   \n",
       "75%        12.000000      35.000000     165.000000       2.000000   \n",
       "max        14.000000      51.000000     233.000000       2.000000   \n",
       "\n",
       "             CASEWGT       PSUFRAME         AGECAT            SEX  \\\n",
       "count  229211.000000  229211.000000  229211.000000  229211.000000   \n",
       "mean       22.107901      73.348304       7.352370       1.477289   \n",
       "std        68.403862     211.852785       2.691575       0.526280   \n",
       "min         0.938440       2.000000      -8.000000      -8.000000   \n",
       "25%         2.714999       8.000000       5.000000       1.000000   \n",
       "50%         4.190787      10.000000       8.000000       1.000000   \n",
       "75%         7.148615      17.000000       9.000000       2.000000   \n",
       "max       862.824350    1215.000000      11.000000       2.000000   \n",
       "\n",
       "                RACE      YEAR  ...      DRUGID_22       ROUTE_22  \\\n",
       "count  229211.000000  229211.0  ...  229211.000000  229211.000000   \n",
       "mean        0.278656    2011.0  ...      -6.977012      -6.999808   \n",
       "std         3.463027       0.0  ...       5.912475       0.044111   \n",
       "min        -8.000000    2011.0  ...      -7.000000      -9.000000   \n",
       "25%         1.000000    2011.0  ...      -7.000000      -7.000000   \n",
       "50%         1.000000    2011.0  ...      -7.000000      -7.000000   \n",
       "75%         2.000000    2011.0  ...      -7.000000      -7.000000   \n",
       "max         4.000000    2011.0  ...    1878.000000       6.000000   \n",
       "\n",
       "          TOXTEST_22       CASETYPE    DISPOSITION       ALCOHOL  \\\n",
       "count  229211.000000  229211.000000  229211.000000  229211.00000   \n",
       "mean       -7.000052       5.377774       4.103743       0.19739   \n",
       "std         0.010233       2.255081      10.315115       0.39803   \n",
       "min        -9.000000       1.000000      -8.000000       0.00000   \n",
       "25%        -7.000000       4.000000       1.000000       0.00000   \n",
       "50%        -7.000000       4.000000       1.000000       0.00000   \n",
       "75%        -7.000000       8.000000       7.000000       0.00000   \n",
       "max        -7.000000       8.000000      96.000000       1.00000   \n",
       "\n",
       "           NONALCILL         PHARMA   NONMEDPHARMA       ALLABUSE  \n",
       "count  229211.000000  229211.000000  229211.000000  229211.000000  \n",
       "mean        0.344613       0.687716       0.226477       0.574571  \n",
       "std         0.475243       0.463426       0.418552       0.494409  \n",
       "min         0.000000       0.000000       0.000000       0.000000  \n",
       "25%         0.000000       0.000000       0.000000       0.000000  \n",
       "50%         0.000000       1.000000       0.000000       1.000000  \n",
       "75%         1.000000       1.000000       0.000000       1.000000  \n",
       "max         1.000000       1.000000       1.000000       1.000000  \n",
       "\n",
       "[8 rows x 86 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df.describe()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Count the number of distinct values per column "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "           Count\n",
      "CASEWGT     2931\n",
      "DRUGID_1    1604\n",
      "DRUGID_2    1074\n",
      "DRUGID_3     787\n",
      "DRUGID_4     634\n",
      "...          ...\n",
      "REPLICATE      2\n",
      "NONALCILL      2\n",
      "PHARMA         2\n",
      "ALLABUSE       2\n",
      "YEAR           1\n",
      "\n",
      "[86 rows x 1 columns]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(array([ 0,  1,  2,  3,  4,  5,  6,  7,  8,  9, 10, 11, 12, 13, 14, 15, 16,\n",
       "        17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33,\n",
       "        34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50,\n",
       "        51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67,\n",
       "        68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84,\n",
       "        85]), <a list of 86 Text xticklabel objects>)"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 2160x720 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "res = df.nunique()\\\n",
    "        .sort_values(ascending=False)\\\n",
    "        .rename('Count')\\\n",
    "        .to_frame()\n",
    "print(res)\n",
    "\n",
    "    \n",
    "nu = df.nunique().reset_index()\n",
    "nu.columns = ['feature','nunique']\n",
    "ax = sns.barplot(x='feature', y='nunique', data=nu)\n",
    "sns.set(rc={'figure.figsize':(30,10)})\n",
    "plt.xticks(rotation=90)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Many of the variables in the dataframe are categorical, but are represented by numbers. In order to tell the data story better, it was decided to replace the numbers with the corresponding label. This replacement was done for all the variables except the drug names because there are > 2600 drug names in the data glossary that was available with the dataset. Also, though there exists a shorter, cleaner way to perform the replacements than to do them one by one, due to time constraints, it was decided to use the method that is working rather than spend more time researching a more 'pythonic' method."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "              METRO  STRATA  PSU  REPLICATE   CASEWGT  PSUFRAME AGECAT  \\\n",
      "CASEID                                                                   \n",
      "1          New York      25  108          2  0.942635         3  18-20   \n",
      "2          New York      29  129          2  5.992011         9   > 65   \n",
      "3       Date County       7   25          1  4.723172         6   > 65   \n",
      "4           Phoenix       8   29          2  4.080147         6  06-11   \n",
      "5            Boston      22   94          2  5.177709        10  25-29   \n",
      "\n",
      "           SEX      RACE  YEAR  ...  DRUGID_22 ROUTE_22  TOXTEST_22  \\\n",
      "CASEID                          ...                                   \n",
      "1         Male     Black  2011  ...         -7      N/A         N/A   \n",
      "2         Male  Hispanic  2011  ...         -7      N/A         N/A   \n",
      "3       Female     Black  2011  ...         -7      N/A         N/A   \n",
      "4         Male  Hispanic  2011  ...         -7      N/A         N/A   \n",
      "5         Male  Hispanic  2011  ...         -7      N/A         N/A   \n",
      "\n",
      "                CASETYPE        DISPOSITION ALCOHOL         NONALCILL  \\\n",
      "CASEID                                                                  \n",
      "1                  Other  Detox, Psych Unit     Yes     Illicit Drugs   \n",
      "2       Adverse Reaction    Other Inpatient      No  No Illicit Drugs   \n",
      "3       Adverse Reaction           D/C Home      No  No Illicit Drugs   \n",
      "4       Adverse Reaction    Other Inpatient      No  No Illicit Drugs   \n",
      "5                  Other        Transferred     Yes     Illicit Drugs   \n",
      "\n",
      "                    PHARMA           NONMEDPHARMA  \\\n",
      "CASEID                                              \n",
      "1       No Pharmaceuticals  No Non-Medical Pharma   \n",
      "2          Pharmaceuticals  No Non-Medical Pharma   \n",
      "3          Pharmaceuticals  No Non-Medical Pharma   \n",
      "4          Pharmaceuticals  No Non-Medical Pharma   \n",
      "5       No Pharmaceuticals  No Non-Medical Pharma   \n",
      "\n",
      "                              ALLABUSE  \n",
      "CASEID                                  \n",
      "1           All Misuse & Abuse Episode  \n",
      "2       Not All Misuse & Abuse Episode  \n",
      "3       Not All Misuse & Abuse Episode  \n",
      "4       Not All Misuse & Abuse Episode  \n",
      "5           All Misuse & Abuse Episode  \n",
      "\n",
      "[5 rows x 86 columns]\n"
     ]
    }
   ],
   "source": [
    "df[\"METRO\"].replace({1: \"Boston\", 2: \"New York\", 3: 'Chicago', 4:'Detroit', 5:'Minneapolis',6:'Fort Lauderdale',\n",
    "                    7:'Date County', 8:'Houston', 9:'Denver', 10:'Phoenix', 11:'Oakland', 12:'San Francisco',\n",
    "                    13:'Seattle', 14:'All Other'}, inplace=True)\n",
    "\n",
    "df[\"AGECAT\"].replace({1:'0-5', 2:'06-11', 3:'12-17', 4:'18-20', 5:'21-24', 6:'25-29', 7:'30-34', 8:'35-44', 9:'45-54', \n",
    "                     10:'55-64', 11:'> 65', -8: 'Not Doc'}, inplace=True)\n",
    "df['SEX'].replace({1:'Male', 2:'Female', -8: 'Not Doc'}, inplace=True)\n",
    "df['RACE'].replace({1:'White', 2:'Black', 3:'Hispanic', 4:'All Other', -8:'Not Doc'}, inplace=True)\n",
    "df['DAYPART'].replace({1:'12:00-5:59 AM', 2:'6:00-11:59 AM', 3:'12:00-5:59 PM', 4:'6:00-11:59 PM'}, inplace=True)\n",
    "df['ROUTE_1'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc'}, inplace=True)\n",
    "df['TOXTEST_1'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing'}, inplace=True)\n",
    "df['ROUTE_2'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_2'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)\n",
    "df['ROUTE_3'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_3'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                     \n",
    "df['ROUTE_4'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_4'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)  \n",
    "df['ROUTE_5'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_5'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_6'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_6'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)  \n",
    "df['ROUTE_7'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_7'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_8'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_8'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_9'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_9'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_10'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_10'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                      \n",
    "df['ROUTE_11'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_11'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_12'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_12'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_13'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_13'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_14'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_14'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)   \n",
    "df['ROUTE_15'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_15'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_16'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_16'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_17'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_17'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_18'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_18'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_19'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_19'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                      \n",
    "df['ROUTE_20'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_20'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_21'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_21'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                       \n",
    "df['ROUTE_22'].replace({1:'Oral', 2:'Injected', 3:'Inhaled, Sniffed, Snorted', 4:'Smoked', 5:'Other', 6:'Transdermal',\n",
    "                     98:'Multiple Routes', -9:'Missing', -8:'Not Doc', -7:'N/A'}, inplace=True)                    \n",
    "df['TOXTEST_22'].replace({1:'Confirmed', 2:'Not Confirmed', -9:'Missing', -7:'N/A'}, inplace=True)                      \n",
    "df['CASETYPE'].replace({1:'Suicide Attempt', 2:'Seeking Detox', 3:'Alcohol (Age<21)', 4:'Adverse Reaction',\n",
    "                      5:'Overmedication', 6:'Malicious Poisoning', 7:'Accidential Ingestion', 8:'Other'}, inplace=True)                 \n",
    "df['DISPOSITION'].replace({1:'D/C Home', 2:'Police/Jail', 3:'Detox/Treat Referral', 4:'ICU', 5:'Surgery', \n",
    "                          6:'Detox, Psych Unit', 7:'Other Inpatient', 8:'Transferred', 9:'Left Against Medical Advice',\n",
    "                          10:'Died', 96:'Other', -8:'Not Documented'}, inplace=True)\n",
    "df['ALCOHOL'].replace({0:'No', 1:'Yes'}, inplace=True)\n",
    "df['NONALCILL'].replace({0:'No Illicit Drugs', 1:'Illicit Drugs'}, inplace=True)\n",
    "df['PHARMA'].replace({0:'No Pharmaceuticals', 1:'Pharmaceuticals'}, inplace=True)                     \n",
    "df['NONMEDPHARMA'].replace({0:'No Non-Medical Pharma', 1:'Non_Medical Pharma'}, inplace=True)                     \n",
    "df['ALLABUSE'].replace({0:'Not All Misuse & Abuse Episode', 1:'All Misuse & Abuse Episode'}, inplace=True)                     \n",
    "                                          \n",
    "                    \n",
    "print(df.head())"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "There are too many drug names (> 2600) to replace them using the method above. Therefore, it was decided to replace them by importing a dictionary and mapping the names to the numbers."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{'drug_name': {1: 'ACYCLOVIR', 2: 'AMIODARONE', 3: 'AMPICILLIN', 4: 'ATENOLOL', 5: 'CAPTOPRIL', 6: 'CEFAZOLIN', 7: 'CEFOTAXIME', 8: 'CEFTAZIDIME', 9: 'CEFTIZOXIME', 10: 'CIPROFLOXACIN', 11: 'CODEINE', 12: 'ENALAPRIL', 13: 'GENTAMICIN', 14: 'IBUPROFEN', 15: 'LABETALOL', 16: 'MEPERIDINE', 17: 'NADOLOL', 18: 'NAPROXEN', 19: 'QUINIDINE', 20: 'RANITIDINE', 21: 'WARFARIN', 22: 'ALLOPURINOL', 23: 'AZATHIOPRINE', 24: 'CHLORAMPHENICOL', 25: 'FENOPROFEN', 26: 'HALOPERIDOL', 27: 'KETOPROFEN', 28: 'NAFCILLIN', 29: 'PENTAMIDINE', 30: 'PROBENECID', 31: 'PROPRANOLOL', 32: 'SULINDAC', 33: 'ZIDOVUDINE', 34: 'CHLOROQUINE', 35: 'CYCLOPHOSPHAMIDE', 36: 'DOXYCYCLINE', 37: 'FLUCYTOSINE', 38: 'INDOMETHACIN', 39: 'OXAZEPAM', 40: 'TETRACYCLINE', 41: 'CHLORPROPAMIDE', 42: 'CLINDAMYCIN', 43: 'CLONIDINE', 44: 'DILTIAZEM', 45: 'ERYTHROMYCIN', 46: 'RIFAMPIN', 47: 'VERAPAMIL', 48: 'ACETAMINOPHEN', 49: 'METHADONE', 50: 'NIFEDIPINE', 51: 'CEFTRIAXONE', 52: 'CEPHRADINE', 53: 'TOLMETIN', 54: 'CEFOTETAN', 55: 'CEFUROXIME', 56: 'PIPERACILLIN', 57: 'CARBAMAZEPINE', 58: 'LIDOCAINE', 59: 'METHOTREXATE', 60: 'LITHIUM', 61: 'CEFAMANDOLE', 62: 'CHLORPROMAZINE', 63: 'FOSCARNET', 64: 'GANCICLOVIR', 65: 'AZTREONAM', 66: 'ETHAMBUTOL', 67: 'TOBRAMYCIN', 68: 'FUROSEMIDE', 69: 'FLUCONAZOLE', 70: 'CEFIXIME', 71: 'CEFPROZIL', 72: 'CEFOPERAZONE', 73: 'PROCAINAMIDE', 74: 'AMPHOTERICIN', 75: 'DIDANOSINE', 76: 'CYCLOSPORINE', 77: 'CEFADROXIL', 78: 'CEFACLOR', 79: 'IMIPENEM-CILASTATIN', 80: 'VALPROIC', 81: 'PREDNISOLONE', 82: 'RIBAVIRIN', 83: 'AMANTADINE', 84: 'AMIKACIN', 85: 'AMOXICILLIN', 86: 'AMOXICILLIN-CLAVULANATE', 87: 'AMPICILLIN-SULBACTAM', 88: 'AZITHROMYCIN', 89: 'CARBENICILLIN', 90: 'CEFMETAZOLE', 91: 'CEFOXITIN', 92: 'CEFPODOXIME', 93: 'CEPHALEXIN', 94: 'CLARITHROMYCIN', 95: 'DAPSONE', 96: 'ENOXACIN', 97: 'GRISEOFULVIN', 98: 'ISONIAZID', 99: 'ITRACONAZOLE', 100: 'KETOCONAZOLE', 101: 'LOMEFLOXACIN', 102: 'LORACARBEF', 103: 'METHENAMINE', 104: 'METHICILLIN', 105: 'METRONIDAZOLE', 106: 'MEZLOCILLIN', 107: 'MINOCYCLINE', 108: 'NITROFURANTOIN', 109: 'NORFLOXACIN', 110: 'OFLOXACIN', 111: 'OXACILLIN', 112: 'PENICILLIN', 113: 'PYRAZINAMIDE', 114: 'SULFADIAZINE', 115: 'SULFAMETHOXAZOLE', 116: 'SULFISOXAZOLE', 117: 'TICARCILLIN', 118: 'TICARCILLIN-CLAVULANATE', 119: 'TRIMETHOPRIM', 120: 'SULFAMETHOXAZOLE-TRIMETHOPRIM', 121: 'VANCOMYCIN', 122: 'ACEBUTOLOL', 123: 'DIAZOXIDE', 124: 'HYDRALAZINE', 125: 'METHYLDOPA', 126: 'METOPROLOL', 127: 'MINOXIDIL', 128: 'PINDOLOL', 129: 'PRAZOSIN', 130: 'TIMOLOL', 131: 'CIMETIDINE', 132: 'FAMOTIDINE', 133: 'THEOPHYLLINE', 134: 'PHENYTOIN', 135: 'NORTRIPTYLINE', 136: 'DESIPRAMINE', 137: 'AMITRIPTYLINE', 138: 'CHLORAL', 139: 'DIAZEPAM', 140: 'LORAZEPAM', 141: 'COLCHICINE', 142: 'CLOXACILLIN', 143: 'DICLOXACILLIN', 144: 'MEBENDAZOLE', 145: 'MICONAZOLE', 146: 'NALIDIXIC', 147: 'QUINACRINE', 148: 'STREPTOMYCIN', 149: 'ACETAZOLAMIDE', 150: 'ADENOSINE', 151: 'ALFENTANIL', 152: 'ALPRAZOLAM', 153: 'AMILORIDE', 154: 'ASPIRIN', 155: 'AMOBARBITAL', 156: 'INAMRINONE', 157: 'ATRACURIUM', 158: 'ATROPINE', 159: 'BENZTROPINE', 160: 'BETAXOLOL', 161: 'BLEOMYCIN', 162: 'BROMOCRIPTINE', 163: 'BUMETANIDE', 164: 'BUPIVACAINE', 165: 'BUPROPION', 166: 'BUSPIRONE', 167: 'BUSULFAN', 168: 'CARBIDOPA', 169: 'CARBOPLATIN', 170: 'CEPHALOTHIN', 171: 'CEPHAPIRIN', 172: 'CHLORAMBUCIL', 173: 'CHLORDIAZEPOXIDE', 174: 'CHLOROTHIAZIDE', 175: 'CHLORPHENIRAMINE', 176: 'CHLORTHALIDONE', 177: 'CHOLESTYRAMINE', 178: 'CISPLATIN', 179: 'CLONAZEPAM', 180: 'CLORAZEPATE', 181: 'CLOZAPINE', 182: 'CROMOLYN', 183: 'CYTARABINE', 184: 'DACARBAZINE', 185: 'DACTINOMYCIN', 186: 'DANAZOL', 187: 'DAUNORUBICIN', 188: 'DEXAMETHASONE', 189: 'DEXTROMETHORPHAN', 190: 'DIFLUNISAL', 191: 'DIGITOXIN', 192: 'DIGOXIN', 193: 'DIHYDROERGOTAMINE', 194: 'DIPHENHYDRAMINE', 195: 'DIPYRIDAMOLE', 196: 'DISOPYRAMIDE', 197: 'DOBUTAMINE', 198: 'DOPAMINE', 199: 'DOXEPIN', 200: 'DOXORUBICIN', 201: 'DROPERIDOL', 202: 'EDROPHONIUM', 203: 'ERGOTAMINE', 204: 'EPOETIN', 205: 'ESMOLOL', 206: 'ETHCHLORVYNOL', 207: 'ETHOSUXIMIDE', 208: 'ETHINYL', 209: 'ETOPOSIDE', 210: 'FELODIPINE', 211: 'FENTANYL', 212: 'FLECAINIDE', 213: 'FLUOROURACIL', 214: 'FLUOXETINE', 215: 'FLUPHENAZINE', 216: 'FLURAZEPAM', 217: 'FLURBIPROFEN', 218: 'FLUTAMIDE', 219: 'FOLIC', 220: 'FOSINOPRIL', 221: 'FURAZOLIDONE', 222: 'GEMFIBROZIL', 223: 'GLIPIZIDE', 224: 'GLYBURIDE', 225: 'GOLD', 226: 'HEPARIN', 227: 'HYDROCHLOROTHIAZIDE', 228: 'HYDROCORTISONE', 229: 'HYDROMORPHONE', 230: 'IDARUBICIN', 231: 'IFOSFAMIDE', 232: 'IMIPRAMINE', 233: 'INDAPAMIDE', 234: 'INSULIN', 235: 'IPRATROPIUM', 236: 'ISOFLURANE', 237: 'ISOSORBIDE', 238: 'ISOSORBIDE', 239: 'ISRADIPINE', 240: 'KANAMYCIN', 241: 'KETAMINE', 242: 'KETOROLAC', 243: 'LEUCOVORIN', 244: 'LEVAMISOLE', 245: 'LEVODOPA', 246: 'LEVOTHYROXINE', 247: 'LINCOMYCIN', 248: 'LOVASTATIN', 249: 'MANNITOL', 250: 'MECLOFENAMATE', 251: 'MEDROXYPROGESTERONE', 252: 'MEFENAMIC', 253: 'MEFLOQUINE', 254: 'MELPHALAN', 255: 'MEPROBAMATE', 256: 'MERCAPTOPURINE', 257: 'METHIMAZOLE', 258: 'METHSUXIMIDE', 259: 'METHYLPREDNISOLONE', 260: 'METHYLTESTOSTERONE', 261: 'METIPRANOLOL', 262: 'METOCLOPRAMIDE', 263: 'METOLAZONE', 264: 'MEXILETINE', 265: 'MIDAZOLAM', 266: 'MILRINONE', 267: 'MISOPROSTOL', 268: 'MITOMYCIN', 269: 'MITOXANTRONE', 270: 'MORICIZINE', 271: 'MORPHINE', 272: 'NABUMETONE', 273: 'NALOXONE', 274: 'NEOMYCIN', 275: 'NEOSTIGMINE', 276: 'NIACIN', 277: 'NICARDIPINE', 278: 'NICOTINE', 279: 'NIMODIPINE', 280: 'NITROGLYCERIN', 281: 'NIZATIDINE', 282: 'NOREPINEPHRINE', 283: 'OMEPRAZOLE', 284: 'OXYBUTYNIN', 285: 'OXYCODONE', 286: 'PANCURONIUM', 287: 'PARAAMINOBENZOIC', 288: 'PENBUTOLOL', 289: 'PENICILLAMINE', 290: 'PENTAZOCINE', 291: 'PENTOBARBITAL', 292: 'PENTOXIFYLLINE', 293: 'PHENAZOPYRIDINE', 294: 'PHENOBARBITAL', 295: 'PHENYLBUTAZONE', 296: 'PHYSOSTIGMINE', 297: 'PIROXICAM', 298: 'POLYMYXIN', 299: 'POTASSIUM', 300: 'POVIDONE', 301: 'PRAVASTATIN', 302: 'PRAZIQUANTEL', 303: 'PREDNISONE', 304: 'PRIMAQUINE', 305: 'PRIMIDONE', 306: 'PROBUCOL', 307: 'PROCARBAZINE', 308: 'PROCHLORPERAZINE', 309: 'PROMAZINE', 310: 'PROPAFENONE', 311: 'PROPANTHELINE', 312: 'PROPOXYPHENE', 313: 'PROPYLTHIOURACIL', 314: 'PROTAMINE', 315: 'PYRIDOSTIGMINE', 316: 'PYRIMETHAMINE', 317: 'QUINAPRIL', 318: 'QUININE', 319: 'RESERPINE', 320: 'SECOBARBITAL', 321: 'OCTREOTIDE', 322: 'SOTALOL', 323: 'SPIRONOLACTONE', 324: 'STREPTOKINASE', 325: 'STREPTOZOCIN', 326: 'SUCCINYLCHOLINE', 327: 'SUCRALFATE', 328: 'SUFENTANIL', 329: 'SULFASALAZINE', 330: 'TAMOXIFEN', 331: 'TEMAZEPAM', 332: 'TERAZOSIN', 333: 'TERFENADINE', 334: 'THIOPENTAL', 335: 'THIORIDAZINE', 336: 'THIOTHIXENE', 337: 'TOLAZAMIDE', 338: 'TOLBUTAMIDE', 339: 'TRAZODONE', 340: 'TRIAMTERENE', 341: 'TRIAZOLAM', 342: 'VASOPRESSIN', 343: 'VECURONIUM', 344: 'VINBLASTINE', 345: 'VINCRISTINE', 346: 'VITAMIN', 347: 'VITAMIN', 348: 'RIBOFLAVIN', 349: 'PYRIDOXINE', 350: 'CYANOCOBALAMIN', 351: 'BIOFLAVONOIDS', 352: 'CALCIUM', 353: 'ASCORBIC', 354: 'POTASSIUM PHOSPHATE-SODIUM PHOSPHATE', 355: 'FLUORIDE', 356: 'SODIUM', 357: 'CITRIC', 358: 'SODIUM', 359: 'MAGNESIUM', 360: 'SODIUM', 361: 'TROMETHAMINE', 362: 'SODIUM', 363: 'AMMONIUM', 364: 'AMMONIUM MOLYBDATE TETRAHYDRATE', 365: 'SELENIUM', 366: 'IODINE', 367: 'GLUTAMIC', 368: 'LYSINE', 369: 'LEVOCARNITINE', 370: 'INOSITOL', 371: 'OMEGA-3 POLYUNSATURATED FATTY ACIDS', 372: 'FILGRASTIM', 373: 'SARGRAMOSTIM', 374: 'TICLOPIDINE', 375: 'ANISINDIONE', 376: 'ALTEPLASE', 377: 'UROKINASE', 378: 'ANTITHROMBIN', 379: 'ANTIHEMOPHILIC FACTOR (OBSOLETE)', 380: 'ANTI-INHIBITOR COAGULANT COMPLEX', 381: 'FACTOR', 382: 'AMINOCAPROIC', 383: 'TRANEXAMIC', 384: 'ESTRONE', 385: 'ESTRADIOL', 386: 'CONJUGATED', 387: 'ESTERIFIED', 388: 'ESTROPIPATE', 389: 'DIETHYLSTILBESTROL', 390: 'PROGESTERONE', 391: 'HYDROXYPROGESTERONE', 392: 'NORETHINDRONE', 393: 'LEVONORGESTREL', 394: 'TESTOSTERONE', 395: 'FLUOXYMESTERONE', 396: 'FINASTERIDE', 397: 'STANOZOLOL', 398: 'OXANDROLONE', 399: 'NANDROLONE', 400: 'CLOMIPHENE', 401: 'UROFOLLITROPIN', 402: 'MENOTROPINS', 403: 'CHORIONIC', 404: 'NAFARELIN', 405: 'HISTRELIN', 406: 'SOMATREM', 407: 'SOMATROPIN', 408: 'ARGININE', 409: 'DESMOPRESSIN', 410: 'OXYTOCIN', 411: 'ERGONOVINE', 412: 'METHYLERGONOVINE', 413: 'DINOPROSTONE', 414: 'METYRAPONE', 415: 'GLUCAGON', 416: 'GLUCOSE', 417: 'CALCITONIN', 418: 'ETIDRONATE', 419: 'PAMIDRONATE', 420: 'GALLIUM', 421: 'RITODRINE', 422: 'CORTICOTROPIN', 423: 'COSYNTROPIN', 424: 'FLUDROCORTISONE', 425: 'CORTISONE', 426: 'TRIAMCINOLONE', 427: 'DEXAMETHASONE', 428: 'BETAMETHASONE', 429: 'METHAZOLAMIDE', 430: 'BENDROFLUMETHIAZIDE', 431: 'METHYCLOTHIAZIDE', 432: 'BENZTHIAZIDE', 433: 'HYDROFLUMETHIAZIDE', 434: 'TRICHLORMETHIAZIDE', 435: 'POLYTHIAZIDE', 436: 'ETHACRYNIC', 437: 'UREA', 438: 'GLYCERIN', 439: 'ISOSORBIDE', 440: 'THYROID', 441: 'LIOTHYRONINE', 442: 'LIOTRIX', 443: 'AMYL', 444: 'LIDOCAINE', 445: 'BEPRIDIL', 446: 'AMLODIPINE', 447: 'ISOXSUPRINE', 448: 'PAPAVERINE', 449: 'ETHAVERINE', 450: 'ISOPROTERENOL', 451: 'EPINEPHRINE', 452: 'EPHEDRINE', 453: 'METHOXAMINE', 454: 'PHENYLEPHRINE', 455: 'CARTEOLOL', 456: 'BISOPROLOL', 457: 'GUANFACINE', 458: 'DOXAZOSIN', 459: 'RAMIPRIL', 460: 'BENAZEPRIL', 461: 'LISINOPRIL', 462: 'PHENTOLAMINE', 463: 'PHENOXYBENZAMINE', 464: 'METYROSINE', 465: 'MECAMYLAMINE', 466: 'SODIUM', 467: 'COLESTIPOL', 468: 'SIMVASTATIN', 469: 'DEXTROTHYROXINE', 470: 'ALBUTEROL', 471: 'METAPROTERENOL', 472: 'TERBUTALINE', 473: 'PIRBUTEROL', 474: 'AMINOPHYLLINE', 475: 'DYPHYLLINE', 476: 'BECLOMETHASONE', 477: 'FLUNISOLIDE', 478: 'ACETYLCYSTEINE', 479: 'CROMOLYN', 480: 'PHENYLPROPANOLAMINE', 481: 'PSEUDOEPHEDRINE', 482: 'NAPHAZOLINE', 483: 'OXYMETAZOLINE', 484: 'TETRAHYDROZOLINE', 485: 'XYLOMETAZOLINE', 486: 'ALPHA', 487: 'CLEMASTINE', 488: 'PYRILAMINE', 489: 'DEXCHLORPHENIRAMINE', 490: 'BROMPHENIRAMINE', 491: 'TRIPROLIDINE', 492: 'PROMETHAZINE', 493: 'TRIMEPRAZINE', 494: 'METHDILAZINE', 495: 'CYPROHEPTADINE', 496: 'AZATADINE', 497: 'PHENINDAMINE', 498: 'BENZONATATE', 499: 'GUAIFENESIN', 500: 'POTASSIUM', 501: 'CAFFEINE', 502: 'DOXAPRAM', 503: 'AMPHETAMINE', 504: 'DEXTROAMPHETAMINE', 505: 'METHAMPHETAMINE', 506: 'PHENTERMINE', 507: 'BENZPHETAMINE', 508: 'PHENDIMETRAZINE', 509: 'DIETHYLPROPION', 510: 'MAZINDOL', 511: 'FENFLURAMINE', 512: 'BENZOCAINE', 513: 'METHOTRIMEPRAZINE', 514: 'HYDROXYCHLOROQUINE', 515: 'OPIUM', 516: 'LEVORPHANOL', 517: 'OXYMORPHONE', 518: 'BUTORPHANOL', 519: 'NALBUPHINE', 520: 'BUPRENORPHINE', 521: 'SALSALATE', 522: 'MAGNESIUM', 523: 'DICLOFENAC', 524: 'ETODOLAC', 525: 'OXAPROZIN', 526: 'PERPHENAZINE', 527: 'THIETHYLPERAZINE', 528: 'CYCLIZINE', 529: 'MECLIZINE', 530: 'DIMENHYDRINATE', 531: 'TRIMETHOBENZAMIDE', 532: 'DRONABINOL', 533: 'ONDANSETRON', 534: 'TRIMIPRAMINE', 535: 'AMOXAPINE', 536: 'PROTRIPTYLINE', 537: 'CLOMIPRAMINE', 538: 'MAPROTILINE', 539: 'SERTRALINE', 540: 'ISOCARBOXAZID', 541: 'PHENELZINE', 542: 'TRANYLCYPROMINE', 543: 'MESORIDAZINE', 544: 'TRIFLUOPERAZINE', 545: 'MOLINDONE', 546: 'LOXAPINE', 547: 'PIMOZIDE', 548: 'METHYLPHENIDATE', 549: 'PEMOLINE', 550: 'ERGOLOID', 551: 'HYDROXYZINE', 552: 'CHLORMEZANONE', 553: 'ZOLPIDEM', 554: 'PARALDEHYDE', 555: 'ACETYLCARBROMAL', 556: 'ESTAZOLAM', 557: 'QUAZEPAM', 558: 'MEPHOBARBITAL', 559: 'BUTABARBITAL', 560: 'METHOHEXITAL', 561: 'ETOMIDATE', 562: 'PROPOFOL', 563: 'NITROUS', 564: 'ETHOTOIN', 565: 'PHENSUXIMIDE', 566: 'PARAMETHADIONE', 567: 'CARISOPRODOL', 568: 'CHLORZOXAZONE', 569: 'CYCLOBENZAPRINE', 570: 'METAXALONE', 571: 'METHOCARBAMOL', 572: 'ORPHENADRINE', 573: 'BACLOFEN', 574: 'DANTROLENE', 575: 'PROCYCLIDINE', 576: 'TRIHEXYPHENIDYL', 577: 'BIPERIDEN', 578: 'SELEGILINE', 579: 'PERGOLIDE', 580: 'ALUMINUM', 581: 'CAFFEINE', 582: 'MAGNESIUM', 583: 'MAGALDRATE', 584: 'HYOSCYAMINE', 585: 'SCOPOLAMINE', 586: 'BELLADONNA', 587: 'METHSCOPOLAMINE', 588: 'CLIDINIUM', 589: 'GLYCOPYRROLATE', 590: 'DICYCLOMINE', 591: 'PANCRELIPASE', 592: 'PANCREATIN', 593: 'URSODIOL', 594: 'MAGNESIUM', 595: 'SODIUM', 596: 'CASCARA', 597: 'PHENOLPHTHALEIN', 598: 'SENNA', 599: 'CASTOR', 600: 'BISACODYL', 601: 'POLYCARBOPHIL', 602: 'PSYLLIUM', 603: 'MINERAL', 604: 'DOCUSATE', 605: 'POLYETHYLENE GLYCOL', 606: 'LACTULOSE', 607: 'LOPERAMIDE', 608: 'BISMUTH', 609: 'SIMETHICONE', 610: 'CHARCOAL', 611: 'DEHYDROCHOLIC', 612: 'MESALAMINE', 613: 'OLSALAZINE', 614: 'DEMECLOCYCLINE', 615: 'OXYTETRACYCLINE', 616: 'SULFAMETHIZOLE', 617: 'RIFABUTIN', 618: 'ETHIONAMIDE', 619: 'CYCLOSERINE', 620: 'PAROMOMYCIN', 621: 'IODOQUINOL', 622: 'COLISTIN', 623: 'COLISTIMETHATE', 624: 'BACITRACIN', 625: 'ATOVAQUONE', 626: 'CLOFAZIMINE', 627: 'PYRANTEL', 628: 'PIPERAZINE', 629: 'METHYLENE', 630: 'CINOXACIN', 631: 'IMMUNE', 632: 'IMMUNEGLOBULIN', 633: 'HEPATITIS', 634: 'VARICELLA ZOSTER IMMUNE GLOBULIN', 635: 'RHO', 636: 'LYMPHOCYTE IMMUNE GLOBULIN', 637: 'DIPHTHERIA', 638: 'ANTIVENIN (CROTAIDAE)', 639: 'ANTIVENIN', 640: 'RABIES', 641: 'RABIES', 642: 'BCG', 643: 'STAPHAGE', 644: 'MENINGOCOCCAL POLYSACCHARIDE VACCINE', 645: 'TYPHOID', 646: 'HAEMOPHILUS B CONJUGATE VACCINE', 647: 'MEASLES', 648: 'RUBELLA', 649: 'MUMPS', 650: 'POLIOVIRUS VACCINE, LIVE', 651: 'POLIOVIRUS', 652: 'INFLUENZA VIRUS VACCINE', 653: 'YELLOW', 654: 'HEPATITIS', 655: 'TETANUS', 656: 'TUBERCULIN PURIFIED PROTEIN DERIVATIVE', 657: 'DIPIVEFRIN', 658: 'LEVOBUNOLOL', 659: 'ACETYLCHOLINE', 660: 'PILOCARPINE', 661: 'ECHOTHIOPHATE IODIDE OPHTHALMIC', 662: 'HOMATROPINE', 663: 'TROPICAMIDE', 664: 'CYCLOPENTOLATE', 665: 'SUPROFEN', 666: 'SULFACETAMIDE SODIUM OPHTHALMIC', 667: 'YELLOW MERCURIC OXIDE OPHTHALMIC', 668: 'TRIFLURIDINE', 669: 'TETRACAINE', 670: 'PROPARACAINE', 671: 'FLUORESCEIN', 672: 'SODIUMHYALURONATEOPHTHALMIC', 673: 'BORIC', 674: 'HYDROXYPROPYL METHLCELLULOSE OPHTHALMIC', 675: 'BOTULINUM TOXIN TYPE A', 676: 'CHLORHEXIDINE', 677: 'CARBAMIDE', 678: 'NYSTATIN', 679: 'BUTOCONAZOLE', 680: 'TIOCONAZOLE', 681: 'CLOTRIMAZOLE', 682: 'TERCONAZOLE', 683: 'GENTIAN', 684: 'SULFANILAMIDE', 685: 'CLINDAMYCIN', 686: 'NONOXYNOL', 687: 'OCTOXYNOL', 688: 'TRETINOIN', 689: 'ISOTRETINOIN', 690: 'BENZOYL', 691: 'ANTHRALIN', 692: 'NITROFURAZONE', 693: 'MAFENIDE', 694: 'SILVER', 695: 'PYRITHIONE', 696: 'SULFACETAMIDE', 697: 'CHLOROXINE', 698: 'MUPIROCIN', 699: 'ECONAZOLE', 700: 'CICLOPIROX', 701: 'TRIACETIN', 702: 'TOLNAFTATE', 703: 'SULCONAZOLE', 704: 'NAFTIFINE', 705: 'LINDANE', 706: 'PERMETHRIN', 707: 'CROTAMITON', 708: 'ALCLOMETASONE', 709: 'CLOBETASOL', 710: 'CLOCORTOLONE', 711: 'DESONIDE', 712: 'DESOXIMETASONE', 713: 'DIFLORASONE', 714: 'FLUOCINOLONE', 715: 'FLUOCINONIDE', 716: 'FLURANDRENOLIDE', 717: 'FLUTICASONE', 718: 'HALOBETASOL', 719: 'MOMETASONE', 720: 'DIBUCAINE', 721: 'BUTAMBEN', 722: 'PRAMOXINE', 723: 'DYCLONINE', 724: 'COCAINE', 725: 'SALICYLIC', 726: 'PODOPHYLLUM', 727: 'PODOFILOX', 728: 'TRICHLOROACETIC', 729: 'SUTILAINS', 730: 'COLLAGENASE', 731: 'MASOPROCOL', 732: 'HYDROQUINONE', 733: 'FORMALDEHYDE', 734: 'CAPSAICIN', 735: 'ALUMINUM CHLORIDE HEXAHYDRATE', 736: 'MONOBENZONE', 737: 'ARNICA', 738: 'HEXACHLOROPHENE', 739: 'BENZALKONIUM', 740: 'SODIUM', 741: 'PHYSIOLOGICAL IRRIGATING SOLUTION', 742: 'MECHLORETHAMINE', 743: 'LOMUSTINE', 744: 'CARMUSTINE', 745: 'FLOXURIDINE', 746: 'THIOGUANINE', 747: 'FLUDARABINE', 748: 'MEGESTROL', 749: 'ESTRAMUSTINE', 750: 'LEUPROLIDE', 751: 'GOSERELIN', 752: 'PENTOSTATIN', 753: 'PLICAMYCIN', 754: 'INTERFERON', 755: 'INTERFERON', 756: 'ALTRETAMINE', 757: 'HYDROXYUREA', 758: 'ALDESLEUKIN', 759: 'PACLITAXEL', 760: 'MITOTANE', 761: 'ASPARAGINASE', 762: 'ETHANOLAMINE', 763: 'SODIUM', 764: 'MORRHUATE', 765: 'BETA-CAROTENE', 766: 'YOHIMBINE', 767: 'ALPROSTADIL', 768: 'DISULFIRAM', 769: 'HYALURONIDASE', 770: 'PROCAINE', 771: 'CHLOROPROCAINE', 772: 'PRILOCAINE', 773: 'MEPIVACAINE', 774: 'DEFEROXAMINE', 775: 'SODIUM', 776: 'NALTREXONE', 777: 'FLUMAZENIL', 778: 'PRALIDOXIME', 779: 'DIGOXIN', 780: 'MESNA', 781: 'IPECAC', 782: 'TRIENTINE', 783: 'SUCCIMER', 784: 'AMBENONIUM', 785: 'GUANIDINE', 786: 'POTASSIUM', 787: 'POTASSIUM', 788: 'FLAVOXATE', 789: 'BETHANECHOL', 790: 'DIMETHYL', 791: 'ACETOHYDROXAMIC', 792: 'METHOXSALEN', 793: 'IOPANOIC', 794: 'BARIUM', 795: 'GADOPENTETATE', 796: 'IODAMIDE', 797: 'IOHEXOL', 798: 'IOPAMIDOL', 799: 'IOVERSOL', 800: 'METRIZAMIDE', 801: 'DIATRIZOATE', 802: 'IOTHALAMATE', 803: 'ETHIODIZED', 804: 'ISOSULFAN', 805: 'PHOSPHORATED CARBOHYDRATE', 806: 'DESFLURANE', 807: 'PLASMA', 808: 'ALBUMIN', 809: 'HETASTARCH', 810: 'POTASSIUM', 811: 'CLADRIBINE', 812: 'DIPHTHERIA-TETANUS TOXOIDS', 813: 'DIPHTHERIA/PERTUSSIS', 814: 'MEASLES-RUBELLA', 815: 'MEASELS/MUMPS/RUBELLA VIRUS VACCINE', 816: 'INTERFERON', 817: 'NORGESTREL', 818: 'ENOXAPARIN', 819: 'LORATADINE', 820: 'INTERFERON', 821: 'HYDROCHLOROTHIAZIDE-TRIAMTERENE', 822: 'AMYLASE', 823: 'ATTAPULGITE', 824: 'BENZOIC', 825: 'BUTALBITAL', 826: 'CASANTHRANOL', 827: 'CITRIC', 828: 'DICHLORALPHENAZONE', 829: 'HYDROCODONE', 830: 'ISOMETHEPTENE', 831: 'PEPSIN', 832: 'PHENIRAMINE', 833: 'PHENYLTOLOXAMINE', 834: 'SALICYLAMIDE', 835: 'SODIUM', 836: 'SODIUM', 837: 'SODIUM', 838: 'JAPANESE ENCEPHALITIS VIRUS VACCINE', 839: 'DIPTH/PERTUSSIS, ACEL/TETANUS', 840: 'NEDOCROMIL', 841: 'DEXTRAN,', 842: 'DEXTRAN,HIGHMOLECULARWEIGHT', 843: 'BISMUTH', 844: 'MUROMONAB-CD3', 845: 'DIHYDROTACHYSTEROL', 846: 'CALCITRIOL', 847: 'ERGOCALCIFEROL', 848: 'CHOLECALCIFEROL', 849: 'THIAMINE', 850: 'HYDROXOCOBALAMIN', 851: 'PHYTONADIONE', 852: 'VITAMIN', 853: 'CALCIUM-VITAMIN', 854: 'MULTIVITAMIN', 855: 'MULTIVITAMIN', 856: 'MULTIVITAMIN', 857: 'MULTIVITAMIN', 858: 'MULTIVITAMIN,', 859: 'TRIFLUPROMAZINE', 860: 'DOXYLAMINE', 861: 'PAROXETINE', 862: 'RIMANTADINE', 863: 'CHOLINE', 864: 'SUMATRIPTAN', 865: 'ALCOHOL', 866: 'PIPERACILLIN-TAZOBACTAM', 867: 'CISAPRIDE', 868: 'DIHYDROCODEINE', 869: 'TRIMETREXATE', 870: 'FELBAMATE', 871: 'GRANISETRON', 872: 'DORNASE', 873: 'TACRINE', 874: 'RISPERIDONE', 875: 'VENLAFAXINE', 876: 'GABAPENTIN', 877: 'FLUVASTATIN', 878: 'LEVOMETHADYL', 879: 'TORSEMIDE', 880: 'OXICONAZOLE', 881: 'TERBINAFINE', 882: 'ZINC', 883: 'AMILORIDE-HYDROCHLOROTHIAZIDE', 884: 'MICONAZOLE', 885: 'GENTAMICIN', 886: 'BETAMETHASONE', 887: 'ERYTHROMYCIN', 888: 'ACYCLOVIR', 889: 'KETOCONAZOLE', 890: 'MINOXIDIL', 891: 'FLUOROURACIL', 892: 'HYDROCORTISONE', 893: 'TRIAMCINOLONE', 894: 'AMPHOTERICIN', 895: 'METRONIDAZOLE', 896: 'SELENIUM', 897: 'CIPROFLOXACIN', 898: 'ATROPINE', 899: 'DICLOFENAC', 900: 'KETOROLAC', 901: 'PREDNISOLONE', 902: 'TOBRAMYCIN', 903: 'NEOMYCIN', 904: 'SALIVA', 905: 'FLUOROMETHOLONE', 906: 'LODOXAMIDE', 907: 'LEVOCABASTINE', 908: 'TRIPLE', 909: 'VITAMINS', 910: 'VITAMIN', 911: 'ETHINYL ESTRADIOL-NORGESTREL', 912: 'MESTRANOL-NORETHINDRONE', 913: 'ETHINYL', 914: 'ETHINYL ESTRADIOL-LEVONORGESTREL', 915: 'ESTERFIED ESTROGENS-METHYLTESTOSTERONE', 916: 'HYDROCHLOROTHIAZIDE-SPIRONOLACTONE', 917: 'HYDROCHLOROTHIAZIDE-RESERPINE', 918: 'BENDROFLUMETHIAZIDE-RAUWOLFIA SERPENTINA', 919: 'HYDRALAZNEHYDROCHOROTHAZDERESERPNE', 920: 'HYDRALAZINE-HYDROCHLOROTHIAZIDE', 921: 'ATENOLOL-CHLORTHALIDONE', 922: 'BENDROFLUMETHIAZIDE-NADOLOL', 923: 'HYDROCHLOROTHIAZIDE-TIMOLOL', 924: 'HYDROCHLOROTHIAZIDE-PROPRANOLOL', 925: 'HYDROCHLOROTHIAZIDE-METHYLDOPA', 926: 'HYDROCHLOROTHIAZIDE-METOPROLOL', 927: 'BENAZEPRIL-HYDROCHLOROTHIAZIDE', 928: 'D03266HYDROCHLOROTHIAZIDE-LISINOPRIL', 929: 'CHLORTHALIDONE-CLONIDINE', 930: 'PHENIRAMINE-PHENYLEPHRINE', 931: 'GUAIFENESIN-THEOPHYLLINE', 932: 'AMINOPHYLLINE-GUAIFENESIN', 933: 'DYPHYLLINE-GUAIFENESIN', 934: 'POTASSIUM', 935: 'EPHEDRINE/PHENOBARBITAL/THEOPHYLLINE', 936: 'EPHEDRINE/HYDROXYZINE/THEOPHYLLINE', 937: 'ACETAMINOPHEN-PSEUDOEPHEDRINE', 938: 'IBUPROFEN-PSEUDOEPHEDRINE', 939: 'APAP/ASA/PPA', 940: 'ACETAMINOPHEN-CHLORPHENIRAMINE', 941: 'ACETAMINOPHEN-PHENYLTOLOXAMINE', 942: 'CHLORPHENIRAMINE-PSEUDOEPHEDRINE', 943: 'CHLORPHENIRAMINE-PHENYLPROPANOLAMINE', 944: 'CHLORPHENIRAMINE-PHENYLEPHRINE', 945: 'BROMPHENIRAMINE-PSEUDOEPHEDRINE', 946: 'BROMPHENIRAMINE-PHENYLPROPANOLAMINE', 947: 'CLEMASTINE-PHENYLPROPANOLAMINE', 948: 'CHLORPHENIRAMINE/PE/PHENYLTOLOXAMINE', 949: 'CHLORPHENIRAMINE/PHENINDAMINE/PPA', 950: 'PHENIRAMINE/PPA/PHENYLTOLOXAMINE/PYRILAMINE', 951: 'CHLORPHENIRAMINE/PE/PPA/PHENYLTOLOXAMINE', 952: 'D03311BROMPHENIRAMINE-PHENYLEPHRINE', 953: 'DIPHENHYDRAMINE-PSEUDOEPHEDRINE', 954: 'CHLORPHENIRAMINE/PHENYLEPHRINE/PYRILAMINE', 955: 'PSEUDOEPHEDRINE-TRIPROLIDINE', 956: 'PHENYLEPHRINE-PROMETHAZINE', 957: 'PHENIRAMINE/PPA/PYRILAMINE', 958: 'APAP/CHLORPHENIRAMINE/PHENYLPROPANOLAMINE', 959: 'APAP/CHLORPHENIRAMINE/PSEUDOEPHEDRINE', 960: 'APAP/BROMPHENIRAMINE/PSEUDOEPHEDRINE', 961: 'ASA/CHLORPHENIRAMINE/PHENYLPROPANOLAMINE', 962: 'ASA/DIPHENHYDRAMINE/PPA', 963: 'APAP/PSEUDOEPHEDRINE/TRIPROLIDINE', 964: 'APAP/CHLORPHENIRAMINE/PHENYLEPHRINE', 965: 'APAP/CPM/PHENYLEPHRINE/PPA/PYRILAMINE', 966: 'CHLORPHENIRAMINE/METHSCOPOLAMINE/PE', 967: 'HOMATROPINE-HYDROCODONE', 968: 'CODEINE-PSEUDOEPHEDRINE', 969: 'APAP/DEXTROMETHORPHAN/PSEUDOEPHEDRINE', 970: 'APAP/CHLORPHENIRAMINE/DEXTROMETHORPHAN/PSE', 971: 'APAP/DEXTROMETHORPHAN/DOXYLAMINE/PSE', 972: 'ASA/BROMPHENIRAMINE/DEXTROMETHORPHAN/PPA', 973: 'HYDROCODONE-PSEUDOEPHEDRINE', 974: 'HYDROCODONE-PHENYLPROPANOLAMINE', 975: 'DEXTROMETHORPHAN-PSEUDOEPHEDRINE', 976: 'DEXTROMETHORPHAN-PHENYLPROPANOLAMINE', 977: 'CHLORPHENIRAMINE-HYDROCODONE', 978: 'CODEINE-PROMETHAZINE', 979: 'CHLORPHENIRAMINE-DEXTROMETHORPHAN', 980: 'DEXTROMETHORPHAN-PROMETHAZINE', 981: 'CHLORPHENIRAMINE/HYDROCODONE/PHENYLEPHRINE', 982: 'CHLORPHENIRAMINE/CODEINE/PSEUDOEPHEDRINE', 983: 'CODEINE/PHENYLEPHRINE/PROMETHAZINE', 984: 'HYDROCODONE/PHENYLEPHRINE/PYRILAMINE', 985: 'BROMPHENIRAMINE/DEXTROMETHORPHAN/PSE', 986: 'CHLORPHENIRAMINE/DEXTROMETHORP/PHENYLEPHRINE', 987: 'CHLORPHENIRAMINE/DEXTROMETHORPHAN/PSE', 988: 'DEXTROMETHORPHAN/PHENYLEPHRINE/PYRILAMINE', 989: 'BROMPHENIRAMINE/DEXTROMETHORPHAN/PPA', 990: 'ACETAMINOPHEN-DEXTROMETHORPHAN', 991: 'GUAIFENESIN-PSEUDOEPHEDRINE', 992: 'EPHEDRINE-GUAIFENESIN', 993: 'GUAIFENESIN-PHENYLEPHRINE', 994: 'GUAIFENESIN-PHENYLPROPANOLAMINE', 995: 'GUAIFENESIN/PHENYLEPHRINE/PPA', 996: 'ETHINYL', 997: 'ESTRADIOL-TESTOSTERONE', 998: 'CHLORPHENIRAMINE/GUAIFENESIN/PHENYLEPHRINE', 999: 'CODEINE-GUAIFENESIN', 1000: 'GUAIFENESIN-HYDROCODONE', 1001: 'GUAIFENESIN-HYDROMORPHONE', 1002: 'CODEINE/GUAIFENESIN/PSE', 1003: 'D03400DEXTROMETHORPHAN-GUAIFENESIN', 1004: 'GUAIFENESIN/HYDROCODONE/PHENYLEPHRINE', 1005: 'GUAIFENESIN/HYDROCODONE/PSEUDOEPHEDRINE', 1006: 'CODEINE/GUAIFENESIN/PHENYLPROPANOLAMINE', 1007: 'DEXTROMETHORPHAN/GUAIFENESIN/PHENYLEPHRINE', 1008: 'DEXTROMETHORPHAN/GUAIFENESIN/PSEUDOEPHEDRINE', 1009: 'DEXTROMETHORPHAN/GUAIFENESIN/PPA', 1010: 'CHLORPHENIRAMINE/HYDROCODONE/PSE', 1011: 'CHLORPHENIRAMINE/DM/GUAIFENESIN/PHENYLEPHRINE', 1012: 'ACETAMINOPHEN-CODEINE', 1013: 'ASPIRIN-CODEINE', 1014: 'APAP/BUTALBITAL/CAFFEINE/CODEINE', 1015: 'ASA/BUTALBITAL/CAFFEINE/CODEINE', 1016: 'ACETAMINOPHEN-HYDROCODONE', 1017: 'ASA/CAFFEINE/DIHYDROCODEINE', 1018: 'ACETAMINOPHEN-OXYCODONE', 1019: 'ASPIRIN-OXYCODONE', 1020: 'MEPERIDINE-PROMETHAZINE', 1021: 'ACETAMINOPHEN-PROPOXYPHENE', 1022: 'ASA/CAFFEINE/PROPOXYPHENE', 1023: 'BELLADONNA-OPIUM', 1024: 'APAP/ASA/CAFFEINE/SALICYLAMIDE', 1025: 'APAP/ASA/CAFFEINE', 1026: 'HYDROXIDE/ASA/CAFFEINE/MG HYDROXIDE', 1027: 'D03445ACETAMINOPHEN-DIPHENHYDRAMINE', 1028: 'ASA/CAFFEINE/SALICYLAMIDE', 1029: 'ASPIRIN-MEPROBAMATE', 1030: 'ASPIRIN-CAFFEINE', 1031: 'ASPIRIN-PHENYLTOLOXAMINE', 1032: 'MAGNESIUM SALICYLATE-PHENYLTOLOXAMINE', 1033: 'APAP/BUTALBITAL/CAFFEINE', 1034: 'ACETAMINOPHEN-BUTALBITAL', 1035: 'ASA/BUTALBITAL/CAFFEINE', 1036: 'APAP/DICHLORALPHENAZONE/ISOMETHEPTENE', 1037: 'AMITRIPTYLINE-CHLORDIAZEPOXIDE', 1038: 'AMITRIPTYLINE-PERPHENAZINE', 1039: 'DROPERIDOL-FENTANYL', 1040: 'ASPIRIN-METHOCARBAMOL', 1041: 'ASPIRIN-CARISOPRODOL', 1042: 'ASA/CARISOPRODOL/CODEINE', 1043: 'ASA/CAFFEINE/ORPHENADRINE', 1044: 'CARBIDOPA-LEVODOPA', 1045: 'ALUMINUMHYDROXIDE-MAGNESIUM HYDROXIDE', 1046: 'AL HYDROXIDE/MG HYDROXIDE/SIMETHICONE', 1047: 'CA CARBONATE/MG HYDROXIDE/SIMETHICONE', 1048: 'ATROPINE/HYOSCYAMINE/PB/SCOPOLAMINE', 1049: 'BELLADONNA-BUTABARBITAL', 1050: 'CHLORDIAZEPOXIDE-CLIDINIUM', 1051: 'BELLADONNA/ERGOTAMINE/PHENOBARBITAL', 1052: 'DOCUSATE-SENNA', 1053: 'DOCUSATE-PHENOLPHTHALEIN', 1054: 'CASANTHRANOL-DOCUSATE', 1055: 'ATROPINE-DIFENOXIN', 1056: 'ATROPINE-DIPHENOXYLATE', 1057: 'ISONIAZID-RIFAMPIN', 1058: 'ERYTHROMYCIN-SULFISOXAZOLE', 1059: 'PHENAZOPYRIDINE-SULFAMETHOXAZOLE', 1060: 'METHENAMINE-SODIUM ACID PHOSPHATE', 1061: 'BENZOIC ACID/METHENAMINE/SODIUM SALICYLATE', 1062: 'NAPHAZOLINE-PHENIRAMINE OPHTHALMIC', 1063: 'CYCLOPENTOLATE-PHENYLEPHRINE OPHTHALMIC', 1064: 'HYDROXYAMPHETAMINE-TROPICAMIDE OPHTHALMIC', 1065: 'BACITRACIN/NEOMYCIN/POLYMYXIN B TOPICAL', 1066: 'GRAMICIDIN/NEOMYCIN/POLYMYXIN B OPHTHALMIC', 1067: 'NEOMYCIN-POLYMYXIN B SULFATE TOPICAL', 1068: 'BACITRACIN-POLYMYXIN', 1069: 'POLYMYXIN B-TRIMETHOPRIM OPHTHALMIC', 1070: 'NEOMYCIN/POLYMYXIN B/PREDNISOLONE OPHTHALMIC', 1071: 'DEXAMETHASONE-TOBRAMYCIN OPHTHALMIC', 1072: 'DEXAMETHASONE/NEOMYCIN/POLYMYXIN B OPHTHALMIC', 1073: 'PREDNISOLONE-SULFACETAMIDE SODIUM OPHTHALMIC', 1074: 'PREDNISOLONE-SULFACETAMIDE SODIUM OPHTHALMIC', 1075: 'FLUORESCEIN-PROPARACAINE OPHTHALMIC', 1076: 'HYDROCORTISONE/NEOMYCIN/POLYMYXIN B OTIC', 1077: 'HYDROCORTISONE-PRAMOXINE TOPICAL', 1078: 'CLIOQUINOL-HYDROCORTISONE TOPICAL', 1079: 'CLIOQUINOL/HYDROCORTISONE/PRAMOXINE TOPICAL', 1080: 'BETAMETHASONE-CLOTRIMAZOLE TOPICAL', 1081: 'NYSTATIN-TRIAMCINOLONE', 1082: 'CAPTOPRIL-HYDROCHLOROTHIAZIDE', 1083: 'CARBINOXAMINE', 1084: 'CARBINOXAMINE-PSEUDOEPHEDRINE', 1085: 'CARAMIPHEN-PHENYLPROPANOLAMINE', 1086: 'BROMODIPHENHYDRAMINE-CODEINE', 1087: 'CARBINOXAMINE/DEXTROMETHORPHAN/PSE', 1088: 'CODEINE/PHENIRAMINE/PHENYLEPHRINE/NA CITRATE', 1089: 'PAMABROM', 1090: 'APAP/PAMABROM/PYRILAMINE', 1091: 'MAGNESIUM', 1092: 'ALGINIC ACID/AL HYDROXIDE/MG CARBONATE', 1093: 'ALGINIC ACID/AL HYDROXIDE/MG TRISILICATE', 1094: 'POTASSIUM', 1095: 'PSYLLIUM-SENNA', 1096: 'HYOSCYAMINE/METHENAM/M-BLUE/PHENYL SALICYL', 1097: 'ANTAZOLINE-NAPHAZOLINE OPHTHALMIC', 1098: 'BENOXINATE-FLUORESCEIN OPHTHALMIC', 1099: 'ACETIC', 1100: 'ANTIPYRINE', 1101: 'ACETIC ACID-HYDROCORTISONE OTIC', 1102: 'ANTIPYRINE-BENZOCAINE', 1103: 'ANTIPYRINE/BENZOCAINE/PHENYLEPHRINE OTIC', 1104: 'ANHYDROUS CALCIUM IODIDE-CODEINE', 1105: 'CETYLPYRIDINIUM', 1106: 'BENZOCAINE-CETYLPYRIDINIUM TOPICAL', 1107: 'BUDESONIDE', 1108: 'PETROLATUM', 1109: 'LACTOBACILLUS', 1110: 'LACTOBACILLUS ACIDOPHILUS AND BULGARICUS', 1111: 'ISOPROPYL', 1112: 'OPHTHALMIC IRRIGATION, INTRAOCULAR', 1113: 'BENZOIN', 1114: 'CANDIDA', 1115: 'CHOLINE SALICYLATE-MAGNESIUM SALICYLATE', 1116: 'COLCHICINE-PROBENECID', 1117: 'CALAMINE', 1118: 'LIDOCAINE-PRILOCAINE', 1119: 'ETHYL', 1120: 'FIBRINOLYSIN AND DESOXYRIBONUCLEASE TOPICAL', 1121: 'MULTIVITAMIN WITH IRON AND FLUORIDE', 1122: 'DOCUSATE-FERROUS', 1123: 'LECITHIN', 1124: 'PHENOL', 1125: 'MENTHOL', 1126: 'MENTHOL-PHENOL', 1127: 'METHACHOLINE', 1128: 'METHYL', 1129: 'PECTIN', 1130: 'NALOXONE-PENTAZOCINE', 1131: 'NAPHAZOLINE-ZINC', 1132: 'ASA/CITRIC', 1133: 'OPHTHALMIC IRRIGATION, EXTRAOCULAR', 1134: 'ACETAMINOPHEN-PENTAZOCINE', 1135: 'THROMBIN', 1136: 'UNDECYLENIC', 1137: 'ALUMINUM', 1138: 'ALUMINUM', 1139: 'CALCIUM', 1140: 'ALUMINUM SULFATE-CALCIUM ACETATE TOPICAL', 1141: 'BENZOCAINE/PHENOL/POVIDONE IODINE TOPICAL', 1142: 'ICHTHAMMOL TOPICAL', 1143: 'MEDRYSONE OPHTHALMIC', 1144: 'PRAMOXINE-ZINC OXIDE TOPICAL', 1145: 'BENZYL BENZOATE TOPICAL', 1146: 'CORN STARCH TOPICAL', 1147: 'SULFUR TOPICAL', 1148: 'COAL TAR TOPICAL', 1149: 'SALICYLIC ACID-SULFUR TOPICAL', 1150: 'ALOE VERA TOPICAL', 1151: 'LANOLIN-MINERAL OIL TOPICAL', 1152: 'ALLANTOIN/CAMPHOR/PHENOL TOPICAL', 1153: 'CAMPHOR TOPICAL', 1154: 'CAMPHOR-PHENOL TOPICAL', 1155: 'CITRIC ACID/GLUCONODELTA-LACTONE/MG CARBONATE', 1156: 'SODIUM IODIDE', 1157: 'FAT EMULSION, INTRAVENOUS', 1158: 'INTRAVENOUS ELECTROLYTE SOLUTION', 1159: 'TRIETHANOLAMINE POLYPEPTIDE OLEATE OTIC', 1160: 'TETRACYCLINE TOPICAL', 1161: 'NIACINAMIDE', 1162: 'ENALAPRIL-HYDROCHLOROTHIAZIDE', 1163: 'PYRIMETHAMINE-SULFADOXINE', 1164: 'BISOPROLOL-HYDROCHLOROTHIAZIDE', 1165: 'DEXBROMPHENIRAMINE', 1166: 'DEXBROMPHENIRAMINE-PSEUDOEPHEDRINE', 1167: 'TACROLIMUS', 1168: 'ACRIVASTINE-PSEUDOEPHEDRINE', 1169: 'BACITRACIN TOPICAL', 1170: 'SALMETEROL', 1171: 'DIPHENHYDRAMINE TOPICAL', 1172: 'LANOLIN TOPICAL', 1173: 'WITCH HAZEL TOPICAL', 1174: 'GLYCERIN-PHENOL TOPICAL', 1175: 'GLYCERIN-WITCH HAZEL TOPICAL', 1176: 'ROCURONIUM', 1177: 'IRON DEXTRAN', 1178: 'OCULAR LUBRICANT', 1179: 'EMOLLIENTS, TOPICAL', 1180: 'STAVUDINE', 1181: 'DOXEPIN TOPICAL', 1182: 'FAMCICLOVIR', 1183: 'POTASSIUM ACETATE', 1184: 'DESOGESTREL', 1185: 'ETHINYL ESTRADIOL-NORGESTIMATE', 1186: 'DESOGESTREL-ETHINYL ESTRADIOL', 1187: 'BUPIVACAINE-EPINEPHRINE', 1188: 'EPINEPHRINE-LIDOCAINE', 1189: 'CALCIPOTRIENE TOPICAL', 1190: 'POTASSIUM GLUCONATE', 1191: 'POTASSIUM PHOSPHATE', 1192: 'MAGNESIUM CHLORIDE', 1193: 'MAGNESIUM OXIDE', 1194: 'MAGNESIUM GLUCONATE', 1195: 'CALCIUM CHLORIDE', 1196: 'CALCIUM GLUCONATE', 1197: 'CALCIUM LACTATE', 1198: 'CALCIUM PHOSPHATE, TRIBASIC', 1199: 'FLUVOXAMINE', 1200: 'DORZOLAMIDE OPHTHALMIC', 1201: 'ALBENDAZOLE', 1202: 'METFORMIN', 1203: 'NEFAZODONE', 1204: 'LAMOTRIGINE', 1205: 'VINORELBINE', 1206: 'ABCIXIMAB', 1207: 'DALTEPARIN', 1208: 'LORATADINE-PSEUDOEPHEDRINE', 1209: 'CONJUGATED ESTROGENS-MEDROXYPROGESTERONE', 1210: 'LOSARTAN', 1211: 'FERROUS GLUCONATE', 1212: 'IRON POLYSACCHARIDE', 1213: 'FERROUS SULFATE', 1214: 'NISOLDIPINE', 1215: 'TRAMADOL', 1216: 'CETIRIZINE', 1217: 'LANSOPRAZOLE', 1218: 'AMLODIPINE-BENAZEPRIL', 1219: 'HYDROCHLOROTHIAZIDE-LOSARTAN', 1220: 'NILUTAMIDE', 1221: 'VARICELLA VIRUS VACCINE', 1222: 'DIVALPROEX SODIUM', 1223: 'NALMEFENE', 1224: 'MOEXIPRIL', 1225: 'ACITRETIN', 1226: 'VALACYCLOVIR', 1227: 'MYCOPHENOLATE MOFETIL', 1228: 'IOPROMIDE', 1229: 'DEXRAZOXANE', 1230: 'EPOPROSTENOL', 1231: 'GADOTERIDOL', 1232: 'DIRITHROMYCIN', 1233: 'SEVOFLURANE', 1234: 'ACARBOSE', 1235: 'CARVEDILOL', 1236: 'AZELAIC ACID TOPICAL', 1237: 'ALENDRONATE', 1238: 'BICALUTAMIDE', 1239: 'BENZOYLPEROXIDE-ERYTHROMYCIN TOPICAL', 1240: 'LAMIVUDINE', 1241: 'SAQUINAVIR', 1242: 'MAGNESIUM AMINO ACIDS CHELATE', 1243: 'TRETINOIN', 1244: 'GLIMEPIRIDE', 1245: 'CALCIUM CITRATE', 1246: 'CALCIUM CARBONATE-SODIUM FLUORIDE', 1247: 'AMIFOSTINE', 1248: 'RILUZOLE', 1249: 'AMPHOTERICIN B LIPID COMPLEX', 1250: 'PORFIMER', 1251: 'ANASTROZOLE', 1252: 'CEFTIBUTEN', 1253: 'HEROIN', 1254: 'COCAINE', 1255: 'MARIJUANA', 1256: 'PHENCYCLIDINE', 1257: 'RESPIRATORY SYNCYTIAL VIRUS IMMUNE GLOBULIN', 1258: 'CEFEPIME', 1259: 'AL HYDROX CARBONATE CARBONATE/MG HYDROXIDE HYDROXIDECARBONATE/MG HYDROXIDE/MG HYDROXIDEIDE/ASA/CA', 1260: 'TROLAMINE SALICYLATE TOPICAL', 1261: 'BENZOCAINE/BUTAMBEN/TETRACAINE', 1262: 'HISTAMINE PHOSPHATE', 1263: 'KAOLIN-PECTIN', 1264: 'SINCALIDE', 1265: 'LACTASE', 1266: 'SODIUM CHLORIDE, HYPERTONIC OPHTHALMIC', 1267: 'BALSAMPERU/CASTOROIL/TRYPSIN TOPICAL', 1268: 'ISOPROTERENOL-PHENYLEPHRINE', 1269: 'PHENIRAMINE/PHENYLTOLOXAMINE/PYRILAMINE', 1270: 'APAP/CHLORPHENIRAMINE/DEXTROMETHORPHAN/PPA', 1271: 'CHLORPHENIRAMINE/METHSCOPOLAMINE/PSE', 1272: 'APAP/DEXTROMETHORPHAN/PSE/PYRILAMINE', 1273: 'HYDROCODONE-POTASSIUM GUAIACOLSULFONATE', 1274: 'FERROUS FUMARATE', 1275: 'ACETAMINOPHEN-CAFFEINE', 1276: 'ACETAMINOPHEN-PHENYLEPHRINE', 1277: 'APAP/CAFFEINE/PYRILAMINE', 1278: 'BACITRACIN OPHTHALMIC', 1279: 'AMINOPHYLLINE/AMOBARBITAL/EPHEDRINE', 1280: 'ASCORBIC ACID-FERROUS FUMARATE', 1281: 'CITRIC ACID/K CITRATE/NA CITRATE', 1282: 'CITRIC ACID-SODIUM CITRATE', 1283: 'ELECTROLYTE REPLACEMENT SOLUTIONS, ORAL', 1284: 'FERROUS FUMARATE-FOLIC ACID', 1285: 'CALCIUM/FERROUS FUMARATE/VITAMIN D', 1286: 'POTASSIUM BICARBONATE-POTASSIUM CITRATE', 1287: 'BACITRACIN/HC/NEOMYCIN/POLYMYXIN B OPHTHALMIC', 1288: 'BACITRACIN/NEOMYCIN/POLYMYXIN B OPHTHALMIC', 1289: 'BACITRACIN-POLYMYXIN B OPHTHALMIC', 1290: 'BENZOYL PEROXIDE-SULFUR TOPICAL', 1291: 'DEXAMETHASONE OPHTHALMIC', 1292: 'EPINEPHRINE OPHTHALMIC', 1293: 'ERYTHROMYCIN OPHTHALMIC', 1294: 'GENTAMICIN OPHTHALMIC', 1295: 'GLYCERIN OPHTHALMIC', 1296: 'HYDROCORTISONE OTIC', 1297: 'OFLOXACIN OPHTHALMIC', 1298: 'OXYMETAZOLINE OPHTHALMIC', 1299: 'SCOPOLAMINE OPHTHALMIC', 1300: 'SULFISOXAZOLE OPHTHALMIC', 1301: 'TETRACAINE OPHTHALMIC', 1302: 'TETRACAINE TOPICAL', 1303: 'RITONAVIR', 1304: 'INDINAVIR', 1305: 'BORIC ACID OPHTHALMIC', 1306: 'CARBAMIDE PEROXIDE OTIC', 1307: 'CHLORAMPHENICOL OPHTHALMIC', 1308: 'CHLORTETRACYCLINEOPHTHALMIC', 1309: 'COLLOIDAL OATMEAL TOPICAL', 1310: 'STERILE WATER', 1311: 'PIPERONYL BUTOXIDE-PYRETHRINS TOPICAL', 1312: 'HYDROGEN PEROXIDE TOPICAL', 1313: 'DOXORUBICIN LIPOSOMAL', 1314: 'AMOBARBITAL-SECOBARBITAL', 1315: 'DEXFENFLURAMINE', 1316: 'TRANDOLAPRIL', 1317: 'DOCETAXEL', 1318: 'GEMCITABINE', 1319: 'INTERFERON BETA-1A', 1320: 'TERBINAFINE', 1321: 'TOPOTECAN', 1322: 'ADAPALENE TOPICAL', 1323: 'IODIXANOL', 1324: 'LATANOPROST OPHTHALMIC', 1325: 'BENZOIC ACID-SALICYLIC ACID TOPICAL', 1326: 'MIRTAZAPINE', 1327: 'IRINOTECAN', 1328: 'MEROPENEM', 1329: 'CIDOFOVIR', 1330: 'NEVIRAPINE', 1331: 'PILOCARPINE', 1332: 'SULFACETAMIDE SODIUM-SULFUR TOPICAL', 1333: 'REMIFENTANIL', 1334: 'AMPHETAMINE-DEXTROAMPHETAMINE', 1335: 'CAFFEINE-SODIUM BENZOATE', 1336: 'TIMOLOL OPHTHALMIC', 1337: 'BETAXOLOL OPHTHALMIC', 1338: 'CARTEOLOL OPHTHALMIC', 1339: 'FEXOFENADINE', 1340: 'FOSPHENYTOIN', 1341: 'FOLLICLE STIMULATING HORMONE', 1342: 'RESORCINOL TOPICAL', 1343: 'RESORCINOL-SULFUR TOPICAL', 1344: 'MIDODRINE', 1345: 'BRIMONIDINE OPHTHALMIC', 1346: 'AMMONIUM LACTATE TOPICAL', 1347: 'OLANZAPINE', 1348: 'ROPIVACAINE', 1349: 'PENTOSAN POLYSULFATE SODIUM', 1350: 'ZAFIRLUKAST', 1351: 'PENCICLOVIR TOPICAL', 1352: 'ZINC GLUCONATE', 1353: 'ZINC SULFATE', 1354: 'MELATONIN', 1355: 'HAEMOPHILUS B-HEPATITIS VACCINE', 1356: 'DILTIAZEM-ENALAPRIL', 1357: 'BISMUTH SUBSALICYLATE/METRONIDAZOLE/TCN', 1358: 'BENTOQUATAM TOPICAL', 1359: 'BUTENAFINE TOPICAL', 1360: 'TRANDOLAPRIL-VERAPAMIL', 1361: 'ALBUTEROL-IPRATROPIUM', 1362: 'RETEPLASE', 1363: 'AZELASTINE NASAL', 1364: 'SODIUM PHENYLBUTYRATE', 1365: 'CHLOROXYLENOL TOPICAL', 1366: 'CHLOROXYLENOL/HYDROCORTISONE/PRAMOXINE OTIC', 1367: 'GADODIAMIDE', 1368: 'GLYCINE IRRIGATION', 1369: 'LACTIC ACID TOPICAL', 1370: 'HYDROCORTISONE-IODOQUINOL TOPICAL', 1371: 'HYDROCORTISONE/NEOMYCIN/POLYMYXIN B OPHTH', 1372: 'IMIGLUCERASE', 1373: 'DONEPEZIL', 1374: 'AMPHOTERICIN B CHOLESTERYL SULFATE', 1375: 'IVERMECTIN', 1376: 'TIZANIDINE', 1377: 'ZILEUTON', 1378: 'ATORVASTATIN', 1379: 'FOSFOMYCIN', 1380: 'AMLEXANOX TOPICAL', 1381: 'LEVOFLOXACIN', 1382: 'MIGLITOL', 1383: 'GLATIRAMER', 1384: 'CABERGOLINE', 1385: 'VALSARTAN', 1386: 'TOPIRAMATE', 1387: 'ENALAPRIL-FELODIPINE', 1388: 'OLOPATADINE OPHTHALMIC', 1389: 'NELFINAVIR', 1390: 'DELAVIRDINE', 1391: 'CAFFEINE-ERGOTAMINE', 1392: 'TAMSULOSIN', 1393: 'TROGLITAZONE', 1394: 'ZINC ACETATE', 1395: 'IMIQUIMOD TOPICAL', 1396: 'ANAGRELIDE', 1397: 'LVP SOLUTION', 1398: 'LVP SOLUTION WITH HYPERTONIC SALENE', 1399: 'PARENTERAL NUTRITION SOLUTION', 1400: 'PARENTERAL NUTRITION SOLUTION W/ ELECTROLYTES', 1401: 'NEOMYCIN OPHTHALMIC', 1402: 'POLYMYXIN B OPHTHALMIC', 1403: 'PHENYLEPHRINE OPHTHALMIC', 1404: 'TOREMIFENE', 1405: 'TAZAROTENE TOPICAL', 1406: 'MIBEFRADIL', 1407: 'HYDROCHLOROTHIAZIDE-MOEXIPRIL', 1408: 'CHROMIUM PICOLINATE', 1409: 'ACETAMINOPHEN-PAMABROM', 1410: 'PRAMIPEXOLE', 1411: 'NAPHAZOLINE NASAL', 1412: 'BROMFENAC', 1413: 'BENZOCAINE-TRIMETHOBENZAMIDE', 1414: 'HYDROCODONE-PHENYLEPHRINE', 1415: 'PHENAZOPYRIDINE-SULFISOXAZOLE', 1416: 'ASPIRIN-DIPHENHYDRAMINE', 1417: 'LETROZOLE', 1418: 'LOPERAMIDE-SIMETHICONE', 1419: 'SORBITOL', 1420: 'SODIUM BIPHOSPHATE-SODIUM PHOSPHATE', 1421: 'SECRETIN', 1422: 'FERROUS SULFATE-FOLIC ACID', 1423: 'APAP/DEXTROMETHORPHAN/GUAIFENESIN/PSE', 1424: 'APAP/DIPHENHYDRAMINE/PSEUDOEPHEDRINE', 1425: 'CALAMINE-PRAMOXINE TOPICAL', 1426: 'DIPHENHYDRAMINE-MAGNESIUM SALICYLATE', 1427: 'FAT SUPPLEMENT, ORAL', 1428: 'CALCIUM HYDROXIDE TOPICAL', 1429: 'POTASSIUM AMINOBENZOATE', 1430: 'POTASSIUM BICARBONATE-SODIUM BICARBONATE', 1431: 'PHENYLEPHRINE NASAL', 1432: 'TRIPELENNAMINE TOPICAL', 1433: 'PAPAIN TOPICAL', 1434: 'PAPAIN-UREA TOPICAL', 1435: 'COLISTIN/HC/NEOMYCIN/THONZONIUM OTIC', 1436: 'LEVMETAMFETAMINE NASAL', 1437: 'PROPYLHEXEDRINE NASAL', 1438: 'CHLOROPHYLLIN', 1439: 'BACITRACIN/HC/NEOMYCIN/POLYMYXIN B TOPICAL', 1440: 'HYDROCORTISONE/NEOMYCIN/POLYMYXIN B TOPICAL', 1441: 'COPPER SULFATE', 1442: 'POVIDONE IODINE OPHTHALMIC', 1443: 'TETRAHYDROZOLINE NASAL', 1444: 'SILVER NITRATE TOPICAL', 1445: 'METHOXSALEN TOPICAL', 1446: 'ESTRADIOL TOPICAL', 1447: 'DOLASETRON', 1448: 'ROPINIROLE', 1449: 'EPINEPHRINE-PRILOCAINE', 1450: 'LAMIVUDINE-ZIDOVUDINE', 1451: 'QUETIAPINE', 1452: 'TIAGABINE', 1453: 'IRBESARTAN', 1454: 'MOMETASONE NASAL', 1455: 'INTERFERON ALFACON-1', 1456: 'HYDROCODONE-IBUPROFEN', 1457: 'AMINOSALICYLIC ACID', 1458: 'ACETIC ACID OTIC', 1459: 'GLYCERIN OTIC', 1460: 'VITAMIN A OPHTHALMIC', 1461: 'TRIAMCINOLONE NASAL', 1462: 'IPRATROPIUM NASAL', 1463: 'ETHANOL TOPICAL', 1464: 'AMPHOTERICIN B LIPOSOMAL', 1465: 'HYLAN G-F 20', 1466: 'POTASSIUM CHLORIDE-SODIUM CHLORIDE', 1467: 'SODIUM CHLORIDE NASAL', 1468: 'LIDOCAINE-OXYTETRACYCLINE', 1469: 'HYDROCHLOROTHIAZIDE-IRBESARTAN', 1470: 'PEGASPARGASE', 1471: 'METHYLCELLULOSE', 1472: 'CELLULOSE', 1473: 'ZOLMITRIPTAN', 1474: 'RITUXIMAB', 1475: 'CEFDINIR', 1476: 'CLOPIDOGREL', 1477: 'SIBUTRAMINE', 1478: 'RALOXIFENE', 1479: 'TROVAFLOXACIN', 1480: 'BECAPLERMIN TOPICAL', 1481: 'OFLOXACIN OTIC', 1482: 'EPROSARTAN', 1483: 'REPAGLINIDE', 1484: 'APAP/CAFFEINE/DIHYDROCODEINE', 1485: 'FEXOFENADINE-PSEUDOEPHEDRINE', 1486: 'DICLOFENAC-MISOPROSTOL', 1487: 'AMOXICILLIN/CLARITHROMYCIN/LANSOPRAZOLE', 1488: 'FOMEPIZOLE', 1489: 'BECLOMETHASONE NASAL', 1490: 'BUDESONIDE', 1491: 'FLUNISOLIDE NASAL', 1492: 'TOLCAPONE', 1493: 'FLUTICASONE NASAL', 1494: 'FLUTICASONE TOPICAL', 1495: 'NARATRIPTAN', 1496: 'FENOFIBRATE', 1497: 'CIPROFLOXACIN OTIC', 1498: 'CIPROFLOXACIN-HYDROCORTISONE OTIC', 1499: 'MONTELUKAST', 1500: 'CALCIUM CARBONATE-MAGNESIUM HYDROXIDE', 1501: 'LEPIRUDIN', 1502: 'LOTEPREDNOL OPHTHALMIC', 1503: 'HYDROCHLOROTHIAZIDE-VALSARTAN', 1504: 'TOLTERODINE', 1505: 'OXYMETHOLONE', 1506: 'STARCH TOPICAL', 1507: 'PHENYLEPHRINE-PRAMOXINE TOPICAL', 1508: 'PHENYLEPHRINE TOPICAL', 1509: 'SILDENAFIL', 1510: 'RISEDRONATE', 1511: 'BRINZOLAMIDE OPHTHALMIC', 1512: 'DORZOLAMIDE-TIMOLOL OPHTHALMIC', 1513: 'SACROSIDASE', 1514: 'CAPECITABINE', 1515: 'PARICALCITOL', 1516: 'BASILIXIMAB', 1517: 'TIROFIBAN', 1518: 'EPTIFIBATIDE', 1519: 'DIPHTHERIA/HAEMOPHILUS/PERTUSSIS,ACEL/TETANUS', 1520: 'INTERFERON ALFA-2B-RIBAVIRIN', 1521: 'CANDESARTAN', 1522: 'PALIVIZUMAB', 1523: 'RIZATRIPTAN', 1524: 'SODIUM HYALURONATE', 1525: ' THALIDOMIDE', 1526: 'CITALOPRAM', 1527: 'EPHEDRINE-POTASSIUM IODIDE', 1528: 'DEXTROMETHORPHAN-POTASSIUM GUAIACOLSULFONATE', 1529: 'INFLIXIMAB', 1530: 'ROTAVIRUS VACCINE', 1531: 'APAP/CAFFEINE/GUAIFENESIN/PHENYLEPHRINE', 1532: 'DOXYCYCLINE TOPICAL', 1533: 'LEFLUNOMIDE', 1534: 'COAL TAR/LACTIC ACID/SALICYLIC ACID TOPICAL', 1535: 'EFAVIRENZ', 1536: 'TRASTUZUMAB', 1537: 'HEMIN', 1538: 'SEVELAMER', 1539: 'TELMISARTAN', 1540: 'ETANERCEPT', 1541: 'SIMETHICONE COATED CELLULOSE', 1542: 'TANNIC ACID TOPICAL', 1543: 'INSULIN REGULAR', 1544: 'INSULIN ISOPHANE', 1545: 'INSULIN ZINC', 1546: 'INSULIN ZINC EXTENDED', 1547: 'INSULIN LISPRO', 1548: 'INSULINISOPHANE-INSULINREGULAR', 1549: 'ESTRADIOL-NORETHINDRONE', 1550: 'ABACAVIR', 1551: 'THYROTROPIN ALPHA', 1552: 'MODAFINIL', 1553: 'LYME DISEASE VACCINE', 1554: 'CELECOXIB', 1555: 'CILOSTAZOL', 1556: 'DENILEUKIN DIFTITOX', 1557: 'SODIUM FERRIC GLUCONATE COMPLEX', 1558: 'PENTASTARCH', 1559: 'LIVER DERIVATIVE COMPLEX', 1560: 'BUTABARBITAL/HYOSCYAMINE/PHENAZOPYRIDINE', 1561: 'CROMOLYN NASAL', 1562: 'CLOTRIMAZOLE TOPICAL', 1563: 'CONJUGATED ESTROGENS TOPICAL', 1564: 'FLUORIDE TOPICAL', 1565: 'NYSTATIN TOPICAL', 1566: 'CILASTATIN', 1567: 'TYPHOID VACCINE, LIVE', 1568: 'ECHINACEA', 1569: \"ST. JOHN'S WORT\", 1570: 'CHAMOMILE', 1571: 'FEVERFEW', 1572: 'GARLIC', 1573: 'GINSENG', 1574: 'GINKGO', 1575: 'GINGER', 1576: 'SAW PALMETTO', 1577: 'VALERIAN', 1578: 'CREATINE', 1579: 'GLUCOSAMINE', 1580: 'CHONDROITIN', 1581: 'CHONDROITIN-GLUCOSAMINE', 1582: 'EVENING PRIMROSE', 1583: 'KAVA', 1584: 'GOLDENSEAL', 1585: 'DEHYDROEPIANDROSTERONE', 1586: 'RED YEAST RICE', 1587: 'LEVALBUTEROL', 1588: 'ORLISTAT', 1589: 'BACITRACIN/NEOMYCIN/POLYMYXIN B/PRAMOXINE TOP', 1590: 'NEOMYCIN/POLYMYXINB/PRAMOXINE TOPICAL', 1591: 'CARBONYL IRON', 1592: 'ROFECOXIB', 1593: 'ROSIGLITAZONE', 1594: 'DOXERCALCIFEROL', 1595: 'MALATHION TOPICAL', 1596: 'PERINDOPRIL', 1597: 'KETOTIFEN OPHTHALMIC', 1598: 'PIOGLITAZONE', 1599: 'ZANAMIVIR', 1600: 'CARBETAPENTANE/CHLORPHENIRAMINE/PHENYLEPHRINE', 1601: 'PHENYLEPHRINE-PYRILAMINE', 1602: 'GANIRELIX', 1603: 'RABEPRAZOLE', 1604: 'TEMOZOLOMIDE', 1605: 'ZALEPLON', 1606: 'SIROLIMUS', 1607: 'EPIRUBICIN', 1608: 'DALFOPRISTIN-QUINUPRISTIN', 1609: 'PEMIROLAST OPHTHALMIC', 1610: 'DOFETILIDE', 1611: 'ENTACAPONE', 1612: 'EXEMESTANE', 1613: 'OSELTAMIVIR', 1614: 'GRAPE SEED OIL', 1615: 'DONG QUAI', 1616: 'MILK THISTLE', 1617: \"CAT'S CLAW\", 1618: 'BEE POLLEN', 1619: 'CRANBERRY', 1620: 'BLACK COHOSH', 1621: 'BLUE COHOSH', 1622: 'WILD YAM', 1623: 'PENNYROYAL', 1624: 'ROYAL JELLY', 1625: 'DAMIANA', 1626: 'DANDELION', 1627: 'SHARK CARTILAGE', 1628: 'FLAX', 1629: 'FENUGREEK', 1630: 'ASPIRIN-DIPYRIDAMOLE', 1631: 'NAPROXEN-PSEUDOEPHEDRINE', 1632: 'LEVETIRACETAM', 1633: 'MOXIFLOXACIN', 1634: 'AMINOLEVULINIC ACID TOPICAL', 1635: 'NEDOCROMIL OPHTHALMIC', 1636: 'GATIFLOXACIN', 1637: 'DEXMEDETOMIDINE', 1638: 'ESTRADIOL-NORGESTIMATE', 1639: 'BEXAROTENE', 1640: 'NITRIC OXIDE', 1641: 'HYDROCHLOROTHIAZIDE-QUINAPRIL', 1642: 'INSULIN LISPRO-INSULIN LISPRO PROTAMINE', 1643: 'CEVIMELINE', 1644: 'OXCARBAZEPINE', 1645: 'PANTOPRAZOLE', 1646: 'GADOVERSETAMIDE', 1647: 'ALOSETRON', 1648: 'UBIQUINONE', 1649: 'S-ADENOSYLMETHIONINE', 1650: 'ZONISAMIDE', 1651: 'STRONTIUM-89 CHLORIDE', 1652: 'SAMARIUM SM 153 LEXIDRONAM', 1653: 'MELOXICAM', 1654: 'VERTEPORFIN', 1655: 'LINEZOLID', 1656: 'ARTICAINE-EPINEPHRINE', 1657: 'ARTICAINE', 1658: 'RIVASTIGMINE', 1659: 'INSULIN GLARGINE', 1660: 'FOSINOPRIL-HYDROCHLOROTHIAZIDE', 1661: 'GEMTUZUMAB', 1662: 'AZELASTINE OPHTHALMIC', 1663: 'ATOVAQUONE-PROGUANIL', 1664: 'CLOBAZAM', 1665: 'FORMOTEROL', 1666: 'TETRABENAZINE', 1667: 'FLUTICASONE-SALMETEROL', 1668: 'TINZAPARIN', 1669: 'VIGABATRIN', 1670: 'DIPHTH/HAEMOPHILUS/PERTUSSIS/TETANUS/POLIO', 1671: 'DIPHTHERIA/PERTUSSIS,ACEL/TETANUS/POLIO', 1672: 'HEPATITIS A-HEPATITIS B VACCINE', 1673: 'CALAMINE-DIPHENHYDRAMINE TOPICAL', 1674: 'TENECTEPLASE', 1675: 'COLESEVELAM', 1676: 'INSULIN ASPART', 1677: 'ARGATROBAN', 1678: 'BALSALAZIDE', 1679: 'DOCOSANOL TOPICAL', 1680: 'GLYBURIDE-METFORMIN', 1681: 'EFLORNITHINE TOPICAL', 1682: 'FLUDEOXYGLUCOSE F18', 1683: 'LEVOFLOXACIN OPHTHALMIC', 1684: 'ZOLEDRONIC ACID', 1685: 'CANDESARTAN-HYDROCHLOROTHIAZIDE', 1686: 'LOPINAVIR', 1687: 'LOPINAVIR-RITONAVIR', 1688: 'MIFEPRISTONE', 1689: 'ARSENIC TRIOXIDE', 1690: 'DICLOFENAC TOPICAL', 1691: 'CALCIUM CARBONATE/FAMOTIDINE/MG HYDROXIDE', 1692: 'IRON SUCROSE', 1693: '5-HYDROXYTRYPTOPHAN', 1694: 'ABACAVIR/LAMIVUDINE/ZIDOVUDINE', 1695: 'HYDROCHLOROTHIAZIDE-TELMISARTAN', 1696: 'APAP/DOXYLAMINE/PSEUDOEPHEDRINE', 1697: 'TACROLIMUS TOPICAL', 1698: 'CARBETAPENTANE/GUAIFENESIN/PHENYLEPHRINE', 1699: 'BENZOYL PEROXIDE-CLINDAMYCIN TOPICAL', 1700: 'NATEGLINIDE', 1701: 'BIVALIRUDIN', 1702: 'PEGINTERFERON ALFA-2B', 1703: 'ZIPRASIDONE', 1704: 'CASPOFUNGIN', 1705: 'ESOMEPRAZOLE', 1706: 'GALANTAMINE', 1707: 'CARBINOXAMINE/HYDROCODONE/PSEUDOEPHEDRINE', 1708: 'TRAVOPROST OPHTHALMIC', 1709: 'BIMATOPROST OPHTHALMIC', 1710: 'VALGANCICLOVIR', 1711: 'ALEMTUZUMAB', 1712: 'ALMOTRIPTAN', 1713: 'IMATINIB', 1714: 'DROSPIRENONE-ETHINYLESTRADIOL', 1715: 'MINOCYCLINE TOPICAL', 1716: 'METHSCOPOLAMINE-PSEUDOEPHEDRINE', 1717: 'NESIRITIDE', 1718: 'CETIRIZINE-PSEUDOEPHEDRINE', 1719: 'HYDROCORTISONE-LIDOCAINE TOPICAL', 1720: 'ACETAMINOPHEN-TRAMADOL', 1721: 'CEFDITOREN', 1722: 'CARBETAPENTANE-CHLORPHENIRAMINE', 1723: 'DARBEPOETIN ALFA', 1724: 'ETONOGESTREL', 1725: 'ETHINYLESTRADIOL-ETONOGESTREL', 1726: 'TENOFOVIR', 1727: 'ANAKINRA', 1728: 'FROVATRIPTAN', 1729: 'DEXMETHYLPHENIDATE', 1730: 'VALDECOXIB', 1731: 'ETHINYL ESTRADIOL-NORELGESTROMIN', 1732: 'BOSENTAN', 1733: 'ERTAPENEM', 1734: 'PIMECROLIMUS TOPICAL', 1735: 'DESLORATADINE', 1736: 'FONDAPARINUX', 1737: 'LOVASTATIN-NIACIN', 1738: 'DUTASTERIDE', 1739: 'NITISINONE', 1740: 'PEGFILGRASTIM', 1741: 'FLUOCINOLONE/HYDROQUINONE/TRETINOIN TOPICAL', 1742: 'ASA/CHLORPHENIRAMINE/DEXTROMETHORPHAN', 1743: 'APAP/DEXTROMETHORPHAN/DOXYLAMINE/PE', 1744: 'CARBINOXAMINE/METHSCOPOLAMINE/PSEUDOEPHEDRINE', 1745: 'BUDESONIDE-FORMOTEROL', 1746: 'PERFLUTREN', 1747: 'ALFUZOSIN', 1748: 'TEGASEROD', 1749: 'FULVESTRANT', 1750: 'IFOSFAMIDE-MESNA', 1751: 'OLMESARTAN', 1752: 'TREPROSTINIL', 1753: 'VORICONAZOLE', 1754: 'RASBURICASE', 1755: 'SODIUM OXYBATE', 1756: 'OXALIPLATIN', 1757: 'ESCITALOPRAM', 1758: 'ADEFOVIR', 1759: 'EPLERENONE', 1760: 'DEXCHLORPHENIRAMINE-PSEUDOEPHEDRINE', 1761: 'DEXCHLORPHENIRAMINE/DEXTROMETHORPHAN/PSE', 1762: 'BUPRENORPHINE-NALOXONE', 1763: 'METFORMIN-ROSIGLITAZONE', 1764: 'PEGINTERFERON ALFA-2A', 1765: 'GLIPIZIDE-METFORMIN', 1766: 'EZETIMIBE', 1767: 'ARIPIPRAZOLE', 1768: 'NITAZOXANIDE', 1769: 'ATOMOXETINE', 1770: 'TERIPARATIDE', 1771: 'TIOTROPIUM', 1772: 'SMALLPOX VACCINE', 1773: 'DIPHTHERIA/HEPB/PERTUSSIS,ACEL/POLIO/TETANUS', 1774: 'CYTARABINE LIPOSOMAL', 1775: 'ADALIMUMAB', 1776: 'CYCLOSPORINE OPHTHALMIC', 1777: 'INSULIN ASPART PROTAMINE', 1778: 'INSULIN ASPART-INSULIN ASPART PROTAMINE', 1779: 'ALEFACEPT', 1780: 'CAMPHOR-MENTHOL TOPICAL', 1781: 'IBRITUMOMAB', 1782: 'ELETRIPTAN', 1783: 'CARBETAPENTANE/PHENYLEPHRINE/PYRILAMINE', 1784: 'ROSUVASTATIN', 1785: 'BUPIVACAINE-FENTANYL', 1786: 'ENFUVIRTIDE', 1787: 'PEGVISOMANT', 1788: 'APREPITANT', 1789: 'BOTULISM ANTITOXIN', 1790: 'GATIFLOXACIN OPHTHALMIC', 1791: 'ANTHRAX VACCINE ADSORBED', 1792: 'GEMIFLOXACIN', 1793: 'MOXIFLOXACIN OPHTHALMIC', 1794: 'DIPHENHYDRAMINE-PHENYLEPHRINE', 1795: 'BROMPHENIRAMINE/DM/GUAIFENESIN/PSE', 1796: 'CHLORPHENIRAMINE/IBUPROFEN/PSEUDOEPHEDRINE', 1797: 'CARBETAPENTANE-PSEUDOEPHEDRINE', 1798: 'AGALSIDASE BETA', 1799: 'GEFITINIB', 1800: 'CHLORPHENIRAMINE/DIHYDROCODEINE/PSE', 1801: 'DIHYDROCODEINE/GUAIFENESIN/PSEUDOEPHEDRINE', 1802: 'BORTEZOMIB', 1803: 'BETAINE', 1804: 'CARBIDOPA/ENTACAPONE/LEVODOPA', 1805: 'HYDROCHLOROTHIAZIDE-OLMESARTAN', 1806: 'PHENYLEPHRINE-POTASSIUM GUAIACOLSULFONATE', 1807: 'BROMPHENIRAMINE/HYDROCODONE/PSEUDOEPHEDRINE', 1808: 'OMALIZUMAB', 1809: 'ATAZANAVIR', 1810: 'EMTRICITABINE', 1811: 'TOSITUMOMAB', 1812: 'IODINE I 131 TOSITUMOMAB', 1813: 'BUPIVACAINE-HYDROMORPHONE', 1814: 'PALONOSETRON', 1815: 'CIPROFLOXACIN-DEXAMETHASONE OTIC', 1816: 'INFLUENZA VIRUS VACCINE, LIVE, TRIVALENT', 1817: 'VARDENAFIL', 1818: 'DAPTOMYCIN', 1819: 'CARBETAPENTANE/DIPHENHYDRAMINE/PHENYLEPHRINE', 1820: 'TADALAFIL', 1821: 'TETRAHYDROZOLINE-ZINC OPHTHALMIC', 1822: 'EPINASTINE OPHTHALMIC', 1823: 'MEMANTINE', 1824: 'SALICYLIC ACID-UREA TOPICAL', 1825: 'FOSAMPRENAVIR', 1826: 'EFALIZUMAB', 1827: 'BROMPHENIRAMINE/DEXTROMETHORPH/PHENYLEPHRINE', 1828: 'LANSOPRAZOLE-NAPROXEN', 1829: 'ESTRADIOL-LEVONORGESTREL', 1830: 'SERTACONAZOLE TOPICAL', 1831: 'CAPSICUM', 1832: 'FLUOXETINE-OLANZAPINE', 1833: 'PNEUMOCOCCAL 7-VALENT CONJUGATE VACCINE', 1834: 'TETANUS-DIPHTH TOXOIDS (TD) ADULT/ADOL', 1835: 'DIPHENHYDRAMINE/HYDROCODONE/PHENYLEPHRINE', 1836: 'TROSPIUM', 1837: 'TELITHROMYCIN', 1838: 'TINIDAZOLE', 1839: 'ACAMPROSATE', 1840: 'APOMORPHINE', 1841: 'LUTROPIN ALFA', 1842: 'BETAMETHASONE-CALCIPOTRIENE TOPICAL', 1843: 'PEMETREXED', 1844: 'AMLODIPINE-ATORVASTATIN', 1845: 'CETUXIMAB', 1846: 'GUAIFENESIN-POTASSIUM GUAIACOLSULFONATE', 1847: 'DEXTROMETHORPHAN/GG/K GUAIACOLSULFONATE', 1848: 'ARTEMETHER-LUMEFANTRINE', 1849: 'CARBINOXAMINE/DEXTROMETHORPHAN/PHENYLEPHRINE', 1850: 'BEVACIZUMAB', 1851: 'ZINC ACETATE TOPICAL', 1852: 'DIPHENHYDRAMINE-ZINC ACETATE TOPICAL', 1853: 'MYCOPHENOLIC ACID', 1854: 'CINACALCET', 1855: 'ILOPROST', 1856: 'HYALURONAN', 1857: 'BENZOYL PEROXIDE-UREA TOPICAL', 1858: 'MOMETASONE', 1859: 'NEBIVOLOL', 1860: 'CADEXOMER IODINE TOPICAL', 1861: 'INSULIN GLULISINE', 1862: 'BRIMONIDINE-TIMOLOLOPHTHALMIC', 1863: 'APAP/CAFFEINE/PHENYLTOLOXAMINE/SALICYLAMIDE', 1864: 'AZACITIDINE', 1865: 'RIFAXIMIN', 1866: 'CHLORPHENIRAMINE-CODEINE', 1867: 'PITCHER PLANT', 1868: 'BROMPHENIRAMINE/CODEINE/PHENYLEPHRINE', 1869: 'PNEUMOCOCCAL 23-POLYVALENT VACCINE', 1870: 'DIPHTHERIA-TETANUS TOXOIDS (DT) PED', 1871: 'HEPATITIS A PEDIATRIC VACCINE', 1872: 'HEPATITIS A ADULT VACCINE', 1873: 'D05341 HAEMOPHILUS B CONJUGATE (HBOC) VACCINE', 1874: 'D05343HAEMOPHILUS BCONJUGATE (PRP-T) VACCINE', 1875: 'GADOBUTROL', 1876: 'EZETIMIBE-SIMVASTATIN', 1877: 'BISACODYL-PEG 3350 WITH ELECTROLYTES', 1878: 'POLYETHYLENE GLYCOL 3350', 1879: 'APAP/PHENYLTOLOXAMINE/SALICYLAMIDE', 1880: 'EMTRICITABINE-TENOFOVIR', 1881: 'ABACAVIR-LAMIVUDINE', 1882: 'DULOXETINE', 1883: 'IBANDRONATE', 1884: 'CARBETAPENTANE-GUAIFENESIN', 1885: 'APAP/DEXTROMETHORPHAN/DOXYLAMINE', 1886: 'APAP/CHLORPHENIRAMINE/DEXTROMETHORPHAN', 1887: 'DEXTROMETHORPHAN/PHENIRAMINE/PHENYLEPHRINE', 1888: 'BISACODYL-MAGNESIUM CITRATE', 1889: 'LANTHANUM CARBONATE', 1890: 'CHLORPHENIRAMINE-METHSCOPOLAMINE', 1891: 'ERLOTINIB 12', 1892: 'SOLIFENACIN', 1893: 'NATALIZUMAB', 1894: 'IBUPROFEN-OXYCODONE', 1895: 'CHLORDIAZEPOXIDE-METHSCOPOLAMINE', 1896: 'PALIFERMIN', 1897: 'PEGAPTANIB OPHTHALMIC', 1898: 'ALOH/DIPHENHYD/LIDOCAINE/MGOH/SIMETH TOPICAL', 1899: 'ESZOPICLONE', 1900: 'DARIFENACIN', 1901: 'CLOFARABINE', 1902: 'ZICONOTIDE', 1903: 'LOTEPREDNOL-TOBRAMYCIN OPHTHALMIC', 1904: 'BROMPHENIRAMINE/HYDROCODONE/PHENYLEPHRINE', 1905: 'PACLITAXEL PROTEIN-BOUND', 1906: 'GADOBENATE DIMEGLUMINE', 1907: 'MENINGOCOCCAL CONJUGATE VACCINE', 1908: 'ENZYMES/HYOSCYAMINE/PHENYLTOLOXAMIN', 1909: 'BROMPHENIRAMINE/CARBETAPENTANE/PHENYLEPHRINE', 1910: 'INSULIN DETEMIR', 1911: 'POVIDONE-TETRAHYDROZOLINE OPHTHALMIC', 1912: 'SODIUM BENZOATE-SODIUM PHENYLACETATE', 1913: 'CICLESONIDE', 1914: 'ASCORBIC ACID-IRON POLYSACCHARIDE', 1915: 'ALPHA-D-GALACTOSIDASE', 1916: 'DESLORATADINE-PSEUDOEPHEDRINE', 1917: 'MICAFUNGIN', 1918: 'PRAMLINTIDE', 1919: 'PREGABALIN', 1920: 'BROMFENAC OPHTHALMIC', 1921: 'ENTECAVIR', 1922: 'ALENDRONATE-CHOLECALCIFEROL', 1923: 'FLUOCINOLONE OPHTHALMIC', 1924: 'TRICHOPHYTON SKIN TEST', 1925: 'EXENATIDE', 1926: 'DROSPIRENONE-ESTRADIOL', 1927: 'HEME IRON POLYPEPTIDE', 1928: 'APAP/GUAIFENESIN/PSEUDOEPHEDRINE', 1929: 'TIGECYCLINE', 1930: 'TIPRANAVIR', 1931: 'DEXCHLORPHENIRAMINE/METHSCOPOLAMINE/PSE', 1932: 'HYDRALAZINE-ISOSORBIDE DINITRATE', 1933: 'DAPSONE TOPICAL', 1934: 'APAP/GUAIFENESIN/PHENYLEPHRINE', 1935: 'RAMELTEON', 1936: 'APAP/DEXTROMETHORPHAN/PHENYLEPHRINE', 1937: 'RASAGILINE', 1938: 'EVEROLIMUS', 1939: 'CALCIUMCARBONATE-RISEDRONATE', 1940: 'BISACODYL/SODIUM BIPHOSPHATE/SODIUM PHOSPHATE', 1941: 'NEPAFENAC OPHTHALMIC', 1942: 'METFORMIN-PIOGLITAZONE', 1943: 'MECASERMIN', 1944: 'LACTOBACILLUS RHAMNOSUS', 1945: 'APAP/CAFFEINE/ISOMETHEPTENE MUCATE', 1946: 'MEASLES/MUMPS/RUBELLA/VARICELLA VIRUS VACCINE', 1947: 'SACCHAROMYCES BOULARDII LYO', 1948: 'FERRIC SUBSULFATE TOPICAL', 1949: 'CEFTRIAXONE-LIDOCAINE', 1950: 'SODIUM HYALURONATE TOPICAL', 1951: 'APAP/DIPHENHYDRAMINE/PHENYLEPHRINE', 1952: 'DEFERASIROX', 1953: 'ACETAMINOPHEN-GUAIFENESIN', 1954: 'GLIMEPIRIDE-ROSIGLITAZONE', 1955: 'SORAFENIB', 1956: 'MECASERMIN RINFABATE', 1957: 'ABATACEPT', 1958: 'LENALIDOMIDE', 1959: 'METHYLSULFONYLMETHANE', 1960: 'CHONDROITIN/GLUCOSAMINE/METHYLSULFONYLMETHANE', 1961: 'IMMUNE GLOBULIN SUBCUTANEOUS', 1962: 'SUNITINIB', 1963: 'RANOLAZINE', 1964: 'GALLIUM CITRATE GA-67', 1965: 'LUBIPROSTONE', 1966: 'MICONAZOLE-ZINC OXIDE TOPICAL', 1967: 'APAP/CHLORPHENIRAMINE/DEXTROMETHORPHAN/PE', 1968: 'INSULIN INHALATION, RAPID ACTING', 1969: 'APAP/PHENIRAMINE/PHENYLEPHRINE', 1970: 'OMEPRAZOLE-SODIUMBICARBONATE', 1971: 'L-METHYLFOLATE', 1972: 'AMMONIUM LACTATE-UREA TOPICAL', 1973: 'IODINE', 1974: 'IODINE-POTASSIUM IODIDE', 1975: 'APAP/DEXTROMETHORPHAN/GUAIFENESIN/PE', 1976: 'TETANUS/DIPHTH/PERTUSS (TDAP) ADULT/ADOL', 1977: 'DIPHTHERIA/TETANUS/PERTUSSIS (DTAP) PED', 1978: 'RABIES VACCINE, HUMAN DIPLOID CELL', 1979: 'RABIES VACCINE, PURIFIED CHICK EMBRYO CELL', 1980: 'DECITABINE', 1981: 'FERROUS FUMARATE/FA/IRON POLYSACCHARIDE', 1982: 'VARENICLINE', 1983: 'ZOSTER VACCINE LIVE', 1984: 'DEXTROMETHORPHAN-PHENYLEPHRINE', 1985: 'FLUORESCEIN', 1986: 'HUMAN PAPILLOMAVIRUS VACCINE', 1987: 'DIPHENHYDRAMINE-IBUPROFEN', 1988: 'DARUNAVIR', 1989: 'FERUMOXSIL', 1990: 'DASATINIB', 1991: 'RANIBIZUMAB OPHTHALMIC', 1992: 'EFAVIRENZ/EMTRICITABINE/TENOFOVIR', 1993: 'ROTIGOTINE', 1994: 'LEVOCETIRIZINE', 1995: 'POSACONAZOLE', 1996: 'IDURSULFASE', 1997: 'GLIMEPIRIDE-PIOGLITAZONE', 1998: 'COMPLEMENT C1 ESTERASE INHIBITOR', 1999: 'GUAR GUM', 2000: 'ANTIHEMOPHILIC FACTOR-VON WILLEBRAND FACTOR', 2001: 'DEXTROMETHORPHAN/DIPHENHYDRAMINE/PE', 2002: 'BENZALKONIUM CHLORIDE-BENZOCAINE TOPICAL', 2003: 'PANITUMUMAB', 2004: 'VORINOSTAT', 2005: 'DEXCHLORPHENIRAMINE/DEXTROMETHO/PE/PYRILAMINE', 2006: 'ARFORMOTEROL', 2007: 'CALAMINE-ZINC', 2008: 'SITAGLIPTIN', 2009: 'BENZOYL PEROXIDE-SALICYLICACID TOPICAL', 2010: 'CICLESONIDE', 2011: 'COAGULATION', 2012: 'ALOE', 2013: 'CLINDAMYCIN-TRETINOIN', 2014: 'ANTIHEMOPHILIC', 2015: 'BENZYL', 2016: 'FLUOCINOLONE', 2017: 'DEXBROMPHENIRAMINE/HYDROCODONE/PHENYLEPHRINE', 2018: 'APAP/CAFFEINE/MAGNESIUM SALICYLATE', 2019: 'COLLAGEN', 2020: 'IOXILAN', 2021: 'DIENOGEST-ESTRADIOL', 2022: 'PALIPERIDONE', 2023: 'TURMERIC', 2024: 'WHEAT', 2025: 'CINNAMON', 2026: 'MILNACIPRAN', 2027: 'ATROPINE/CPM/HYOSCYAMINE/PSE/SCOPOLAMINE', 2028: 'ALPHA-LIPOIC', 2029: 'AMLODIPINE-VALSARTAN', 2030: 'LISDEXAMFETAMINE', 2031: 'ALISKIREN', 2032: 'LAPATINIB', 2033: 'ECULIZUMAB', 2034: 'METFORMIN-SITAGLIPTIN', 2035: 'RETAPAMULIN', 2036: 'ACETAMINOPHEN-ASPIRIN', 2037: 'BISMUTH SUBCITRATE POTASSIUM/METRONIDAZO/TCN', 2038: 'DEXCHLORPHENIRAMINE/METHSCOPOLAMINE/PE', 2039: 'TEMSIROLIMUS', 2040: 'AMBRISENTAN', 2041: 'ARMODAFINIL', 2042: 'LUTEIN', 2043: 'AZITHROMYCIN', 2044: 'MARAVIROC', 2045: 'ACETIC/ANTIPYRINE/BENZOCAINE/POLYCOS OTIC', 2046: 'HELIUM', 2047: 'HELIUM-OXYGEN', 2048: 'BIOTIN', 2049: 'MENTHOL-ZINC', 2050: 'APAP/CHLORPHENIRAMINE/PE/PHENYLTOLOXAMINE', 2051: 'CHLOROPHYLLIN COPPER COM/PAPAIN/UREA TOPICAL', 2052: 'COLLAGEN', 2053: 'AMLODIPINE-OLMESARTAN', 2054: 'ASA/CHLORPHENIRAMINE/PHENYLEPHRINE', 2055: 'RALTEGRAVIR', 2056: 'DORIPENEM', 2057: 'IXABEPILONE', 2058: 'CHLORPHENIRAMINE/GUAIFENESIN/METHSCOPOLAMI/PE', 2059: 'NILOTINIB', 2060: 'SULFACETAMIDE SODIUM/SULFUR/UREA TOPICAL', 2061: 'CITRIC ACID-POTASSIUM BICARBONATE', 2062: 'BROMPHENIRAMINE-DIPHENHYDRAMINE', 2063: 'BENZYL ALCOHOL-ZINC ACETATE TOPICAL', 2064: 'SAPROPTERIN', 2065: 'RUFINAMIDE', 2066: 'PERMETHRIN/PIPERONYL BUTOXIDE/PYRETHR TOPICAL', 2067: 'ETRAVIRINE', 2068: 'ALISKIREN-HYDROCHLOROTHIAZIDE', 2069: 'NIACIN-SIMVASTATIN', 2070: 'DESVENLAFAXINE', 2071: 'BENDAMUSTINE', 2072: 'NAPROXEN-SUMATRIPTAN', 2073: 'REGADENOSON', 2074: 'OLOPATADINE', 2075: 'CERTOLIZUMAB', 2076: 'METHYLNALTREXONE', 2077: 'DABIGATRAN', 2078: 'FESOTERODINE', 2079: 'METFORMIN-REPAGLINIDE', 2080: 'DIFLUPREDNATE OPHTHALMIC', 2081: 'CHLOPHEDIANOL/DEXCHLORPHENIRAMINE/PSE', 2082: 'CHLOPHEDIANOL/GUAIFENESIN/PSEUDOEPHEDRINE', 2083: 'BENZOCAINE-MENTHOL', 2084: 'GENISTEIN', 2085: 'CLEVIDIPINE', 2086: 'GLUTAMINE', 2087: 'ROMIPLOSTIM', 2088: 'BIFIDOBACTERIUM INFANTIS', 2089: 'LACOSAMIDE', 2090: 'CARBETAPENTANE/PSEUDOEPHEDRINE/PYRILAMINE', 2091: 'SILODOSIN', 2092: 'RIVAROXABAN', 2093: 'ELTROMBOPAG', 2094: 'FENOFIBRIC', 2095: 'BIMATOPROST', 2096: 'ADAPALENE-BENZOYL PEROXIDE TOPICAL', 2097: 'HEPARIN', 2098: 'HYDROCORTISONE/SALICYLIC ACID/SULFUR TOPICAL', 2099: 'DEXLANSOPRAZOLE', 2100: 'USTEKINUMAB', 2101: 'FEBUXOSTAT', 2102: 'CARBETAPENTANE/PE/POTASSIUM GUAIACOLSULFONATE', 2103: 'PRASUGREL', 2104: 'DEGARELIX', 2105: 'BENZOCAINE-RESORCINOL TOPICAL', 2106: 'GOLIMUMAB', 2107: 'AMLODIPINE/HYDROCHLOROTHIAZIDE/VALSARTAN', 2108: 'ILOPERIDONE', 2109: 'TOLVAPTAN', 2110: 'TAPENTADOL', 2111: 'DRONEDARONE', 2112: 'FERUMOXYTOL', 2113: 'INFLUENZA VIRUS VACCINE, H1N1, INACTIVATED', 2114: 'LIRAGLUTIDE', 2115: 'SAXAGLIPTIN', 2116: 'MORPHINE-NALTREXONE', 2117: 'ASENAPINE', 2118: 'POLY-L-LACTIC', 2119: 'BEPOTASTINE', 2120: 'TELAVANCIN', 2121: 'INFLUENZA VIRUS VACCINE, H1N1, LIVE', 2122: 'ALISKIREN-VALSARTAN', 2123: 'DIPHENHYDRAMINE/LIDOCANE/NYSTATIN TOPICAL', 2124: 'PRALATREXATE', 2125: 'TOCILIZUMAB', 2126: 'AMLODIPINE-TELMISARTAN', 2127: 'PAZOPANIB', 2128: 'COPPER', 2129: 'OFATUMUMAB', 2130: 'SILVER', 2131: 'DALFAMPRIDINE', 2132: 'DEXTROMETHORPHAN-DOXYLAMINE', 2133: 'IPILIMUMAB', 2134: 'PNEUMOCOCCAL 13-VALENT CONJUGATE vaccine', 2135: 'BIOFLAVONOIDS-ZINC', 2136: 'ESOMEPRAZOLE-NAPROXEN', 2137: 'DUTASTERIDE-TAMSULOSIN', 2138: 'PITAVASTATIN', 2139: 'SIPULEUCEL-T', 2140: 'DENOSUMAB', 2141: 'ANTI-THYMOCYTEGLOBULIN(RABBIT)', 2142: 'HEPATITIS', 2143: 'ONABOTULINUMTOXINA', 2144: 'ABOBOTULINUMTOXINA', 2145: 'RACEPINEPHRINE', 2146: 'CABAZITAXEL', 2147: 'CAFFEINE-MAGNESIUM', 2148: 'FORMOTEROL-MOMETASONE', 2149: 'AMLODIPINE/HYDROCHLOROTHIAZIDE/OLMESARTAN', 2150: 'ALCAFTADINE OPHTHALMIC', 2151: 'ROFLUMILAST', 2152: 'PEGLOTICASE', 2153: 'MAGNESIUM/POTASSIUM/SODIUM SULFATES', 2154: 'FINGOLIMOD', 2155: 'DROSPIRENONE/ETHINYL ESTRADIOL/LEVOMEFOLATE', 2156: 'LURASIDONE', 2157: 'CEFTAROLINE', 2158: 'METFORMIN-SAXAGLIPTIN', 2159: 'TESAMORELIN', 2160: 'ERIBULIN', 2161: 'PENICILLIN G BENZATHINE', 2162: 'PENICILLIN G POTASSIUM', 2163: 'PENICILLIN V POTASSIUM', 2164: 'BROMPHENIRAMINE/CHLOPHEDIANOL/PSE', 2165: 'VILAZODONE', 2166: 'AZILSARTAN', 2167: 'BELIMUMAB', 2168: 'LIDOCAINE-SODIUM BICARBONATE', 2169: 'VANDETANIB', 2170: 'ABIRATERONE', 2171: 'LINAGLIPTIN', 2172: 'BOCEPREVIR', 2173: 'TELAPREVIR', 2174: 'EMTRICITABINE/RILPIVIRINE/TENOFOVIR', 2175: 'VEMURAFENIB', 2176: 'XYLENE', 2177: 'TURPENTINE', 2178: 'TRICHLOROETHANE', 2179: 'TOLUENE', 2180: 'NAPHTHALENE', 2181: 'METHYLENE CHLORIDE', 2182: 'METHANOL', 2183: 'FORMALDEHYDE', 2184: 'ETHYLENE GLYCOL', 2185: 'ETHYL ETHER', 2186: 'ACETONE', 2187: 'CYANOACRYLATE', 2188: 'ISOBUTYL NITRITE', 2189: 'AEROSOL SPRAY-NOS', 2190: 'BUTANE', 2191: 'TRICHLOROFLUOROMETHANE', 2192: 'METHANE', 2193: 'PETROLEUM HYDROCARBONS', 2194: 'CARBON TETRACHLORIDE', 2195: 'BUTYL ALCOHOL', 2196: 'ALPHA TERPINEOL', 2197: 'FREON', 2198: 'DICHLOROBENZENE', 2199: 'PROPOXUR', 2200: 'PROPANE', 2201: 'PHENOLIC DISINFECTANTS', 2202: 'MINERAL SEAL OIL', 2203: 'FLUORINE', 2204: 'HYDROCARBON', 2205: 'CHLORINATED HYDROCARBONS', 2206: 'CRESOL', 2207: 'BUTYL ACETATE', 2208: 'CLEANER/UNKNOWN COMPOSITION', 2209: 'COSMETIC/UNKNOWN COMPOSITION', 2210: 'PESTICIDE/UNKNOWN COMPOSITION', 2211: 'VOLATILE/UNKNOWN COMPOSITION', 2212: 'PAINT/UNKNOWN COMPOSITION', 2213: 'TRICHLOROETHANE/TRICHLOROETHYLENE', 2214: 'PETROLEUM HYDROCARBONS/TRICHLOROETHANE', 2215: 'ETHANOL-NP', 2216: 'TRICHLOROMETHANE', 2217: 'FLUORINATEDHYDROCARBONS', 2218: 'ISOBUTANE', 2219: 'CHLORODIFLUOROMETHANE', 2220: 'ETHYL ACETATE', 2221: 'LYSERGIC ACID DIETHYLAMIDE', 2222: 'METHYLENEDIOXYMETHAMPHETAMINE', 2223: 'FLUNITRAZEPAM', 2224: 'BROMELAIN', 2225: 'NOMIFENSINE MALEATE', 2226: 'MECLOZINE HCL', 2227: 'NITRAZEPAM', 2228: 'ZOMEPIRAC', 2229: 'XYLAZINE', 2230: 'VITAMIN K', 2231: 'L-TRYPTOPHAN', 2232: 'SULFORIDAZINE', 2233: 'SULFADINE', 2234: 'SALINE', 2235: 'PRAZEPAM', 2236: 'PHENMETRAZINE HCL', 2237: 'PHENACETIN', 2238: 'METHACYCLINE', 2239: 'MERBROMIN', 2240: 'LUTREXIN', 2241: 'LORMETAZEPAM', 2242: 'LACTOSE', 2243: 'KETOTIFEN FUMARATE', 2244: 'INFANT FORMULA', 2245: 'HYDROXY-N-METHYLMORPHINAN', 2246: 'FENPROPOREX', 2247: 'ERYTHRITYL TETRANITRATE', 2248: 'DYPYRONE', 2249: 'DIHYDROMORPHINONE', 2250: 'ALDOSTERONE', 2251: 'CHLOROPYRAMINE', 2252: 'CARBAMATE', 2253: 'BROMAZEPAM', 2254: 'ACEPROMAZINE', 2255: 'METHCATHINONE', 2256: 'CATHINONE', 2257: 'METHYLENEDIOXYAMPHETAMINE', 2258: 'METHAQUALONE', 2259: 'MESCALINE', 2260: 'PSILOCYBIN', 2261: 'MORNING GLORY SEEDS', 2262: 'DATURA SAUVEOLENS', 2263: 'GAMMA BUTYROLACTONE', 2264: 'EUCALYPTUS OIL', 2265: 'PEPPER', 2266: 'DIMETHOXYMETHAMPHETAMINE', 2267: 'DATURA STRAMONIUM', 2268: 'CANTHARIDINE', 2269: 'ISOPROPAMIDE IODIDE', 2270: 'ALLOBARBITAL', 2271: 'CLOBENZOREX', 2272: 'AMBROXOL', 2273: 'TETRAMYCIN', 2274: 'RHODOMYCIN', 2275: 'ZOPICLONE', 2276: 'MYCADRINE', 2277: 'POTASSIUM', 2278: 'PYRETHRUM', 2279: 'ARECOLINE', 2280: 'PHOSPHATIDYLETHANOLAMINE', 2281: 'CHLORPHENTERMINE', 2282: 'BARBITURIC ACID', 2283: 'BARBITAL', 2284: 'BROMO-DIMETHOXYPHENETHYLAMINE', 2285: 'MARIJUANA/METHAMPHETAMINE', 2286: 'FORMALDEHYDE/MARIJUANA', 2287: 'COCAINE/METHAMPHETAMINE', 2288: 'COCAINE/MARIJUANA', 2289: 'COCAINE/HEROIN', 2290: 'MARIJUANA/PHENCYCLIDINE', 2291: 'COCAINE/PHENCYCLIDINE', 2292: 'LYSERGIC ACID DIETHYLAMIDE/METHAMPHETAMINE', 2293: 'LYSERGIC ACID DIETHYLAMIDE/PHENCYCLIDINE', 2294: 'HEROIN/MARIJUANA', 2295: 'AMOBARBITAL/DEXTROAMPHETAMINE/THYROID DESICCATED', 2296: 'PENTOBARBITAL/PHENOBARBITAL', 2297: 'CAFFEINE/EPHEDRINE', 2298: 'ACETAMINOPHEN/CHLORZOXAZONE', 2299: 'ASPIRIN/CAFFEINE/CODEINE/PHENACETIN', 2300: 'APAP/CHLORPHENIRAMINE/PHENYLEPHRINE/DEXTROMETHORPHAN/GUAIFENESIN', 2301: 'COCAINE/ETHANOL', 2302: 'SALICYLAMIDE/SCOPOLAMINE', 2303: 'CODEINE/TERPIN HYDRATE', 2304: 'ACETAMINOPHEN/CAFFEINE/CODEINE', 2305: 'AMYLASE/PROTEASE', 2306: 'ASPIRIN/CAFFEINE/CODEINE', 2307: 'ANTIFUNGALS-NOS', 2308: 'ANTIMALARIAL AGENTS-NOS', 2309: 'ANTITUBERCULOSIS AGENTS-NOS', 2310: 'ANTIVIRAL AGENTS-NOS', 2311: 'CEPHALOSPORINS-NOS', 2312: 'MACROLIDES-NOS', 2313: 'ANTIBIOTICS-NOS', 2314: 'PENICILLINS-NOS', 2315: 'QUINOLONES-NOS', 2316: 'SULFONAMIDES-NOS', 2317: 'TETRACYCLINES-NOS', 2318: 'URINARY ANTI-INFECTIVES-NOS', 2319: 'AMINOGLYCOSIDES-NOS', 2320: 'ANTIHYPERLIPIDEMIC AGENTS-NOS', 2321: 'RADIOPHARMACEUTICALS-NOS', 2322: 'ANTITOXINS AND ANTIVENINS-NOS', 2323: 'BACTERIAL VACCINES-NOS', 2324: 'STIMULATINGFACTORS-NOS', 2325: 'IMMUNE GLOBULINS-NOS', 2326: 'RECOMBINANT HUMAN ERYTHROPOIETINS-NOS', 2327: 'TOXOIDS-NOS', 2328: 'VIRAL VACCINES-NOS', 2329: 'CARDIOVASCULAR AGENTS-NOS', 2330: 'ANGIOTENSIN CONVERTINGENZYME INHIBITORS-NOS', 2331: 'ANTIADRENERGIC AGENTS, PERIPHERALLY ACTOMG-NOS', 2332: 'ANTIANGINAL AGENTS-NOS', 2333: 'ANTIARRHYTHMIC AGENTS-NOS', 2334: 'BETA-ADRENERGIC BLOCKING AGENTS-NOS', 2335: 'CALCIUM CHANNEL BLOCKING AGENTS-NOS', 2336: 'INOTROPIC AGENTS-NOS', 2337: 'PERIPHERAL VASODILATORS-NOS', 2338: 'VASODILATORS-NOS', 2339: 'VASOPRESSORS-NOS', 2340: 'ANTIHYPERTENSIVE COMBINATIONS-NOS', 2341: 'ANGIOTENSIN II INHIBITORS-NOS', 2342: 'ANALGESICS-NOS', 2343: 'NARCOTIC ANALGESICS-NOS', 2344: 'NONSTEROIDAL ANTI-INFLAMMATORY AGENTS-NOS', 2345: 'SALICYLATES-NOS', 2346: 'ANTICONVULSANTS-NOS', 2347: 'ANTIPARKINSON AGENTS-NOS', 2348: 'BARBITURATES-NOS', 2349: 'BENZODIAZEPINES-NOS', 2350: 'ANXIOLYTICS, SEDATIVES AND HYPNOTICS-NOS', 2351: 'CNS STIMULANTS-NOS', 2352: 'GENERAL ANESTHETICS-NOS', 2353: 'ANTIPSYCHOTICS-NOS', 2354: 'ANTICOAGULANTS-NOS', 2355: 'ANTIPLATELET AGENTS-NOS', 2356: 'THROMBOLYTICS-NOS', 2357: 'GASTROINTESTINAL AGENTS-NOS', 2358: 'ANTACIDS-NOS', 2359: 'ANTICHOLINERGICS/ANTISPASMODICS-NOS', 2360: 'ANTIDIARRHEALS-NOS', 2361: 'DIGESTIVE ENZYMES-NOS', 2362: 'GI STIMULANTS-NOS', 2363: 'H2 ANTAGONISTS-NOS', 2364: 'LAXATIVES-NOS', 2365: 'HORMONES-NOS', 2366: 'ADRENAL CORTICAL STERIODS-NOS', 2367: 'ANTIDIABETIC AGENTS-NOS', 2368: 'SEX HORMONES-NOS', 2369: 'THYROID DRUGS-NOS', 2370: 'IMMUNOSUPPRESSIVE AGENTS-NOS', 2371: 'ANTIDOTES-NOS', 2372: 'CHELATING AGENTS-NOS', 2373: 'CHOLINERGIC MUSCLE STIMULANTS-NOS', 2374: 'LOCAL INJECTABLE ANESTHETICS-NOS', 2375: 'PSORALENS-NOS', 2376: 'RADIOCONTRAST AGENTS-NOS', 2377: 'GENITOURINARY TRACT AGENTS-NOS', 2378: 'IRON PRODUCTS-NOS', 2379: 'MINERALS AND ELECTROLYTES-NOS', 2380: 'ORAL NUTRITIONAL SUPPLEMENTS-NOS', 2381: 'VITAMIN AND MINERAL COMBINATIONS-NOS', 2382: 'INTRAVENOUS NUTRITIONAL PRODUCTS-NOS', 2383: 'ANTIHISTAMINES-NOS', 2384: 'ANTITUSSIVES-NOS', 2385: 'BRONCHODILATORS-NOS', 2386: 'DECONGESTANTS-NOS', 2387: 'EXPECTORANTS-NOS', 2388: 'RESPIRATORY AGENTS-NOS', 2389: 'RESPIRATORY INHALANT PRODUCTS-NOS', 2390: 'ANTIASTHMATIC COMBINATIONS-NOS', 2391: 'UPPER RESPIRATORY COMBINATIONS-NOS', 2392: 'ANORECTAL PREPARATIONS-NOS', 2393: 'ANTISEPTIC AND GERMICIDES-NOS', 2394: 'DERMATOLOGICAL AGENTS-NOS', 2395: 'TOPICAL ANESTHETICS-NOS', 2396: 'MOUTH AND THROAT PRODUCTS-NOS', 2397: 'STERILE IRRIGATINGSOLUTIONS-NOS', 2398: 'PLASMA EXPANDERS-NOS', 2399: 'HMG-COA REDUCTASE INHIBITORS-NOS', 2400: 'MUSCLE RELAXANTS-NOS ', 2401: 'ANDROGENS AND ANABOLIC STEROIDS-NOS', 2402: 'NARCOTIC ANALGESIC COMBINATIONS-NOS', 2403: 'ANTIRHEUMATICS-NOS', 2404: 'ANTIMIGRAINE AGENTS-NOS', 2405: 'ANTIGOUT AGENTS-NOS', 2406: 'BISPHOSPHONATES-NOS', 2407: 'NUTRACEUTICAL PRODUCTS-NOS', 2408: 'HERBAL PRODUCTS-NOS', 2409: 'FIBRIC ACID DERIVATIVES-NOS', 2410: 'LEUKOTRIENE MODIFIERS-NOS', 2411: 'NASAL PREPARATIONS-NOS', 2412: 'ANTIDEPRESSANTS-NOS', 2413: 'ANOREXIANTS-NOS', 2414: 'INTERFERONS-NOS', 2415: 'MONOCLONAL ANTIBODIES-NOS', 2416: 'IMPOTENCE AGENTS-NOS', 2417: 'VAGINAL PREPARATIONS-NOS', 2418: 'ANTIPSORIATICS-NOS', 2419: 'PROTON PUMP INHIBITORS-NOS', 2420: 'DRUG UNKNOWN', 2421: 'GAMMA HYDROXY BUTRATE', 2422: 'PASSION FLOWER', 2423: 'METHAPHENILENE', 2424: 'CODEINE COMBINATION-NOS', 2425: 'HALLUCINOGEN-NOS', 2426: 'POLY-DRUGS', 2427: 'ANTINEOPLASTICS-NOS', 2428: 'ANTIBIOTICS/ANTINEOPLASTICS-NOS', 2429: 'HORMONES/ANTINEOPLASTICS-NOS', 2430: 'DIURETICS-NOS', 2431: 'ANTIEMETIC/ANTIVERTIGO AGENTS-NOS', 2432: 'VITAMINS-NOS', 2433: 'OPHTHALMIC PREPARATIONS-NOS', 2434: 'OTIC PREPARATIONS-NOS', 2435: 'ANALGESIC COMBINATIONS-NOS', 2436: 'COX-2 INHIBITOR-NOS', 2437: 'SSRI ANTIDEPRESSANTS-NOS', 2438: 'TRICYCLIC ANTIDEPRESSANTS-NOS', 2439: 'MONOAMINE OXIDASE INHIBITORS-NOS', 2440: 'PSYCHOTHERAPEUTIC COMBINATIONS-NOS', 2441: 'PHENOTHIAZINE ANTIPSYCHOTICS-NOS', 2442: 'ISOSORBIDE-NOS', 2443: 'IMMUNIZATION-NOS', 2444: 'PHENCYCLIDINECOMBINATIONS-NOS', 2445: 'PNEUMOCOCCAL VACCINE', 2446: 'FOLATE', 2447: 'PENTOBARBITAL/PHENYTOIN', 2448: 'BARBITAL SODIUM', 2449: 'GADOLINIUM', 2450: 'HEPATITIS A VACCINE INACTIVATED', 2451: 'ZINC', 2452: '4-BROMO-2,5-DIMETHOXYPHENETHYLAMINE', 2453: '2,5-DIMETHOXY-4-IODOPHENETHYLAMINE', 2454: 'AMPHETAMINE/COCAINE', 2455: 'METHANDROSTENLONE', 2456: 'MARIJUANA/OPIUM', 2457: 'ALPROSTADIL/PAPAVERINE/PHENTOLAMINE', 2458: 'CYANIDE/HEROIN/STRYCHNINE', 2459: 'HYDROXYCODEINONE', 2460: '2,5-DIMETHOXY-4-ETHYL-PHENETHYLAMINE', 2461: '2,5-DIMETHOXY-4-(N)-PROPYLTHIOPHENETHYLAMINE', 2462: 'ANTI-RETROVIRAL AGENTS-NOS', 2463: 'AROPLATIN', 2464: 'IDRAPARINUX', 2465: 'COCAINE/LYSERGIC DIETHYLAMIDE', 2466: 'SALVIA DIVINORUM', 2467: 'TIPIFARNIB', 2468: 'FLUOROURACIL-LEUCOVORIN', 2469: 'IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE', 2470: 'CARPROFEN', 2471: 'RIFAMPIN/ISONIAZID/PYRAZINAMIDE/ETHAMBUTOL', 2472: 'THALLIUM', 2473: 'POLYMYXIN B OTIC', 2474: 'ALLANTOIN/PRAMOXINE', 2475: 'COCAINE/MARIJUANA/FORMALDEHYDE', 2476: 'COCAINE/OPIUM', 2477: 'CYCLOPHOSPHAMIDE/DOXORUBICIN/VINCRISTINE/PREDNISONE', 2478: 'DIPHTHERIA/PERTUSISIS/POLIO/HAEMOPHILUS/TETANUS', 2479: 'ETORICOXIB', 2480: 'FLUPENTHIXOL', 2481: 'FUSIDIC ACID', 2482: 'HEROIN/METHAMPHETAMINE', 2483: 'IODINE CONTRAT AGENT', 2484: 'MARIJUANA/LYSERGIC ACID DIETHYLAMIDE', 2485: 'METHYLENEDIOXYMETHAMPHETAMINE/PSILOCYBIN', 2486: 'NEOMYCIN-POLYMYXIN B SULFATE OTIC', 2487: 'OXALIPLATIN/FLUOROURACIL/LEUCOVORIN', 2488: 'PHOSPHORUS', 2489: 'ADRENERGIC BRONCHODILATORS-NOS', 2490: 'OMEGA-6 POLYUNSATURATED FATTY ACIDS', 2491: 'TOPICAL ANTIFUNGALS-NOS', 2492: 'DEXTROMETHORPHAN COMBINATIONS-NOS', 2493: 'CLENBUTEROL', 2494: 'FENTANYL/HEROIN', 2495: 'SULFONYLUREAS-NOS', 2496: 'COCAINE/FORMALDEHYDE', 2497: 'COCAINE/METHYLENEDIOXYMETHAMPHETAMINE', 2498: 'CYPROTEREONE ACETATE-ETHINYL ESTRADIOL', 2499: 'FAT DISSOLVING AGENTS-NOS', 2500: 'HEROIN/METHYLENEDIOXYMETHAMPHETAMINE', 2501: 'PROPOLIS', 2502: 'SENNA', 2503: 'FENFLURAMINE/PHENTERMINE', 2504: 'ACNE', 2505: 'CLONIXIN', 2506: 'PROGESTINS-NOS', 2507: 'RABIES', 2508: 'INFLUENZA VIRUS VACCINE, H1N1-NOS', 2509: 'ACAI BERRY', 2510: 'ALUM', 2511: 'AMMONIA', 2512: 'BENZYLPIPERAZINE', 2513: 'BLUE GREEN ALGAE', 2514: 'CYCLOPHOSPHAMIDE/DOXORUBICIN/RITUXIMAB/VINCRISTINE/PREDNISONE', 2515: 'HOODIA', 2516: 'HYALURONIC ACID', 2517: 'PAPAVERINE/PHENTOLAMINE', 2518: 'STATIN-NOS', 2519: 'TEA TREE OIL', 2520: 'TRIFLUOROMETHYLPHENYLPIPERAZINE', 2521: '4-METHYLMETHCATHINONE', 2522: 'PHENAZEPAM', 2523: '4-BROMO-3,6-DIMETHOXYBENZOCYCLOBUTEN', 2524: 'SYNTHETIC CANNABINOID', 2525: 'AFATINIB', 2526: 'AMPHETAMINE/MARIJUANA', 2527: 'AXITINIB', 2528: 'BLEOMYCIN/DACARBAZINE/DOXORUBICIN/VINBLASTINE', 2529: 'CAFFEINE COMBINATIONS-NOS', 2530: 'CAPECITABINE/OXALIPLATIN', 2531: 'COLLOIDAL SILVER', 2532: 'DOCETAXEL/FLUOROURACIL/OXALIPLATIN', 2533: 'DOMPERIDONE', 2534: 'FLUOROURACIL/IRINOTECAN/LEUCOVORIN', 2535: 'IFOSFAMIDE/CARBOPLATIN/ETOPOSIDE/RITUXIMAB', 2536: 'KETAMINE/MARIJUANA', 2537: 'L-TRYPTOPHAN/MELATONIN', 2538: 'MARIJUANA/OXYCODONE', 2539: 'METAMIZOLE', 2540: '3,4-METHYLENEDIOXYPYROVALERONE', 2541: 'PANOBINOSTAT', 2542: 'PROBIOTICS-NOS', 2543: 'SPERMICIDES-NOS', 2544: 'TILMICOSIN', 2545: 'AMPHETAMINES-NOS', 2546: 'ILLICIT COMBINATIONS-NOS', 2547: 'VITAMIN D', 2548: 'TRENBOLONE', 2549: 'PYLORI ERADICATIONAGENTS-NOS', 2550: 'SMOKING CESSATION AGENTS-NOS', 2551: '4-BROMO-2,5-DIMETHOXYAMPHETAMINE', 2552: 'PROTEASE INHIBITORS-NOS', 2553: '4-METHOXYMETHCATHINONE', 2554: 'ELASTIN', 2555: 'TALCUM POWDER TOPICAL', 2556: 'METHYLENEDIOXYMETHAMPHETAMINE/CAFFEINE', 2557: 'ENERGY DRINK', 2558: 'CAFFEINE/MULTIVITAMIN NTA'}}\n",
      "CASEID\n",
      "1                                ALCOHOL\n",
      "2                             DABIGATRAN\n",
      "3                        ANTIBIOTICS-NOS\n",
      "4                                INSULIN\n",
      "5                                ALCOHOL\n",
      "                       ...              \n",
      "229207               HYDROCHLOROTHIAZIDE\n",
      "229208                        CLONAZEPAM\n",
      "229209           AMOXICILLIN-CLAVULANATE\n",
      "229210                       AMOXICILLIN\n",
      "229211    ACETAMINOPHEN-CHLORPHENIRAMINE\n",
      "Name: DRUGID_1, Length: 229211, dtype: object\n",
      "CASEID\n",
      "1         MARIJUANA\n",
      "2               NaN\n",
      "3               NaN\n",
      "4               NaN\n",
      "5            HEROIN\n",
      "            ...    \n",
      "229207          NaN\n",
      "229208          NaN\n",
      "229209          NaN\n",
      "229210          NaN\n",
      "229211          NaN\n",
      "Name: DRUGID_2, Length: 229211, dtype: object\n"
     ]
    }
   ],
   "source": [
    "drug_dict = drugnames.to_dict() \n",
    "\n",
    "print(drug_dict)\n",
    "\n",
    "for column, drug_dict in drug_dict.items():\n",
    "    df['DRUGID_1'] = df['DRUGID_1'].map(drug_dict)\n",
    "    df['DRUGID_2'] = df['DRUGID_2'].map(drug_dict)\n",
    "    df['DRUGID_3'] = df['DRUGID_3'].map(drug_dict)\n",
    "    df['DRUGID_4'] = df['DRUGID_4'].map(drug_dict)\n",
    "    df['DRUGID_5'] = df['DRUGID_5'].map(drug_dict)\n",
    "    df['DRUGID_6'] = df['DRUGID_6'].map(drug_dict)\n",
    "    df['DRUGID_7'] = df['DRUGID_7'].map(drug_dict)\n",
    "    df['DRUGID_8'] = df['DRUGID_8'].map(drug_dict)\n",
    "    df['DRUGID_9'] = df['DRUGID_9'].map(drug_dict)\n",
    "    df['DRUGID_10'] = df['DRUGID_10'].map(drug_dict)\n",
    "    df['DRUGID_11'] = df['DRUGID_11'].map(drug_dict)\n",
    "    df['DRUGID_12'] = df['DRUGID_12'].map(drug_dict)\n",
    "    df['DRUGID_13'] = df['DRUGID_13'].map(drug_dict)\n",
    "    df['DRUGID_14'] = df['DRUGID_14'].map(drug_dict)\n",
    "    df['DRUGID_15'] = df['DRUGID_15'].map(drug_dict)\n",
    "    df['DRUGID_16'] = df['DRUGID_16'].map(drug_dict)\n",
    "    df['DRUGID_17'] = df['DRUGID_17'].map(drug_dict)\n",
    "    df['DRUGID_18'] = df['DRUGID_18'].map(drug_dict)\n",
    "    df['DRUGID_19'] = df['DRUGID_19'].map(drug_dict)\n",
    "    df['DRUGID_20'] = df['DRUGID_20'].map(drug_dict)\n",
    "    df['DRUGID_21'] = df['DRUGID_21'].map(drug_dict)\n",
    "    df['DRUGID_22'] = df['DRUGID_22'].map(drug_dict)\n",
    "\n",
    "print(df['DRUGID_1'])\n",
    "print(df['DRUGID_2'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Subplot histograms of all quantitative variables"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[<matplotlib.axes._subplots.AxesSubplot object at 0x00000167C2831B48>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B99F5308>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B92EC4C8>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x00000167B9943208>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B92E0F48>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B935CCC8>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x00000167B957EA48>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B95B57C8>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x00000167B95BB648>]],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA7kAAAQCCAYAAABpDT/4AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4xLjMsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+AADFEAAAgAElEQVR4nOzdfXTV1Z3v8XfICRFMWsSeEBopqz60TOEWHGIvzJpJamdIAuEIRlmjRPC2MwW5lQdvGxtCCsUWQY2AVIPTTju1qLfkUk2QFUIfKLg60QJpCwuH21spUCFOSIBKEknI0/2DxRljqDwlhPx8v9ZiJWefffb5fQ9yPJ/fb+99Yjo6OjqQJEmSJCkA+vX2AUiSJEmS1F0MuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwAj19gEoeNra2vjRj37EK6+8QltbGy0tLdx+++3Mnz+f/v37A7B161bmzJnDqlWrmDRpUqfHf+9732PTpk10dHTQ3t7O3/3d3/HQQw/Rv39/XnrpJZYtW8YNN9zQ6TGf/vSn+drXvsbnP/95KisrGTRoEABPPvkk3/3ud9m8eTM33nhjdPw33niD1atXA7BhwwbWr19PY2Mjp0+fZtiwYSxYsIDRo0dTWVnJY489BkBdXR1tbW0MGTIEgNmzZ3c5dkkCOHz4MH//93/Pt7/9baZNmxZt//73v88f/vAHPve5z7Flyxb+5V/+pdPjZs+eTWZmJjk5OcyYMYMdO3bw85//nGHDhkX7/PrXv2bmzJk8/PDD/NM//RMNDQ2sWLGC3bt3ExMTQ79+/cjNzY0+b35+Prfccgv/9E//1Om5br31Vl555RVuuOEGPv3pT/OpT32Kfv360d7eTkxMDPPmzeMf/uEfANi/fz+PPfYYb7/9NgAf/ehHWbBgAampqT3y+knSWYcPH2bChAl86lOfirZ1dHQwc+ZM7r77brZt28batWs5deoUbW1t3HzzzSxcuJDk5GQOHz5MJBLht7/9bacxz74Xr1ix4kqXoyvEkKtu981vfpN33nmH5557jsTERN59912+9rWvsWjRIp544gkAXnzxRSKRCD/84Q87BcXNmzfz85//nPXr13PNNdfQ3NzMvHnzePrpp/lf/+t/AZCamtrlg+FZn/rUp9i1a1f0g9m2bdu4/fbb2bp1azTkvv7660QiEQBWrlzJzp07Wb16NSkpKQC89tprzJ49m5deeom/+Zu/oaysDIDvfOc7nDhxgsWLF/fAqyYpaPr168djjz3G2LFjo+8/F+vjH/84ZWVlPPjgg9G20tJSPvaxj0VvP/nkkwwcOJCNGzcSExNDTU0N//iP/8jQoUP527/92wt+rueee47BgwcDsHv3bu6//3527NhB//79mTdvHgsWLGDChAkA7Ny5k9mzZ/OLX/wielJRknrKNddcE/08BlBTU8PkyZMZPnw4X//613nppZein+PWrl3LggUL+PGPf9xbh6urgNOV1a0OHz7MK6+8wqOPPkpiYiIAAwcOZOnSpdHg+dZbb7Fjxw4WLlzIoUOH+N3vfhd9fG1tLW1tbTQ1NQEQHx/PN77xjehjzyctLY1f//rX0WM5ffo0999/P1u3bgXg9OnT/Pa3v+Xv/u7vqKur47nnnuOpp56KvjECjB8/nvz8fE6dOnX5L4ikD61rrrmGL37xi3zta1/j9OnTlzTGHXfcwSuvvBK9ferUKX7zm98wfvz4aFttbS3Nzc20tLQAMGTIEL7zne8wfPjwSz72P//5zwwePJhQKBR9jnfffTd6/2233cbq1auJjY295OeQpEs1ZMgQhg8fzq9//WtaWlo6vT/df//9zJ49uxePTlcDr+SqW73xxhvcfPPNJCQkdGoPh8NkZmYC8L//9//m85//PNdffz2TJk3ihz/8YXTq8J133sm2bdv427/9W0aOHMmtt97K3//933PbbbdFx9q1axdTpkzpNP7MmTO56667SEtL41vf+hYAv/zlL/n85z9Pamoqb775JsePH2f//v3cfPPNXH/99fz85z/npptuIikpqUsdU6dO7dbXRdKH05w5c3jttddYtWoVX//61y/68X/1V3/F1q1b2b17N6NHj+anP/0pX/jCFzhx4kS0z4MPPsj8+fMZN24ct956K3/913/NpEmTOk1xvhD3338//fr149133+Wtt97ikUceoV+/M+fCFy9ezNKlS3niiScYO3Yst912G5MnT46ezJSkK+m3v/0tf/rTn7jrrrtoaGjgzjvv5BOf+AR//dd/zfjx46OfOfXhZchVtzq7nusvOX36NC+99BKPPvoocCbU3nvvvbz99tsMHTqUxMREfvCDH/DWW2/x+uuvs2PHDmbNmsX06dPJy8sDPni68pgxY3j77bf585//zC9/+Uu+/OUvExcXx7hx43j99dfZv38/6enpwJn1HO/V0NBAbm4uAO+++y4TJ06MTpGWpEvRr18/nnjiCaZOndpp6vDZ8Ph+7e3tXe6bMmUKGzduZPTo0ZSWlrJw4UJ+8IMfRO8fMWIEFRUVvPHGG+zcuZN///d/59lnn+Wpp57iC1/4AjExMX/xud57Jfa905X/4z/+gy9+8YvcdNNNjB07lsmTJzNhwgSqqqrYuXMnP/nJT1i7di3r16/vskeCJHW3pqam6AWOtrY2rrvuOp544gmGDh1Kfn4+s2fPZseOHezcuZPHH3+cdevW8cILL1zUe62Cxb9ddavPfvaz/PGPf6ShoaFTe01NDbNmzaK8vJyTJ0/yrW99iy984QssWLCAmJgY1q1bB5zZFOo3v/kNw4YNY9q0aTzxxBN873vf48UXX7yg5w+FQowbN45XX32Vffv2RTdFSU9Pp6qqitdff53Pf/7z0WM9cOBA9IpIQkICZWVllJWVcccdd3SpQZIuxdChQ1m6dClf//rXo+831113HX/+85+79D127BjXXXddp7ZIJMKWLVt46623aGho6LT5SmtrK4sXL+add95h1KhRfPGLX+Rf//VfmTNnDuvXr/+Lz9XQ0EBzczMf+chHznnMn/nMZxg7dixVVVXs37+foqIi4uPj+Zu/+Rvmz5/Pyy+/zC233MKWLVsu67WRpAtxdk1uWVkZmzZtYt26daSnp/OLX/yCn/zkJ1x33XVkZmZSWFhIeXk5b775Jv/xH//BRz/6UZqammhubu403rFjx9xPIOAMuepWQ4YMIRKJUFBQEA2JDQ0NfPOb32TQoEH8+Mc/5oEHHuCXv/wlW7duZevWrXzzm9/k//yf/8O7775LU1MTTz75ZKcPZP/v//0/PvOZz1zwMaSlpfGv//qvfO5znyMuLg44E3Jfe+013n777ehYQ4YMYebMmcyfP5/q6uro448cOcJvfvMbz/BJ6jZZWVmkpaXx3HPPAWd2Nj506BC7du2K9vn1r3/NkSNHuPXWWzs9dsiQIXz605+moKCgy1KNUCjEgQMHKC4ujq7JbW1tZf/+/dH3urS0NDZv3kxNTQ1wZhbLc889x2233ca11157zuM9duwYe/fu5b/9t//Gxz72MUpKSqioqIje/+c//5mampqLem+WpO527bXXsnLlSt58881o21tvvUVsbCyf+MQnuPbaaxk7dmz0vRfOXHipqKiIzuxTMDldWd1uyZIlFBcXc8899xAbG8vp06f5h3/4B7Kzs/nHf/xHiouLO/WfOnUqa9eu5eWXX+Z//s//SUxMDPfccw8xMTG0t7czatSo6JpdOPea3NjYWF566SXgzAe6RYsW8aUvfSl6/8c+9jEGDhzImDFjOk3de+ihh9i4cSNf/epXOXXqFPX19Xz0ox9l0qRJ0anLktQdCgsLqaqqAuAjH/kITz/9NE8++SSNjY20tbUxePBg/uVf/uWcV1enTJlCQUEB3/nOd7rc99RTT/HEE0+QmZnJgAEDaG9vZ8KECXzlK18BYNy4cXz5y19m1qxZwJlpf5/5zGd48sknO41zdk0unFlaMmvWrOgGV8899xxPPvkkjz/+OAMGDKB///7Mnj270wZYknSljRs3jm984xt8/etfp76+ntjYWMLhMN/73vf46Ec/CkBRURGPPvoo2dnZ9OvXj9jYWObNm8d//+//vZePXj0ppuP9CxMlSZIkSeqjnI8pSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZKky/LUU08xadIksrOz+bd/+zcAFi5cSEZGBlOmTGHKlCn87Gc/A6CyspJIJEJGRgarVq2KjrFv3z5ycnLIzMxk0aJFtLa2AlBdXU1ubi5ZWVnMmTOHxsbGK1+gpD7FkCtJkqRLtmPHDl5//XU2btzIT37yE9atW8cf//hH9u7dy/PPP09ZWRllZWVMmDCBpqYmCgoKKC4upry8nL1797J9+3YA8vLyWLx4MVu2bKGjo4OSkhIAli5dyvTp06moqGDUqFFdvopQkt4vsN+Te+JEI+3t5/92pOuvT+DYsYYrcERXTtBqsp6r35WqqV+/GK677toef54gudD3wr4kiP+GIJh1BbEm6P26rrb3ws997nP86Ec/IhQKUVNTQ1tbG9dccw3V1dUUFBRQU1PDhAkTePDBB9mzZw/Dhw9n2LBhAEQiESoqKrj55ptpampizJgxAOTk5LBmzRqmTZvGzp07eeaZZ6Lt9913H3l5eRd8fB+Wz4R9/fih79fQ148f+k4N53sfDGzIbW/vuOAPdkH7AAjBq8l6rn5BrCkILua9sC8JYk0QzLqCWBMEt65LFRcXx5o1a/jBD35AVlYWra2tjBs3jiVLlpCYmMjs2bPZsGEDAwcOJBwORx+XlJRETU0NR48e7dQeDoepqanhxIkTJCQkEAqFOrVfjIs5IXD99QkXNfbVpq8fP/T9Gvr68UMwaghsyJUkSdKVM2/ePL785S/zwAMP8Nprr0WvvgLMmDGD0tJSMjMziYmJibZ3dHQQExNDe3v7OdvP/nyv998+n2PHGi7opEQ4nEhtbf1FjX016evHD32/hr5+/NB3aujXL+YDw7hrciVJknTJ9u/fz759+wAYMGAAGRkZlJeXs2XLlmifjo4OQqEQycnJ1NbWRttra2tJSkrq0l5XV0dSUhKDBw+mvr6etra2Tv0l6YMYciVJknTJDh8+TGFhIadPn+b06dP84he/4LbbbuPRRx/lnXfeoaWlhfXr1zNhwgRGjx7NgQMHOHToEG1tbWzatIm0tDRSUlKIj4+nqqoKgLKyMtLS0oiLiyM1NZXy8nIASktLSUtL681yJfUBTleWJEnSJUtPT2fPnj1MnTqV2NhYMjIyePDBB7nuuuu49957aW1tJSMjg8mTJwOwYsUK5s6dS3NzM+np6WRlZQFQVFREYWEhDQ0NjBw5kpkzZwKwZMkS8vPzWbt2LUOHDmXlypW9VqukviGmo6MjkDsnfFjWX5xL0GqynqvflarpfOsv1NWFvhf2JUH8NwTBrCuINUHv1+V74cX5sHwm7OvHD32/hr5+/NB3anBNriRJkiTpQ8OQK0mSJEkKDEOuJEmSJCkwDLmSJEmSpMAw5EqSJEmSAsOvEAISPzKAa+K7/6Voam6l/uSpbh9XkrpbT70Pgu+FkqTOPuj/OeFw4iWP6/9vdJYhF7gmPkTkq2XdPu4rT07h6t+AW5J67n0QfC+UJHXmZ2/1NKcrS5IkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZIC44JC7tNPP012djbZ2dk8/vjjAFRWVhKJRMjIyGDVqlXRvvv27SMnJ4fMzEwWLVpEa2srANXV1eTm5pKVlcWcOXNobGwE4OTJk8yaNYuJEyeSm5tLbW0tAKdPnyYvL4+JEydy5513sn///m4tXJIkSZIUPOcNuZWVlfzqV7/i5ZdfprS0lDfeeINNmzZRUFBAcXEx5eXl7N27l+3btwOQl5fH4sWL2bJlCx0dHZSUlACwdOlSpk+fTkVFBaNGjaK4uBiA1atXk5qayubNm5k2bRrLli0DYN26dQwYMIDNmzdTUFDAwoULe+o1kCRJkiQFxHlDbjgcJj8/n/79+xMXF8dNN93EwYMHGT58OMOGDSMUChGJRKioqODIkSM0NTUxZswYAHJycqioqKClpYWdO3eSmZnZqR1g27ZtRCIRACZPnsyrr75KS0sL27Zt44477gDgtttu4/jx41RXV/fIiyBJkiRJCobzhtxbbrklGloPHjzI5s2biYmJIRwOR/skJSVRU1PD0aNHO7WHw2Fqamo4ceIECQkJhEKhTu1Ap8eEQiESEhI4fvz4Ocf6z//8z24oWZIkSZIUVKEL7fiHP/yB2bNn8/DDDxMbG8vBgwej93V0dBATE0N7ezsxMTFd2s/+fK/3337vY/r169flMWfbL9T11ydccN+eFA4nfqiet6dYz9UviDW919NPP83mzZsBSE9P5+GHH6ayspLly5fT3NzMxIkTeeihh4AzexMsWrSIxsZGUlNTWbp0KaFQiOrqavLy8jh27Bif/OQnKSoq4tprr+XkyZN87Wtf46233mLw4MGsXr2acDjM6dOnWbRoEXv37uWaa66hqKiIm266qTdfBkmSpKveBYXcqqoq5s2bR0FBAdnZ2ezYsSO6QRRAbW0tSUlJJCcnd2qvq6sjKSmJwYMHU19fT1tbG7GxsdH+cOYqcF1dHcnJybS2ttLY2MigQYMYMmQIR48e5ROf+ESnsS7UsWMNtLd3nLdfT38wr62t79HxzyUcTuyV5+0p1nP1u1I19esX0ysnsN67N0FMTAz//M//zKZNmygqKmLdunUMHTqU2bNns337dtLT08nLy+Pb3/42Y8aMoaCggJKSEqZPnx7dmyA7O5tnnnmG4uJi8vLyonsTfPe736W0tJRly5axevXqTnsT7Ny5k4ULF0b3OZAkSdK5nffS6Ntvv81XvvIVioqKyM7OBmD06NEcOHCAQ4cO0dbWxqZNm0hLSyMlJYX4+HiqqqoAKCsrIy0tjbi4OFJTUykvLwegtLSUtLQ04MwVkdLSUgDKy8tJTU0lLi6O9PR0ysrKANi1axfx8fF8/OMf7/5XQJLOw70JJEmS+o7zXsn9/ve/T3NzMytWrIi23XPPPaxYsYK5c+fS3NxMeno6WVlZABQVFVFYWEhDQwMjR45k5syZACxZsoT8/HzWrl3L0KFDWblyJQDz588nPz+f7OxsEhMTKSoqAmDGjBksXryY7Oxs+vfvH/3qIkm60m655Zbo72f3Jrjvvvt6bW+CiznhF9SlG0GdHh/EuoJYEwS3LkkKgvOG3MLCQgoLC89538aNG7u0jRgxgg0bNnRpT0lJYd26dV3aBw0axLPPPtulPT4+nscee+x8hydJV0xf25sAgrl0I4hT/iGYdQWxJuj9unpr6YYk9RUX92lJkj6kqqqq+B//43/w1a9+lTvvvLPLHgQXszfBe/vDf+1NAJxzb4L3jyVJV5unnnqKSZMmkZ2dzb/9278BZ/YziEQiZGRksGrVqmjfffv2kZOTQ2ZmJosWLaK1tRWA6upqcnNzycrKYs6cOTQ2NgJw8uRJZs2axcSJE8nNze30HitJ52LIlaTzcG8CSfrLduzYweuvv87GjRv5yU9+wrp16/i///f/UlBQQHFxMeXl5ezdu5ft27cDkJeXx+LFi9myZQsdHR3RDfXObs5XUVHBqFGjKC4uBohuzrd582amTZvGsmXLeq1WSX2DIVeSzuO9exNMmTKFKVOm8NJLL0X3Jpg0aRI33nhjp70Jli9fTlZWFu+++26nvQlKSkqYNGkSu3btYsGCBcCZvQl+97vfkZ2dzYsvvsjixYuBM3sTnD59muzsbJYtW+beBJKuSp/73Of40Y9+RCgU4tixY7S1tXHy5Mke35xPkv6SC/6eXEn6sHJvAkn6YHFxcaxZs4Yf/OAHZGVlddk4ryc25xsyZMgVrFBSX2LIlSRJ0mWbN28eX/7yl3nggQc4ePDgOTfh687N+S7UxWzS1dd3ze7rx98devs16O3n7w5BqMGQK0mSpEu2f/9+Tp8+zV/91V8xYMAAMjIyqKioIDY2NtrnYjbni42NPefmfMnJyZ0257tQF7PLfF/eDbwvHX9PhqjefA360t/BX9JXajjfLvOuyZUkSdIlO3z4MIWFhZw+fZrTp0/zi1/8gnvuuafHN+eTpL/EK7mSJEm6ZOnp6ezZs4epU6cSGxtLRkYG2dnZDB48mLlz59Lc3Ex6enqnzfkKCwtpaGhg5MiRnTbny8/PZ+3atQwdOpSVK1cCZzbny8/PJzs7m8TERIqKinqtVkl9gyFXkiRJl2Xu3LnMnTu3U9v48eN7dHM+SfpLnK4sSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTAMuZIkSZKkwDDkSpIkSZICw5ArSZIkSQoMQ64kSZIkKTBCvX0AkiRJkvRhlPiRAVwT3zORrKm5lfqTp3pk7KudIVeSJEnqQQYZ/SXXxIeIfLWsR8Z+5ckp1PfIyFc/Q64kSZLUgwwy0pXlmlxJkiRJUmAYciVJkiRJgWHIlSRJkiQFhiFXkiRJkhQYhlxJkiRJUmAYciVJkiRJgWHIlSRJkiQFhiFXkiRJkhQYhlxJkiRJUmAYciVJknRZnn76abKzs8nOzubxxx8HYOHChWRkZDBlyhSmTJnCz372MwAqKyuJRCJkZGSwatWq6Bj79u0jJyeHzMxMFi1aRGtrKwDV1dXk5uaSlZXFnDlzaGxsvPIFSupTDLmSJEm6ZJWVlfzqV7/i5ZdfprS0lDfeeIOf/exn7N27l+eff56ysjLKysqYMGECTU1NFBQUUFxcTHl5OXv37mX79u0A5OXlsXjxYrZs2UJHRwclJSUALF26lOnTp1NRUcGoUaMoLi7uzXIl9QGGXEmSJF2ycDhMfn4+/fv3Jy4ujptuuonq6mqqq6spKCggEomwZs0a2tvb2bNnD8OHD2fYsGGEQiEikQgVFRUcOXKEpqYmxowZA0BOTg4VFRW0tLSwc+dOMjMzO7VL0gcJ9fYBSJIkqe+65ZZbor8fPHiQzZs388ILL7Bjxw6WLFlCYmIis2fPZsOGDQwcOJBwOBztn5SURE1NDUePHu3UHg6Hqamp4cSJEyQkJBAKhTq1X4zrr0+44L7hcOJFjX21OHvcffX4u1Nvvwa9/fzvdynHc7XVcCkMuZIkSbpsf/jDH5g9ezYPP/wwN954I88880z0vhkzZlBaWkpmZiYxMTHR9o6ODmJiYmhvbz9n+9mf7/X+2+dz7FgD7e0d5+0XDidSW1t/UWNfqJ4MDadb2ugfF9vt4zY1t1J/8lS3jws9+3r01N/hhbiU/4Z6OlBeyvH05mt4ofr1i/nAE1iGXEmSJF2Wqqoq5s2bR0FBAdnZ2fz+97/n4MGD0WnGHR0dhEIhkpOTqa2tjT6utraWpKSkLu11dXUkJSUxePBg6uvraWtrIzY2Ntpf/6V/XCyRr5Z1+7ivPDmFqz/qSOfmmlxJkiRdsrfffpuvfOUrFBUVkZ2dDZwJtY8++ijvvPMOLS0trF+/ngkTJjB69GgOHDjAoUOHaGtrY9OmTaSlpZGSkkJ8fDxVVVUAlJWVkZaWRlxcHKmpqZSXlwNQWlpKWlpar9UqqW/wSq4kSZIu2fe//32am5tZsWJFtO2ee+5h1qxZ3HvvvbS2tpKRkcHkyZMBWLFiBXPnzqW5uZn09HSysrIAKCoqorCwkIaGBkaOHMnMmTMBWLJkCfn5+axdu5ahQ4eycuXKK1+kpD7FkCtJkqRLVlhYSGFh4Tnvy83N7dI2fvx4Nm7c2KV9xIgRbNiwoUt7SkoK69atu/wDlfSh4XRlSZIkSVJgGHIlSZIkSYFhyJUkSZIkBcYFh9yGhgYmT57M4cOHAVi4cCEZGRlMmTKFKVOm8LOf/QyAyspKIpEIGRkZrFq1Kvr4ffv2kZOTQ2ZmJosWLaK1tRWA6upqcnNzycrKYs6cOTQ2NgJw8uRJZs2axcSJE8nNze20rbwkSZIkSedyQSF39+7d3HvvvRw8eDDatnfvXp5//nnKysooKytjwoQJNDU1UVBQQHFxMeXl5ezdu5ft27cDkJeXx+LFi9myZQsdHR2UlJQAsHTpUqZPn05FRQWjRo2iuLgYgNWrV5OamsrmzZuZNm0ay5Yt6+bSJUmSJElBc0Eht6SkhCVLlkS/fPvUqVNUV1dTUFBAJBJhzZo1tLe3s2fPHoYPH86wYcMIhUJEIhEqKio4cuQITU1NjBkzBoCcnBwqKipoaWlh586d0S8KP9sOsG3bNiKRCACTJ0/m1VdfpaWlpdtfAEmSJElScFxQyF22bBmpqanR23V1dYwbN45HH32UkpISdu3axYYNGzh69CjhcDjaLykpiZqami7t4XCYmpoaTpw4QUJCAqFQqFM70OkxoVCIhIQEjh8/fvkVS9IlctmGJEnS1e+Svid32LBhPPPMM9HbM2bMoLS0lMzMTGJiYqLtHR0dxMTE0N7efs72sz/f6/233/uYfv0ufJ+s669PuOC+PSkcTvxQPW9PsZ6rXxBreq/du3dTWFh4zmUbZ2e5ANFlG+vWrWPo0KHMnj2b7du3k56eTl5eHt/+9rcZM2YMBQUFlJSUMH369OiyjezsbJ555hmKi4vJy8uLLtv47ne/S2lpKcuWLWP16tW9UL0kfTgkfmQA18Rf0sdjSVeRS/pX/Pvf/56DBw9Gpxl3dHQQCoVITk7udKWhtraWpKSkLu11dXUkJSUxePBg6uvraWtrIzY2NtofzlwFrqurIzk5mdbWVhobGxk0aNAFH+OxYw20t3ect19PfzCvra3v0fHPJRxO7JXn7SnWc/W7UjX16xfTayewzi7bePjhh4HOyzZqamqYMGECDz74YNvGuF0AACAASURBVKdlG0B02cbNN9/cZdnGmjVrmDZtGjt37oyeOMzJyeG+++4jLy+Pbdu28cILLwBnlm088sgjtLS0EBcX1wuvgCQF3zXxISJfLev2cV95ckq3jynpL7ukkNvR0cGjjz7KuHHjGDhwIOvXr+fOO+9k9OjRHDhwgEOHDnHDDTewadMm7rrrLlJSUoiPj6eqqoqxY8dSVlZGWloacXFxpKamUl5eTiQSobS0lLS0NADS09MpLS3lgQceoLy8nNTUVD/YSeo179/87uyyjSVLlpCYmMjs2bPZsGEDAwcO7PFlG0OGDLng4w7qrJagzhwIYl1BrAmCW5ckBcElhdwRI0Ywa9Ys7r33XlpbW8nIyGDy5MkArFixgrlz59Lc3Ex6ejpZWVkAFBUVUVhYSENDAyNHjmTmzJkALFmyhPz8fNauXcvQoUNZuXIlAPPnzyc/P5/s7GwSExMpKirqjnolqVv0hWUbEMxZLUGcDQHBrCuINUHv19Wbs1okqS+4qJC7devW6O+5ubnk5uZ26TN+/Hg2btzYpX3EiBFs2LChS3tKSgrr1q3r0j5o0CCeffbZizk8Sbpi+sKyDUmSpA+ji7skIEkC/mvZxjvvvENLSwvr169nwoQJnZZttLW1sWnTJtLS0jot2wDOuWwDOOeyDcBlG5IkSRfI7eMk6RK4bEOSJOnqZMiVpIvgsg1JkqSrm9OVJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmX7OmnnyY7O5vs7Gwef/xxACorK4lEImRkZLBq1apo33379pGTk0NmZiaLFi2itbUVgOrqanJzc8nKymLOnDk0NjYCcPLkSWbNmsXEiRPJzc2ltrb2yhcoqc8x5EqSJOmSVFZW8qtf/YqXX36Z0tJS3njjDTZt2kRBQQHFxcWUl5ezd+9etm/fDkBeXh6LFy9my5YtdHR0UFJSAsDSpUuZPn06FRUVjBo1iuLiYgBWr15NamoqmzdvZtq0aSxbtqzXapXUdxhyJUmSdEnC4TD5+fn079+fuLg4brrpJg4ePMjw4cMZNmwYoVCISCRCRUUFR44coampiTFjxgCQk5NDRUUFLS0t7Ny5k8zMzE7tANu2bSMSiQAwefJkXn31VVpaWnqnWH2oJX5kAOFw4gf+Ac7b51yPUfcL9fYBSJIkqW+65ZZbor8fPHiQzZs3c9999xEOh6PtSUlJ1NTUcPTo0U7t4XCYmpoaTpw4QUJCAqFQqFM70OkxoVCIhIQEjh8/zpAhQ65EeVLUNfEhIl8t6/ZxX3lySrePKUOuJEmSLtMf/vAHZs+ezcMPP0xsbCwHDx6M3tfR0UFMTAzt7e3ExMR0aT/7873ef/u9j+nX7+ImIl5/fcJF9dcZp1va+uSVxr54zD3pUl6PILyGhlxJkiRdsqqqKubNm0dBQQHZ2dns2LGj0wZRtbW1JCUlkZyc3Km9rq6OpKQkBg8eTH19PW1tbcTGxkb7w5mrwHV1dSQnJ9Pa2kpjYyODBg26qOM7dqyB9vaO8/YLwgf77tQ/LrZHrlxCz169rK2t75Fx++p/Hxf7eoTDiT32Gnanfv1iPvAElmtyJUmSdEnefvttvvKVr1BUVER2djYAo0eP5sCBAxw6dIi2tjY2bdpEWloaKSkpxMfHU1VVBUBZWRlpaWnExcWRmppKeXk5AKWlpaSlpQGQnp5OaWkpAOXl5aSmphIXF9cLlUrqS7ySK0mSpEvy/e9/n+bmZlasWBFtu+eee1ixYgVz586lubmZ9PR0srKyACgqKqKwsJCGhgZGjhzJzJkzAViyZAn5+fmsXbuWoUOHsnLlSgDmz59Pfn4+2dnZJCYmUlRUdOWLlNTnGHIlSZJ0SQoLCyksLDznfRs3buzSNmLECDZs2NClPSUlhXXr1nVpHzRoEM8+++zlH6ikDxWnK0uSJEmSAsOQK0mSJEkKDKcrS5IkSerz+urXHqn7GXIlSZIk9Xl99WuP1P2crixJkiRJCgxDriRJkiQpMJyuLEmSJEkBc6lrlM/3mKbmVupPnrrUw7oiDLmSJEmSFDA9tUb5lSenUN/to3YvpytLkiRJkgLDkCtJkiRJCgxDriRJkiQpMAy5kiRJkqTAMORKkiRJkgLDkCtJkiRJCgxDriRJkiQpMAy5kiRJkqTAMORKkiRJkgLDkCtJkiRJCgxDriRJkiQpMAy5kiRJkqTAMORKkiRJkgLDkCtJkiRJCgxDriRJkiQpMAy5kiRJkqTAMORKkiRJkgLjgkJuQ0MDkydP5vDhwwBUVlYSiUTIyMhg1apV0X779u0jJyeHzMxMFi1aRGtrKwDV1dXk5uaSlZXFnDlzaGxsBODkyZPMmjWLiRMnkpubS21tLQCnT58mLy+PiRMncuedd7J///5uLVqSJEmSFEznDbm7d+/m3nvv5eDBgwA0NTVRUFBAcXEx5eXl7N27l+3btwOQl5fH4sWL2bJlCx0dHZSUlACwdOlSpk+fTkVFBaNGjaK4uBiA1atXk5qayubNm5k2bRrLli0DYN26dQwYMIDNmzdTUFDAwoULe6J2SZIkSVLAnDfklpSUsGTJEpKSkgDYs2cPw4cPZ9iwYYRCISKRCBUVFRw5coSmpibGjBkDQE5ODhUVFbS0tLBz504yMzM7tQNs27aNSCQCwOTJk3n11VdpaWlh27Zt3HHHHQDcdtttHD9+nOrq6u6vXpIugrNaJEmSrn7nDbnLli0jNTU1evvo0aOEw+Ho7aSkJGpqarq0h8NhampqOHHiBAkJCYRCoU7t7x8rFAqRkJDA8ePHzznWf/7nf15mqZJ06ZzVIkmSBKdb2giHE3vkT+JHBnTLMYYu9gHt7e3ExMREb3d0dBATE/MX28/+fK/3337vY/r169flMWfbL8b11ydcVP+eEg4nfqiet6dYz9UviDW919lZLQ8//DDQeVYLEJ3VcvPNN3eZ1bJmzRqmTZvGzp07eeaZZ6Lt9913H3l5eWzbto0XXngBODOr5ZFHHonOapk/fz7QeVbLxz/+8StdviRJEgD942KJfLWsR8Z+5ckp1HfDOBcdcpOTk6NT6QBqa2tJSkrq0l5XV0dSUhKDBw+mvr6etrY2YmNjo/3hzFXguro6kpOTaW1tpbGxkUGDBjFkyBCOHj3KJz7xiU5jXYxjxxpob+84b7+e/mBeW9sdf00XJxxO7JXn7SnWc/W7UjX16xfTayewzl5dPas3Z7VcTMgN6gm/oJ5UCWJdQawJglvXpWpoaOCee+7h2Wef5YYbbmDhwoVUVVUxYMCZqzIPPvggEyZMoLKykuXLl9Pc3MzEiRN56KGHgDPLPBYtWkRjYyOpqaksXbqUUChEdXU1eXl5HDt2jE9+8pMUFRVx7bXX9mapkvqAiw65o0eP5sCBAxw6dIgbbriBTZs2cdddd5GSkkJ8fDxVVVWMHTuWsrIy0tLSiIuLIzU1lfLyciKRCKWlpaSlpQGQnp5OaWkpDzzwAOXl5aSmphIXF0d6ejplZWWkpqaya9cu4uPjvXIh6arSV2a1BPGEXxBPFEEw6wpiTdD7dfXmCb9z2b17N4WFhdHlHAB79+7l+eef73SR4uwyj3Xr1jF06FBmz57N9u3bSU9PJy8vj29/+9uMGTOGgoICSkpKmD59enSZR3Z2Ns888wzFxcXk5eX1QpWS+pKL/p7c+Ph4VqxYwdy5c5k0aRI33ngjWVlZABQVFbF8+XKysrJ49913mTlzJgBLliyhpKSESZMmsWvXLhYsWADA/Pnz+d3vfkd2djYvvvgiixcvBmDGjBmcPn2a7Oxsli1bxuOPP95d9UpSt7icWS3v7Q//NasFOOeslvePJUlXk/dvUnrq1Cmqq6spKCggEomwZs0a2tvbu3XzUkn6IBd8JXfr1q3R38ePH8/GjRu79BkxYgQbNmzo0p6SksK6deu6tA8aNIhnn322S3t8fDyPPfbYhR6aJF1xzmqRpDPev5yjrq6OcePGsWTJEhITE5k9ezYbNmxg4MCB3bbM42JcTVe9JZ1fd8wuu+jpypKkzrNampubSU9P7zSrpbCwkIaGBkaOHNlpVkt+fj5r165l6NChrFy5EjgzqyU/P5/s7GwSExMpKioCzsxqWbx4MdnZ2fTv399ZLZL6hGHDhkU32YMz72WlpaVkZmb22DKPD3K1LNuQdGEuZDnI+ZZtGHIl6SI4q0WSPtjvf/97Dh48GJ1m3NHRQSgU6tbNSyXpg1z0mlxJkiTpL+no6ODRRx/lnXfeoaWlhfXr1zNhwoROyzza2trYtGkTaWlpnZZ5AOdc5gF0WuYhSR/EK7mSJEnqNiNGjGDWrFnce++9tLa2kpGRweTJkwG6bZmHJH0QQ64kSZIu23uXc+Tm5pKbm9ulT3ct85CkD+J0ZUmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSJEmBYciVJEmSJAWGIVeSJEmSFBiGXEmSJElSYBhyJUmSdFkaGhqYPHkyhw8fBqCyspJIJEJGRgarVq2K9tu3bx85OTlkZmayaNEiWltbAaiuriY3N5esrCzmzJlDY2MjACdPnmTWrFlMnDiR3Nxcamtrr3xxkvocQ64kSZIu2e7du7n33ns5ePAgAE1NTRQUFFBcXEx5eTl79+5l+/btAOTl5bF48WK2bNlCR0cHJSUlACxdupTp06dTUVHBqFGjKC4uBmD16tWkpqayefNmpk2bxrJly3qlRkl9iyFXkiRJl6ykpIQlS5aQlJQEwJ49exg+fDjDhg0jFAoRiUSoqKjgyJEjNDU1MWbMGABycnKoqKigpaWFnTt3kpmZ2akdYNu2bUQiEQAmT57Mq6++SktLSy9UKakvCfX2AUiSJKnvev/V1aNHjxIOh6O3k5KSqKmp6dIeDoepqanhxIkTJCQkEAqFOrW/f6xQKERCQgLHjx9nyJAhPV2WpD7MkCtJkqRu097eTkxMTPR2R0cHMTExf7H97M/3ev/t9z6mX7+Lm4h4/fUJF9VfUu8KhxMvewxDriRJkrpNcnJypw2iamtrSUpK6tJeV1dHUlISgwcPpr6+nra2NmJjY6P94cxV4Lq6OpKTk2ltbaWxsZFBgwZd1PEcO9ZAe3vHeft1xwdrSZevtrb+vH369Yv5wBNYrsmVJElStxk9ejQHDhzg0KFDtLW1sWnTJtLS0khJSSE+Pp6qqioAysrKSEtLIy4ujtTUVMrLywEoLS0lLS0NgPT0dEpLSwEoLy8nNTWVuLi43ilMUp/hlVxJkiR1m/j4eFasWMHcuXNpbm4mPT2drKwsAIqKiigsLKShoYGRI0cyc+ZMAJYsWUJ+fj5r165l6NChrFy5EoD58+eTn59PdnY2iYmJFBUV9VpdkvoOQ64kSZIu29atW6O/jx8/no0bN3bpM2LECDZs2NClPSUlhXXr1nVpHzRoEM8++2z3HqikwHO6siRJkiQpMAy5kiRJkqTAMORKkiRJkgLDkCtJkiRJCgxDriRJkiQpMAy5kiRJkqTAMORKkiRJkgLDkCtJkiRJCozQ5Tx4xowZHD9+nFDozDCPPPIIf/rTn1i7di2tra3cf//95ObmAlBZWcny5ctpbm5m4sSJPPTQQwDs27ePRYsW0djYSGpqKkuXLiUUClFdXU1eXh7Hjh3jk5/8JEVFRVx77bWXWa4kSZIkKcgu+UpuR0cHBw8epKysLPonOTmZVatW8eKLL1JaWsr69et58803aWpqoqCggOLiYsrLy9m7dy/bt28HIC8vj8WLF7NlyxY6OjooKSkBYOnSpUyfPp2KigpGjRpFcXFx91QsSd1oxowZZGdnM2XKFKZMmcLu3bt55ZVXmDRpEhkZGbzwwgvRvpWVlUQiETIyMli1alW0fd++feTk5JCZmcmiRYtobW0FoLq6mtzcXLKyspgzZw6NjY1XvD5JkqS+5pJD7h//+EcAvvSlL3HHHXfw/PPPU1lZybhx4xg0aBADBw4kMzOTiooK9uzZw/Dhwxk2bBihUIhIJEJFRQVHjhyhqamJMWPGAJCTk0NFRQUtLS3s3LmTzMzMTu2SdDXxZJ8kSdLV55JD7smTJxk/fjzPPPMMP/zhD/nxj39MdXU14XA42icpKYmamhqOHj16Qe3hcJiamhpOnDhBQkJCdBr02XZJupp4sk+SJOnqc8lrcm+99VZuvfXW6O27776b5cuXM2fOnGhbR0cHMTExtLe3ExMTc8HtZ3++1/tvn8/11ydcbEk9IhxO/FA9b0+xnqtfEGs6n7Mn+77xjW/Q0tLCzJkzmThxYpeTenv27PFknyRJ0hVyySF3165dtLS0MH78eOBMQE1JSaG2tjbap7a2lqSkJJKTky+ova6ujqSkJAYPHkx9fT1tbW3ExsZG+1+MY8caaG/vOG+/nv5gXltb36Pjn0s4nNgrz9tTrOfqd6Vq6tcv5qo5gQVX/8k+CO4Jv6CeVAliXUGsCYJblyQFwSWH3Pr6etasWcOPf/xjWlpaePnll3niiSfIy8vj+PHjDBgwgJ/+9Kd861vf4tOf/jQHDhzg0KFD3HDDDWzatIm77rqLlJQU4uPjqaqqYuzYsZSVlZGWlkZcXBypqamUl5cTiUQoLS0lLS2tO+uWpMt2tZ/sg2Ce8AviiSIIZl1BrAl6v66r7YSfJF1tLnlN7u233056ejpTp07lrrvu4q677mLs2LE89NBDzJw5k6lTpzJ58mQ++9nPEh8fz4oVK5g7dy6TJk3ixhtvJCsrC4CioiKWL19OVlYW7777LjNnzgRgyZIllJSUMGnSJHbt2sWCBQu6p2JJ6ib19fU8/vjjNDc309DQED3Z99prr3H8+HFOnTrFT3/6U9LS0hg9enT0ZF9bWxubNm0iLS2t08k+4Jwn+wBP9kmSJF2gy/qe3AULFnQJn5FIhEgk0qXv+PHj2bhxY5f2ESNGsGHDhi7tKSkprFu37nIOT5J61O23387u3buZOnUq7e3tTJ8+vdPJvpaWFu6++24++9nPAkRP9jU3N5Oent7pZF9hYSENDQ2MHDmy08m+/Px81q5dy9ChQ1m5cmWv1SpJktRXXFbIlaQPO0/2SZIkXV0uebqyJEmSJElXG0OuJEmSJCkwDLmSJEmSpMAw5EqSJEmSAsOQK0mSJEkKDEOuJEmSJCkwDLmSJEmSpMAw5EqSJEmSAsOQK0mSJEkKDEOuJEmSJCkwDLmSJEmSpMAw5EqSJEmSAiPU2wcgSZKkYJoxYwbHjx8nFDrzkfORRx7hT3/6E2vXrqW1tZX777+f3NxcACorK1m+fDnNzc1MnDiRhx56CIB9+/axaNEiGhsbSU1NZenSpdHxJOlcvJIrSZKkbtfR0cHBgwcpKyuL/klOTmbVqlW8+OKLlJaWsn79et58802ampooKCiguLiY8vJy9u7dy/bt2wHIy8tj8eLFbNmyhY6ODkpKSnq5MklXO0OuJEmSut0f//hHAL70pS9xxx138Pzzz1NZWcm4ceMYNGgQAwcOJDMzk4qKCvbs2cPw4cMZNmwYoVCISCRCRUUFR44coampiTFjxgCQk5NDRUVFb5YlqQ9wrockSZK63cmTJxk/fjzf+MY3aGlpYebMmUycOJFwOBztk5SUxJ49ezh69GiX9pqami7t4XCYmpqaizqO669PuPxiJF0x4XDiZY9hyJUkSVK3u/XWW7n11lujt++++26WL1/OnDlzom0dHR3ExMTQ3t5OTEzMBbdfjGPHGmhv7zhvv+74YC3p8tXW1p+3T79+MR94AsvpypIkSep2u3bt4rXXXove7ujoICUlhdra2mhbbW0tSUlJJCcnX1B7XV0dSUlJV6YASX2WIVeSJEndrr6+nscff5zm5mYaGhp4+eWXeeKJJ3jttdc4fvw4p06d4qc//SlpaWmMHj2aAwcOcOjQIdra2ti0aRNpaWmkpKQQHx9PVVUVAGVlZaSlpfVyZZKudk5XliRJUre7/fbb2b17N1OnTqW9vZ3p06czduxYHnroIWbOnElLSwt33303n/3sZwFYsWIFc+fOpbm5mfT0dLKysgAoKiqisLCQhoYGRo4cycyZM3uzLEl9gCFXkiRJPWLBggUsWLCgU1skEiESiXTpO378eDZu3NilfcSIEWzYsKHHjlFS8DhdWZIkSZIUGIZcSZIkSVJgGHIlSZIkSYFhyJUkSZIkBYYhV5IkSZIUGIZcSZIkSVJgGHIlSZIkSYFhyJUkSZIkBYYhV5IkSZIUGIZcSZIkSVJgGHIlSZIkSYFhyJUkSZIkBYYhV5IkSZIUGIZcSZIkSVJgGHIlSZIkSYFhyJUkSZIkBYYhV5IkSZIUGIZcSZIkSVJgGHIlSZIkSYFhyJUkSZIkBYYhV5IkSZIUGIZcSZIkSVJgGHIlSZIkSYER6u0DkCQF2+mWNsLhxG4dMxxOpKm5lfqTp7p1XEmS1PcZciVJPap/XCyRr5Z1+7ivPDmF+m4fVZIk9XVOV5YkSZIkBYYhV5IkSZIUGE5X7kE9sQ7tLNeiSZIkSVJXhtwe1FPr0MC1aJIkSZJ0Lld1yH3llVdYu3Ytra2t3H///eT+f/buPyzKOt//+BOYEUloEXdGjMxTm2VHN60wo1rIziYgjCbqHoWkMkO99hh6NgrRYPX4O1ZZt9C2049dsk0yA3MB62SoSVvq2fRys706pqZiCGLxQ4EB5vuHl/N1RGVAkJnh9bguL7w/c98f3p+54cP9nvu+33dCQleH5PECrvejp2/n/FjUNzTh28OnXdte6Yy4zmqLp9NcKCLdneZBEWkLl01yy8rKWLVqFRs3bqRHjx5MmjSJESNGcOutt3Z1aC6htUuhr+Yy6c48+6wKqyJto7lQRLo7zYMi0lYum+SWlJRw3333ERgYCEBkZCRFRUX8x3/8RxdH5ho685EcIuI6NBdenuoeiHQPmgdFpK1cNsk9efIkJpPJvmw2m9m3b5/T23t7e7Xp+5l7+7Vp/a7utzP7dseY27q/neXv3xPfTrh822QKuKrLt6+kvr6Rmpq6Du+3NZ21D67193A113IudLff/R5GH55a9GGH9wuw5vl/65QEurXf+6v5np02p1xlv1cakzvPg105H3W3uVDHhF3Xt2K+Nn0rZkfO/M62to6XzWazdVRAHWnNmjXU19cze/ZsAHJzc9m/fz8LFy7s4shERK4dzYUi0t1pHhSRtnLZ5+QGBwdTXl5uXy4vL8dsNndhRCIi157mQhHp7jQPikhbuWySe//99/PZZ59RWVnJ2bNn+fDDDwkPD+/qsERErinNhSLS3WkeFJG2ctl7cvv27cucOXNITEzEarUyYcIE7rzzzq4OS0TkmtJcKCLdneZBEWkrl70nV0RERERERKStXPZyZREREREREZG2UpIrIiIiIiIiHkNJroiIiIiIiHgMJbkiIiIiIiLiMZTkioiIiIiIiMfo1knuBx98wOjRoxk1ahTr1q3r6nCc9tJLLxETE0NMTAwrVqwAoKSkBIvFwqhRo1i1apV93QMHDhAXF0dkZCTz5s2jsbGxq8Ju1fLly0lNTQUuH3dpaSkJCQlERUUxc+ZMamtruzLky9q6dStxcXFER0ezaNEiwL33UX5+vv1nbvny5YD77yNP567zW2umTJlCTEwMY8eOZezYsezdu7erQ2q3mpoaYmNjOXbsGHD5OcLdXDyuuXPnMmrUKPs+++ijj7o4wrZpy99ccU/uOl9eaj50h7E4O/e56vGRs3Ocq84TnppHtGDrpr7//nvbyJEjbadPn7bV1tbaLBaL7ZtvvunqsFq1c+dO27//+7/b6uvrbQ0NDbbExETbBx98YIuIiLB99913NqvVaps6daqtuLjYZrPZbDExMba///3vNpvNZps7d65t3bp1XRn+ZZWUlNhGjBhhe/7552022+XjTkpKsm3evNlms9lsL730km3FihVdE/AVfPfdd7YHH3zQduLECVtDQ4Nt8uTJtuLiYrfdR2fOnLENHz7cdurUKZvVarVNmDDBtnPnTrfeR57OXee31jQ3N9sefPBBm9Vq7epQrtqXX35pi42NtQ0ePNh29OhR29mzZy87R7iTi8dls9lssbGxtrKysi6OrH3a+jdX3I+7zpeXmg/dYSxtmftc8fjI2TnOVed0T80jLqXbnsktKSnhvvvuIzAwkOuuu47IyEiKioq6OqxWmUwmUlNT6dGjB0ajkZ/97GccPnyYAQMG0L9/fwwGAxaLhaKiIo4fP05dXR3Dhg0DIC4uziXH+MMPP7Bq1SpmzJgBcNm4rVYru3btIjIy0qHd1Xz00UeMHj2a4OBgjEYjq1atws/Pz233UVNTE83NzZw9e5bGxkYaGxsxGAxuvY88nbvOb6359ttvAZg6dSpjxozhrbfe6uKI2i83N5eMjAzMZjMA+/btu+Qc4W4uHtfZs2cpLS0lLS0Ni8XC6tWraW5u7uIondeWv7nintx1vrzUfOgOY3F27nPV4yNn5zhXndM9MY+4HENXB9BVTp48iclksi+bzWb27dvXhRE5Z+DAgfb/Hz58mMLCQh577LEWYykrK2sxRpPJRFlZ2TWN1xnp6enMmTOHEydOAC33zfm4JjrsNgAAIABJREFUT58+jb+/PwaDwaHd1Rw5cgSj0ciMGTM4ceIEDz30EAMHDnTbfeTv709ycjLR0dH4+fkxfPhwjEajW+8jT+eu81trqqqqCAsL44UXXsBqtZKYmMjNN9/MAw880NWhtdnixYsdli+1z9zxd+ficVVUVHDfffeRkZFBQEAA06dPZ8OGDfzqV7/qogjbpi1/c8U9uet8ean5MDo62uXH4uzc56rHR87Ocdddd51LzhOemEdcTrc9k9vc3IyXl5d92WazOSy7um+++YapU6fy3HPP0b9//0uOxR3G+O6779KvXz/CwsLsbZeL+1Lxu9p44NyZz88++4wlS5awfv169u3bx9GjR912H3399de89957fPLJJ+zYsQNvb2927tzp1vvI07nDz1V73HXXXaxYsYKAgACCgoKYMGEC27Zt6+qwOoSn7rP+/fvz8ssvYzab8fPzY8qUKW65z5z5myvuyV1/9y41H65evdrtxnK5999d9svl5jhXj99T8ogr6bZJbnBwMOXl5fbl8vJy+6UHrm7Pnj088cQT/OY3v2HcuHGXHcvF7RUVFS43xoKCAnbu3MnYsWNZvXo1W7duZcOGDZeMOygoiOrqapqamgDX3Wc//elPCQsLIygoiJ49e/LLX/6SkpISt91Hn376KWFhYfTp04cePXoQFxfH559/7tb7yNO58/x2Jbt37+azzz6zL9tsNvtVA+7OU/fZP//5T7Zs2WJfdsd95uzfXHFP7ro/LzUfhoSEuN1Y3PkYFi4/x7nyz5Un5RFX0m2T3Pvvv5/PPvuMyspKzp49y4cffkh4eHhXh9WqEydO8Otf/5rMzExiYmIAGDp0KIcOHeLIkSM0NTWxefNmwsPDCQkJwdfXlz179gDnKuS62hjfeOMNNm/eTH5+Ps888wwPP/wwS5cuvWTcRqOR0NBQCgoKAMjLy3O58QCMHDmSTz/9lKqqKpqamtixYwdRUVFuu48GDRpESUkJZ86cwWazsXXrVu6991633keezl3nt9ZUV1ezYsUK6uvrqamp4f333+eRRx7p6rA6xOXmcXdns9lYsmQJP/74I1arlfXr17vVPmvL31xxT+46X15qPnzxxRfdbizufAwLl5/jXHWe8LQ84krc6+PUDtS3b1/mzJlDYmIiVquVCRMmcOedd3Z1WK167bXXqK+vZ9myZfa2SZMmsWzZMmbNmkV9fT0RERFERUUBkJmZyfz586mpqWHw4MEkJiZ2Vehtcrm4MzIySE1NZc2aNfTr14+VK1d2caQtDR06lGnTphEfH4/VauWBBx5g8uTJ3HLLLW65jx588EG++uor4uLiMBqN/PznPycpKYlHHnnEbfeRp3PX+a01I0eOZO/evTz66KM0NzcTHx/PXXfd1dVhdQhfX9/LzuPubNCgQSQlJTF58mQaGxsZNWoUsbGxXR2W09r6N1fcj7vOl5eaD++55x63G8uV5j5XPz6CK89xrjhPdJc8AsDLZrPZujoIERERERERkY7QbS9XFhEREREREc+jJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY9h6OoAxP0dO3aMRx55hNtuu83eZrPZSExMZMKECRQXF7NmzRrOnj1LU1MTt956K3PnziU4OJhjx45hsVj4+9//7tDna6+9xjfffMOyZcvYuHEjixcv5sYbb3RY55lnnuH2229v8b3PnDlDcHAwS5YsoX///vb2rVu3MnPmTFatWsXo0aPt7X/4wx946aWXWLJkCePHj3fo54EHHuDee+/llVdeuWwct99+OytWrLi6N1FEPE5jYyOvv/46H3zwAQDNzc3ce++9PPPMM/Tu3ZvU1FQGDhzIU0895bDdXXfdxQcffOAw18TFxVFXV8df//pXvLy87O0PP/wwRqORnj174uXlRUNDA97e3jz33HOEh4fzzDPPcOTIEQC+/vprbrvtNry9vbn++uvJyclx2P5CGRkZ3H333a32LyJyodtvv90+z3h5eXH27Fn8/f357W9/y89//nM+//xznn76aW6++WaH7Xr37s2bb77pcKzl5eWFzWbDz8+P559/nrvuuos//OEPnD59mvT09Bbf++I59eDBg2RlZXH48GG8vLy4/vrrmT17NqGhoQ7bXWp+/eMf/8hf//pXAL777jt69+5NQEAAcO64MTs7m507dxIUFOTQ1/jx40lMTOyYN1OuipJc6RA9e/YkPz/fvlxWVkZsbCwDBgzg+eefZ+PGjYSEhACwZs0aZs+ezTvvvON0/6Ghobzyyist2o8dO9bie9tsNhYtWsSqVatYuXKlvf3tt9/GYrHw5ptvOiS5ADfccAP5+fkOSe6HH37Idddd51QcIiIXS0lJobm5mbfeeouf/OQnWK1W3nzzTSZNmsR7773ndD979+6loaEBo9HIjh07WiSXmZmZ/PznP7cvFxUVkZaWxqeffsrq1avt7bfffjt/+tOfWhyUXbz9xa7Uv4jIxS6eZ1577TUWLVrE+vXrAbjpppscjtsudvGx1tatW5k1axbFxcVOx/Dtt9/y+OOPs3TpUn7xi18A8NlnnzFjxgz+8pe/MHDgQODy82tSUhJJSUkATJkyhYSEBKKiohy+xxNPPNHiQ0pxHbpcWTpF3759GTBgAJ9//jlWq5UzZ87YX3v88ceZPn16p33v+vp6Tp48yU9+8hN729GjR/niiy+YO3cuR44c4csvv3TY5he/+AX/93//x/fff29ve//99xkzZkynxSkinmvfvn3s2rWLZcuW2ecio9HI008/zS233MJf/vIXp/v6y1/+wkMPPcSYMWP405/+dMV1bTYbx44dc5j/OlJn9y8inqWxsZETJ05c1ZwRFhZGeXk5VVVVTm/z6quvMn78eHuCe76f3/3udw5XrrRlfhX3ojO50in+/ve/89133zF+/HhqamoYN24cN910E3fffTdhYWFERka2qb/du3czduxY+/LQoUNZuHAhAHV1dYwdO5bm5mZOnTrFT37yE0aNGmX/BA7+/yTWp08fRo8ezZtvvklWVpb9dYPBQHR0NJs2bSIpKYnS0lJqa2sZOHAg33777WXjAEhMTHQ4Aywi8r//+78MGTIEPz+/Fq898MAD7Ny506mDvh9++IGCggI2bNhA7969WblyJf/3f//Hrbfeal/n2WefxdfXlx9++AGABx98kLVr1zod67PPPutw0NejRw/efffdDutfRLqXxx9/HIDTp0/j6+vLyJEjWbp0qf317777rsWxVFRUFDNnzmzRl81mY/369dx2220trkK5kv379/Pss8+2aI+IiLD/35n59UrefPNNNm3a5NC2YsUKbr/9dqfjlM6jJFc6xPlEE6CpqYnevXvz4osv0q9fP1JTU5k+fTpffPEFu3btYsWKFeTk5LBu3Tq8vS99MUFzc7PDa1e6TPjCy5V37NhBSkoKI0eOpFevXgA0NDSwceNGlixZAsC4ceOYPHkyJ06coF+/fvZ+xo4dy7x580hKSiI/P59HH320xffS5coi0hFsNpvDvbUXam5uxsfHB4CNGzdy66232usO3H///fz5z3+2f8gH//9y4qNHj/Lkk09yxx13ONQjaI2zlyu3t38R6V7OX678j3/8g6SkJEaMGEGfPn3sr7d2ufL5Ewrn6wDccsstDrdeOMPLy4vm5uYrruPM/HolulzZtSnJlQ5x8X2x53388cf88MMPjB8/nsjISCIjI5kzZw4RERF89dVX3HLLLdTV1VFfX4+vr699u1OnThEYGNjmOH7xi1/w5JNPkpyczF//+lf8/f0pKCigqqqK//qv/2LRokXAuckvJyeH5557zr7tnXfeSVNTEwcOHKCgoICcnBy2bt3ajndDRLq7u+++m1dffZWzZ8/i5+dHQ0MDtbW19O7dm7/97W8MHTqU6upq+9nR82pqaqivr+f666/HZrPxzjvv8OOPP/Lwww8DcPbsWb744gvmzJlD7969Hbbt378/K1asIDExkaFDh3LnnXd26Jg6u38R8SyDBw9m7ty5pKamcscdd7Qo3Hk5HXFCYdiwYXz55ZeMHDnSof2ll17ipptuwmKxtGl+Ffeje3KlU/Xq1ct++cd5R48excfHh5tuuolevXpxzz33ONwHUVZWRlFRkcMlJW0xdepUevXqZf/U75133mHGjBl88sknbN26la1bt/Lb3/6Wd9991+FeYTh3NnfJkiXcfPPN7UqyRUTg3IdmI0aMIDU1lR9//JGjR4+SkJDArFmz+Oc//0lCQgLh4eEUFhZSVlYGnDu7+6c//Ynhw4fTq1cvdu7cyalTp/if//kf+9y1Y8cOTCaTvYDLxe6++24effRRfvvb37Z6FqM9Ort/EfEssbGx3HnnnQ6XK18LTz31FO+++65Dgbzt27eTk5PDoEGD2jW/invRmVzpVPfddx8vvPACzz//PNXV1fj4+GAymXj11Vft96NlZmayZMkSYmJi8Pb2xsfHh2eeeYYRI0a063sajUZeeOEFpk2bRlxcHAcOHCA7O9thnUcffZQ1a9bw/vvvO7SPGTOGrKysFuufd6l7cn18fNi4cWO7YhURz/Xiiy/y+uuv89hjjwFgtVrx8fGhV69efPzxx4wbN46nn37aXj+grq6Of/3Xf+V3v/sdcK6WwK9+9Sv7YyvgXP2A6dOns3r16steJvef//mfREdHk5uby6RJk1qN8+J7cgEee+wxJk6c2CH9i0j39sILLzBmzBh27NhBjx49LnlPLsDrr7/uVH+5ubkOx2+33357iyd2DBgwgLVr15KVlcXy5ctpbm4mKCiINWvWcNttt/H73/++1fnVaDReMY5L3ZN7Yc0Y6VpeNpvN1tVBiIiIdBdVVVXs37+f+++/v6tDERER8UhKckVERERERMRj6J5cEREREXFKTU0NsbGxHDt2DID169cTGxuLxWJh7ty5NDQ0AHDgwAHi4uKIjIxk3rx5NDY2AlBaWkpCQoL9kTG1tbXAuSsckpKSiI6OJiEhgfLycuDcExJSUlKIjo5m3LhxHDx4sAtGLSLuRkmuiIiIiLRq7969TJ48mcOHDwNw6NAhXnvtNd555x02bdpEc3Mzb7/9NgApKSmkp6ezZcsWbDYbubm5ACxYsID4+HiKiooYMmSIvQZGVlYWoaGhFBYWMnHiRBYvXgxATk4Ofn5+FBYWkpaWxty5c6/9wEXE7SjJFREREZFW5ebmkpGRgdlsBqBHjx5kZGTg7++Pl5cXt912G6WlpRw/fpy6ujqGDRsGQFxcHEVFRVitVnbt2kVkZKRDO0BxcTEWiwU4V5F3+/btWK1WiouLGTNmDADDhw+nsrKS0tLSaz10EXEzqq4sIiIiIq06f3b1vJCQEEJCQgCorKxk3bp1LF26lJMnT2IymezrmUwmysrKOH36NP7+/hgMBod2wGEbg8GAv78/lZWVl+zr+++/54YbbujUsYqIe/PYJPf06Vqam1uvqdWnjz+nTtVcg4jaxhXjUkzOUUzOaU9M3t5e9O7dq5Mi8kyaCzueK8YErhmXK8YE7h+Xq82FZWVlTJs2jfHjxzNixAj27NmDl5eX/XWbzYaXl5f964UuXr5wG29v7xbbnG8XEbkSj01ym5ttTh3YnV/XFbliXIrJOYrJOa4Yk6fRXNg5XDEmcM24XDEmUFwd5eDBg0ybNo0pU6YwdepUAIKDg+2FowAqKiowm80EBQVRXV1NU1MTPj4+lJeX2y99NpvNVFRUEBwcTGNjI7W1tQQGBtK3b19OnjzJTTfd5NBXW5w6VeP0+2oyBVBeXt2m/ruaYr42FPO14WzM3t5e9Onjf/nXOzIoEREREekeampqeOqpp0hOTrYnuHDuMmZfX1/27NkDQH5+PuHh4RiNRkJDQykoKAAgLy+P8PBwACIiIsjLywOgoKCA0NBQjEYjERER5OfnA7B79258fX11qbKItEpJroiIiIi02YYNG6ioqOCNN95g7NixjB07lt///vcAZGZmsnTpUqKiojhz5gyJiYkAZGRkkJuby+jRo9m9ezezZ88GIDk5mS+//JKYmBjefvtt0tPTAZgyZQoNDQ3ExMSwePFiVqxY0TWDFRG34rGXK4uIiIhIx9u6dSsATzzxBE888cQl1xk0aBAbNmxo0R4SEkJOTk6L9sDAQNauXdui3dfXl+XLl19dwCLS7ehMroiIiIiIiHgMJbkiIldh69atxMXFER0dzaJFiwAoKSnBYrEwatQoVq1aZV/3wIEDxMXFERkZybx582hsbASgtLSUhIQEoqKimDlzJrW1tQBUVVWRlJREdHQ0CQkJDoVcREREROTSlOSKiLTT0aNHycjIIDs7m02bNvHVV1+xbds20tLSyM7OpqCggP3797Nt2zYAUlJSSE9PZ8uWLdhsNnJzcwFYsGAB8fHxFBUVMWTIELKzswHIysoiNDSUwsJCJk6c2OIZlSIiIiLSkpJcEZF2+uijjxg9ejTBwcEYjUZWrVqFn58fAwYMoH///hgMBiwWC0VFRRw/fpy6ujqGDRsGQFxcHEVFRVitVnbt2kVkZKRDO0BxcTEWiwWA2NhYtm/fjtVq7ZrBioiIiLgJFZ4SEWmnI0eOYDQamTFjBidOnOChhx5i4MCBmEwm+zpms5mysjJOnjzp0G4ymSgrK+P06dP4+/tjMBgc2gGHbQwGA/7+/lRWVtK3b99rOEoRERER96IkV0SknZqamti9ezc5OTlcd911zJw5k549e+Ll5WVfx2az4eXlRXNz8yXbz3+90MXLF27j7d22C3Cu9KD0i5lMAW3q+1pxxbhcMSZwzbhcMSZQXCIinkxJrohIO/30pz8lLCyMoKAgAH75y19SVFSEj4+PfZ3y8nLMZjPBwcEOhaMqKiowm80EBQVRXV1NU1MTPj4+9vXh3FngiooKgoODaWxspLa2lsDAwDbFeOpUDc3NtlbXM5kCKC+vblPf14IrxuWKMYFrxuWKMYH7x+Xt7dWmD7BERLobJblAwPV+9PTt+Leirr6R6qqzHd6viLiGkSNH8vzzz1NVVUWvXr3YsWMHUVFR/PGPf+TIkSPceOONbN68mfHjxxMSEoKvry979uzhnnvuIT8/n/DwcIxGI6GhoRQUFGCxWMjLyyM8PByAiIgI8vLymDFjBgUFBYSGhmI0Grt41NLdXO3fyCudmdTfSXE1DdamTjmbrp918SSdlTvBud/BjqAkF+jpa8Dym/wO7/eD343F9T4nFpGOMnToUKZNm0Z8fDxWq5UHHniAyZMnc8sttzBr1izq6+uJiIggKioKgMzMTObPn09NTQ2DBw8mMTERgIyMDFJTU1mzZg39+vVj5cqVACQnJ5OamkpMTAwBAQFkZmZ22Vil++qsv5Ggv5PienoYfXRMKNKKzv670BGU5IqIXIUJEyYwYcIEh7awsDA2bdrUYt1BgwaxYcOGFu0hISHk5OS0aA8MDGTt2rUdF6yIiIhIN+BUBZOXXnqJmJgYYmJiWLFiBQAlJSVYLBZGjRrFqlWr7OseOHCAuLg4IiMjmTdvHo2NjQCUlpaSkJBAVFQUM2fOpLa2FoCqqiqSkpKIjo4mISHBfs9aQ0MDKSkpREdHM27cOA4ePNihAxcRERERERHP02qSW1JSwqeffsr7779PXl4e//jHP9i8eTNpaWlkZ2dTUFDA/v372bZtGwApKSmkp6ezZcsWbDYbubm5ACxYsID4+HiKiooYMmQI2dnZAGRlZREaGkphYSETJ05k8eLFAOTk5ODn50dhYSFpaWnMnTu3s94DERERERER8RCtJrkmk4nU1FR69OiB0WjkZz/7GYcPH2bAgAH0798fg8GAxWKhqKiI48ePU1dXx7BhwwCIi4ujqKgIq9XKrl27iIyMdGgHKC4uxmKxABAbG8v27duxWq0UFxczZswYAIYPH05lZSWlpaWd8iaIiIhcKOB6P0ymgEv+Ay77Wmv/Aq736+KRiYiIeL5W78kdOHCg/f+HDx+msLCQxx57DJPJZG83m82UlZVx8uRJh3aTyURZWRmnT5/G398fg8Hg0A44bGMwGPD396eysvKSfX3//ffccMMNTg3MVUrrX02FPld8Vp5ico5ico4rxiQCKkgoIiLizpwuPPXNN98wffp0nnvuOXx8fDh8+LD9NZvNhpeXF83NzXh5ebVoP//1QhcvX7iNt7d3i23OtzurLc+G7EztfQ6fKz7DTzE5RzE5pz0x6dmQIiIiItIap7LGPXv28MQTT/Cb3/yGcePGERwcbC8QBVBeXo7ZbG7RXlFRgdlsJigoiOrqapqamhzWh3NngSsqKgBobGyktraWwMBA+vbty8mTJ1v0JSIiIiIiInI5rSa5J06c4Ne//jWZmZnExMQA554NeejQIY4cOUJTUxObN28mPDyckJAQfH192bNnDwD5+fmEh4djNBoJDQ2loKAAgLy8PMLDwwGIiIggLy8PgIKCAkJDQzEajURERJCff+5Ssd27d+Pr6+v0pcoiIiIiIiLSPbV6ufJrr71GfX09y5Yts7dNmjSJZcuWMWvWLOrr64mIiCAqKgqAzMxM5s+fT01NDYMHDyYxMRGAjIwMUlNTWbNmDf369WPlypUAJCcnk5qaSkxMDAEBAWRmZgIwZcoU0tPTiYmJoUePHvZHF4mIiIiIiIhcTqtJ7vz585k/f/4lX9u0aVOLtkGDBrFhw4YW7SEhIeTk5LRoDwwMZO3atS3afX19Wb58eWvhiYiIiIiIiNg5X8lJRERERERExMUpyRURERERERGPoSRXREREREREPIbTz8kVERHP1WBt6rTnhtfVN1JddbZT+hYRERG5mJJcERGhh9EHy2/yO6XvD343lupO6VlERESkJV2uLCIiIiIiIh5DSa6IiIiIiIh4DF2uLCIiIuKkgOv96OnbOYdPDdamTulXRKS7UZIrIiIi4qSevoZOvX9dRESuni5XFhEREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERp9TU1BAbG8uxY8cAKCkpwWKxMGrUKFatWmVf78CBA8TFxREZGcm8efNobGwEoLS0lISEBKKiopg5cya1tbUAVFVVkZSURHR0NAkJCZSXlwPQ0NBASkoK0dHRjBs3joMHD17jEYuIO1KSKyIiIiKt2rt3L5MnT+bw4cMA1NXVkZaWRnZ2NgUFBezfv59t27YBkJKSQnp6Olu2bMFms5GbmwvAggULiI+Pp6ioiCFDhpCdnQ1AVlYWoaGhFBYWMnHiRBYvXgxATk4Ofn5+FBYWkpaWxty5c6/9wEXE7SjJFREREZFW5ebmkpGRgdlsBmDfvn0MGDCA/v37YzAYsFgsFBUVcfz4cerq6hg2bBgAcXFxFBUVYbVa2bVrF5GRkQ7tAMXFxVgsFgBiY2PZvn07VquV4uJixowZA8Dw4cOprKyktLT0Wg9dRNyMoasDEBERERHXd/7s6nknT57EZDLZl81mM2VlZS3aTSYTZWVlnD59Gn9/fwwGg0P7xX0ZDAb8/f2prKy8ZF/ff/89N9xwQ6eNU0Tcn5JcEREREWmz5uZmvLy87Ms2mw0vL6/Ltp//eqGLly/cxtvbu8U259vbok8f/zat31lMpgC37LuzKOZro7vG7HSSW1NTw6RJk1i7di0HDx5k5cqV9tfKysoYOnQor7zyCi+99BLvvfce119/PQC/+tWvSEhI4MCBA8ybN4/a2lpCQ0NZsGABBoOB0tJSUlJSOHXqFDfffDOZmZn06tWLqqoqnn32WY4ePUpQUBBZWVkOn+SJiIiISNcJDg62F4gCKC8vx2w2t2ivqKjAbDYTFBREdXU1TU1N+Pj42NeHc2eBKyoqCA4OprGxkdraWgIDA+nbty8nT57kpptucuirLU6dqqG52ebUup2ZEJSXV3dKvyZTQKf13VkU87XRWTF3duLsTMze3l5X/ADLqY/CLi40EBERQX5+Pvn5+fz3f/83/v7+9kIA+/fvZ+XKlfbXExISgI4rQCAiIiIiXW/o0KEcOnSII0eO0NTUxObNmwkPDyckJARfX1/27NkDQH5+PuHh4RiNRkJDQykoKAAgLy+P8PBw4NyxZV5eHgAFBQWEhoZiNBrtx5wAu3fvxtfXV5cqi0irnEpyLy40cKEVK1YwadIk/uVf/gU4l+S+8sorWCwWFi5cSH19fYcWIBARERGRrufr68uyZcuYNWsWo0eP5pZbbiEqKgqAzMxMli5dSlRUFGfOnCExMRGAjIwMcnNzGT16NLt372b0gX4HAAAgAElEQVT27NkAJCcn8+WXXxITE8Pbb79Neno6AFOmTKGhoYGYmBgWL17MihUrumawIuJWnLpc+XJnUQ8fPswXX3xhf722tpY77riDlJQUBgwYQGpqKtnZ2Tz00EMdVoCgb9++7R+tiIiIiFyVrVu32v8fFhbGpk2bWqwzaNAgNmzY0KI9JCSEnJycFu2BgYGsXbu2Rbuvry/Lly+/yohFpLu5qsJT69evJz4+nh49egDQq1cvXn31VfvrU6dOJS0tjfDw8A4rQOAsTygy4Io3iism5ygm57hiTG01ZcoUKisr7R/WLVy4kO+++441a9bQ2NjI448/br9to6SkhKVLl1JfX090dDRz5swBaHPNAhERERG5vKtKcj/++GNee+01+3JpaSklJSVMmDABOJeYGgyGDi1A4Cxniwy4wo3Tl+KKN7crJucoJue0J6bWigxcazabjcOHD/PJJ5/Yk9yysjLmzJnDxo0b6dGjB5MmTWLEiBHceOONpKWlkZOTQ79+/Zg+fTrbtm0jIiKClJQUFi1axLBhw0hLSyM3N5f4+Hh7zYKYmBhefvllsrOzSUlJ6eJRi4iIiLi2ttVgv0BlZSV1dXX079/f3tazZ09efPFFjh49is1mY926dTzyyCMdWoBARMRVfPvtt8C5q1bGjBnDW2+9RUlJCffddx+BgYFcd911REZGUlRUxL59+xgwYAD9+/fHYDBgsVgoKipqV80CEREREbm8dp/JPXbsGMHBwQ5tQUFBLFy4kJkzZ2K1Wrn77rt58skngXMFCObPn09NTQ2DBw92KECQmprKmjVr6Nevn/3RRMnJyaSmphITE0NAQACZmZntDVVEpFNUVVURFhbGCy+8gNVqJTExkejoaIcaBGazmX379jnUGTjfXlZW1qLdmZoFIiIiInJ5bUpyLyw0cOedd9ofA3ShyMhI+5mHC3VUAQIREVdx1113cdddd9mXJ0yYwNKlS5k5c6a97Xztgebm5kvWJrhce1tqFlyJq1ze7Wn1Ca5GZ47HHd+rrorZVd8rV41LRMSdXNU9uSIi3dnu3buxWq2EhYUB5xLUkJAQhxoE52sNXFyb4HLtztQsaAvVJ2ifznw/Oms8nfVeuerPxtW4mvfKFd4PV6tPICLiatp9T66ISHdXXV3NihUrqK+vp6amhvfff58XX3yRzz77jMrKSs6ePcuHH35IeHg4Q4cO5dChQxw5coSmpiY2b95MeHh4u2oWiIiIiMjl6UyuiEg7jRw5kr179/Loo4/S3NxMfHw899xzD3PmzCExMRGr1cqECRO48847AVi2bBmzZs2ivr6eiIgIoqKigLbXLBARERGRy1OSKyJyFWbPns3s2bMd2iwWCxaLpcW6YWFhbNq0qUV7W2sWiIiIiMjl6XJlERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGP4XSSW1NTQ2xsLMeOHQNg7ty5jBo1irFjxzJ27Fg++ugjAEpKSrBYLIwaNYpVq1bZtz9w4ABxcXFERkYyb948GhsbASgtLSUhIYGoqChmzpxJbW0tAFVVVSQlJREdHU1CQgLl5eUdNmgRERERERHxTE4luXv37mXy5MkcPnzY3rZ//37eeust8vPzyc/P55FHHqGuro60tDSys7MpKChg//79bNu2DYCUlBTS09PZsmULNpuN3NxcABYsWEB8fDxFRUUMGTKE7OxsALKysggNDaWwsJCJEyeyePHiDh66iIiIiIiIeBqnktzc3FwyMjIwm80AnD17ltLSUtLS0rBYLKxevZrm5mb27dvHgAED6N+/PwaDAYvFQlFREcePH6euro5hw4YBEBcXR1FREVarlV27dhEZGenQDlBcXIzFYgEgNjaW7du3Y7VaO/wNEBEREREREc9hcGali8+iVlRUcN9995GRkUFAQADTp09nw4YNXHfddZhMJvt6ZrOZsrIyTp486dBuMpkoKyvj9OnT+Pv7YzAYHNoBh20MBgP+/v5UVlbSt29fpwbWp4+/U+t1NpMpoEu27SyKyTmKyTmuGJOIiIiIuDenktyL9e/fn5dfftm+PGXKFPLy8oiMjMTLy8vebrPZ8PLyorm5+ZLt579e6OLlC7fx9na+TtapUzU0N9taXa+zD7LLy6vbtZ3JFNDubTuLYnKOYnJOe2Ly9vZymQ+wRERERMQ1tau68j//+U+2bNliX7bZbBgMBoKDgx0KRJWXl2M2m1u0V1RUYDabCQoKorq6mqamJof14dxZ4IqKCgAaGxupra0lMDCwPeGKiIiIiIhIN9GuJNdms7FkyRJ+/PFHrFYr69ev55FHHmHo0KEcOnSII0eO0NTUxObNmwkPDyckJARfX1/27NkDQH5+PuHh4RiNRkJDQykoKAAgLy+P8PBwACIiIsjLywOgoKCA0NBQjEZjR4xZREREREREPFS7LlceNGgQSUlJTJ48mcbGRkaNGkVsbCwAy5YtY9asWdTX1xMREUFUVBQAmZmZzJ8/n5qaGgYPHkxiYiIAGRkZpKamsmbNGvr168fKlSsBSE5OJjU1lZiYGAICAsjMzOyI8YqIiIiIiIgHa1OSu3XrVvv/ExISSEhIaLFOWFgYmzZtatE+aNAgNmzY0KI9JCSEnJycFu2BgYGsXbu2LeGJiIiIiIhIN9euy5VFRERERODcbWgxMTHExMSwfPlyAA4cOEBcXByRkZHMmzePxsZGAEpLS0lISCAqKoqZM2dSW1sLQFVVFUlJSURHR5OQkGCv5dLQ0EBKSgrR0dGMGzeOgwcPds0gRcStKMkVERERkXY5e/YsixcvJicnh/z8fHbv3k1JSQkpKSmkp6ezZcsWbDYbubm5ACxYsID4+HiKiooYMmQI2dnZAGRlZREaGkphYSETJ060P74yJycHPz8/CgsLSUtLY+7cuV02VhFxH0pyRURERKRdmpqaaG5u5uzZszQ2NtLY2IjBYKCuro5hw4YBEBcXR1FREVarlV27dhEZGenQDlBcXIzFYgEgNjaW7du3Y7VaKS4uZsyYMQAMHz6cyspKSktLu2CkIuJO2lV4SkRERETE39+f5ORkoqOj8fPzY/jw4RiNRkwmk30dk8lEWVkZp0+fxt/fH4PB4NAOcPLkSfs2BoMBf39/KisrHdrPb/P9999zww03OB2jqzxf3WQKcMu+O4tivja6a8xKckVERESkXb7++mvee+89PvnkEwICAnj22WfZuXMnXl5e9nVsNhteXl72rxe6ePnCbby9vVtsc769LU6dqqG52ebUup2ZEJSXV3dKvyZTQKf13VkU87XRWTF3duLsTMze3l5X/ABLlyuLiIiISLt8+umnhIWF0adPH3r06EFcXByff/65vXAUQEVFBWazmaCgIKqrq2lqagKgvLwcs9kMgNlspqKiAoDGxkZqa2sJDAykb9++nDx5skVfIiJXoiRXRKQDLF++nNTUVEBVRUWk+xg0aBAlJSWcOXMGm83G1q1buffee/H19WXPnj3AuerL4eHhGI1GQkNDKSgoACAvL4/w8HAAIiIiyMvLA6CgoIDQ0FCMRiMRERHk5+cDsHv3bnx9fdt0qbKIdE9KckVErtJnn33G+++/b19WVVER6S4efPBBYmJiiIuLY8yYMTQ2NpKUlERmZiZLly4lKiqKM2fOkJiYCEBGRga5ubmMHj2a3bt3M3v2bACSk5P58ssviYmJ4e233yY9PR2AKVOm0NDQQExMDIsXL2bFihVdNlYRcR+6J1dE5Cr88MMPrFq1ihkzZvD1119z/PjxFlVFV69ezcSJE9m1axcvv/yyvf2xxx4jJSWF4uJi1q1bB5yrKrpw4UJ7VdHk5GTAsaqozmKIiCtJSkoiKSnJoW3QoEFs2LChxbohISHk5OS0aA8MDGTt2rUt2n19fe3P3hURcZbO5IqIXIX09HTmzJnD9ddfD3DJSqAdXVVURERERC5PZ3JFRNrp3XffpV+/foSFhbFx40YAmpubXaqqqCc8OsMdH39wJXqMiKOuitlV3ytXjUtExJ0oyRURaaeCggLKy8sZO3YsP/74I2fOnMHLy6vVqqI+Pj6XrCoaHBx8yaqiN910k0NfbeHsozNc4XEAl9JVj2zQY0Qc++1MXbV/r+ZnsjN1xKMzRES6O12uLCLSTm+88QabN28mPz+fZ555hocffpilS5eqqqiIiIhIF1KSKyLSwVRVVERERKTr6HJlEZEOEBcXR1xcHKCqoiIiIiJdSWdyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8htNJbk1NDbGxsRw7dgyA9evXExsbi8ViYe7cuTQ0NADw0ksvMXLkSMaOHcvYsWNZt24dAAcOHCAuLo7IyEjmzZtHY2MjAKWlpSQkJBAVFcXMmTOpra0FoKqqiqSkJKKjo0lISKC8vLxDBy4iIiIiIiKex6kkd+/evUyePJnDhw8DcOjQIV577TXeeecdNm3aRHNzM2+//TYA+/fvZ+XKleTn55Ofn09CQgIAKSkppKens2XLFmw2G7m5uQAsWLCA+Ph4ioqKGDJkCNnZ2QBkZWURGhpKYWEhEydOZPHixR09dhEREREREfEwTiW5ubm5ZGRkYDabAejRowcZGRn4+/vj5eXFbbfdRmlpKXAuyX3llVewWCwsXLiQ+vp6jh8/Tl1dHcOGDQMgLi6OoqIirFYru3btIjIy0qEdoLi4GIvFAkBsbCzbt2/HarV27OhFRERERETEoziV5C5evJjQ0FD7ckhICA888AAAlZWVrFu3jn/7t3+jtraWO+64g5SUFN5//32qqqrIzs7m5MmTmEwm+/Ymk4mysjJOnz6Nv78/BoPBoR1w2MZgMODv709lZWXHjFpEREREREQ8kuFqNi4rK2PatGmMHz+eESNGAPDqq6/aX586dSppaWmEh4fj5eVlb7fZbHh5edm/Xuji5Qu38fZ2vk5Wnz7+bRlKpzGZArpk286imJyjmJzjijGJiIiIiHtrd5J78OBBpk2bxpQpU5g6dSpwrohUSUkJEyZMAM4lpgaDgeDgYIfCURUVFZjNZoKCgqiurqapqQkfHx/Ky8vtl0SbzWYqKioIDg6msbGR2tpaAgMDnY7v1Kkampttra7X2QfZ5eXV7drOZApo97adRTE5RzE5pz0xeXt7ucwHWCIiIiLimtr1CKGamhqeeuopkpOT7QkuQM+ePXnxxRc5evQoNpuNdevW8cgjjxASEoKvry979uwBID8/n/DwcIxGI6GhoRQUFACQl5dHeHg4ABEREeTl5QFQUFBAaGgoRqPxqgYrIiIiIiIinq1dZ3I3bNhARUUFb7zxBm+88QYADz/8MMnJySxcuJCZM2ditVq5++67efLJJwHIzMxk/vz51NTUMHjwYBITEwHIyMggNTWVNWvW0K9fP1auXAlAcnIyqampxMTEEBAQQGZmZkeMV0RERERERDxYm5LcrVu3AvDEE0/wxBNPXHKdyMhIe7XkCw0aNIgNGza0aA8JCSEnJ6dFe2BgIGvXrm1LeCIiIiIiItLNtetyZRERERERERFXpCRXREREREREPIaSXBEREREREfEYSnJFRERERETEYyjJFREREREREY+hJFdEREREREQ8hpJcERERERER8RhKckVERERERMRjKMkVERERERERj6EkV0RERERERDyGklwRERERERHxGEpyRURERERExGMoyRURERERERGPoSRXREREREREPIaSXBERERFpt61btxIXF0d0dDSLFi0CoKSkBIvFwqhRo1i1apV93QMHDhAXF0dkZCTz5s2jsbERgNLSUhISEoiKimLmzJnU1tYCUFVVRVJSEtHR0SQkJFBeXn7tBygibkdJroiIiIi0y9GjR8nIyCA7O5tNmzbx1VdfsW3bNtLS0sjOzqagoID9+/ezbds2AFJSUkhPT2fLli3YbDZyc3MBWLBgAfHx8RQVFTFkyBCys7MByMrKIjQ0lMLCQiZOnMjixYu7bKwi4j6U5IqIiIhIu3z00UeMHj2a4OBgjEYjq1atws/PjwEDBtC/f38MBgMWi4WioiKOHz9OXV0dw4YNAyAuLo6ioiKsViu7du0iMjLSoR2guLgYi8UCQGxsLNu3b8dqtXbNYEXEbRi6OgARERERcU9HjhzBaDQyY8YMTpw4wUMPPcTAgQMxmUz2dcxmM2VlZZw8edKh3WQyUVZWxunTp/H398dgMDi0Aw7bGAwG/P39qayspG/fvk7H2KePf0cM9aqZTAFu2XdnUczXRneNWUmuiIiIiLRLU1MTu3fvJicnh+uuu46ZM2fSs2dPvLy87OvYbDa8vLxobm6+ZPv5rxe6ePnCbby923Yh4qlTNTQ325xatzMTgvLy6k7p12QK6LS+O4tivjY6K+bOTpydidnb2+uKH2DpcmURkavw+9//ntGjRxMTE8Mbb7wBqOCKiHQfP/3pTwkLCyMoKIiePXvyy1/+kpKSEof5qry8HLPZTHBwsEN7RUUFZrOZoKAgqquraWpqclgfzp0FrqioAKCxsZHa2loCAwOv4QhFxB0pyRURaacvvviCv/3tb2zatIn33nuPnJwcvv76axVcEZFuY+TIkXz66adUVVXR1NTEjh07iIqK4tChQxw5coSmpiY2b95MeHg4ISEh+Pr6smfPHgDy8/MJDw/HaDQSGhpKQUEBAHl5eYSHhwMQERFBXl4eAAUFBYSGhmI0GrtmsCLiNpTkioi007333suf//xnDAYDp06doqmpiaqqKhVcEZFuY+jQoUybNo34+HhGjx7NDTfcwOTJk1m2bBmzZs1i9OjR3HLLLURFRQGQmZnJ0qVLiYqK4syZMyQmJgKQkZFBbm4uo0ePZvfu3cyePRuA5ORkvvzyS2JiYnj77bdJT0/vsrGKiPvQPbkiIlfBaDSyevVqXn/9daKioloUVunqgisiIp1twoQJTJgwwaEtLCyMTZs2tVh30KBBbNiwoUV7SEgIOTk5LdoDAwNZu3ZtxwUrIt2CU0luTU0NkyZNYu3atdx4442UlJSwdOlS6uvriY6OZs6cOcC5+83mzZtHbW0toaGhLFiwAIPBQGlpKSkpKZw6dYqbb76ZzMxMevXqRVVVFc8++yxHjx4lKCiIrKwsTCYTDQ0NzJs3j/3799OzZ08yMzP52c9+1qlvhIhIez3zzDM8/fTTzJgxg8OHD7tUwRVPqCrqjpUhr0QVVh11Vcyu+l65alwiIu6k1SR37969zJ8/n8OHDwNQV1dHWloaOTk59OvXj+nTp7Nt2zYiIiJISUlh0aJFDBs2jLS0NHJzc4mPj7ffbxYTE8PLL79MdnY2KSkp9vvN/vjHP5KXl8fixYvJysoiJycHPz8/CgsL2bVrF3PnzrXfuyYi4ioOHjxIQ0MDd9xxB35+fowaNYqioiJ8fHzs67Sl4IqPj88lC64EBwe3u+CKs1VFXaFS4qV0VTVLVVh17LczddX+vZqfyc7UEVVFRUS6u1ZPCeTm5pKRkWE/6Nq3b1+n329WXFzMmDFjABg+fDiVlZWUlpZ2/OhFRK7CsWPHmD9/Pg0NDTQ0NPDxxx8zadIkFVwRERER6UKtnsm9uJrntbjf7FJ9ff/999xwww1XMVQRkY4VERHBvn37ePTRR/Hx8WHUqFHExMQQFBTErFmzqK+vJyIiwqHgyvz586mpqWHw4MEOBVdSU1NZs2YN/fr1Y+XKlcD/Y+/+45q87/3/P6MB1EJncYk46lzrurppq9voWtYNjm4CGiKVtrepTLt2ndY5bf10OASOTE+t1jFx3hS7bl27qu1krhLLwdiuHm0t3aScbR4617lWrBWLQV0FFAxwff/wZr4iyu8kcPG4327eIO/rR17XO/GdPLneuXLxgisZGRlyOByKiIhQbm5u0I4VAACgr+j0haeu9bmynvy82ZXb8Dm03oOaOoaaOqY31tRZCxcu1MKFC1u0ccEVAACA4Ol0yL3yc2X++LzZ8OHDdfLkSX32s59tsa/O4HNoPY+aOoaaOqYrNfE5NAAAALSn09+TO378eL9/3iw+Pl4ul0uS9M477ygsLIypygAAAACAdnX6TG5YWJjvC7799Xmz2bNna9myZXI4HAoNDdWaNWt66ngBAAAAACbW4ZC7Z88e3+/+/rxZWFiYnnrqqY6WBgAAAACApC5MVwYAAAAAoLci5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDWtXN/z973+vLVu2+G5/9NFHSklJ0fnz51VWVqbBgwdLkn70ox9p8uTJKikp0apVq9TQ0KApU6Zo8eLFkqRDhw4pKytLdXV1iomJ0fLly2W1WlVZWan09HSdOnVKN910k3Jzc3Xdddd183ABAAAAAGbW5TO5999/v1wul1wul3JzczVs2DD96Ec/Unl5ubZs2eJbNnnyZNXX1yszM1P5+fkqLi5WeXm59u3bJ0lKT0/XsmXLtHv3bhmGoYKCAknS8uXLNWvWLLndbo0bN075+fk9c8QAAAAAANPqkenKP/3pT7V48WINHjxYlZWVyszMlNPp1Pr169Xc3KyDBw9q1KhRGjlypKxWq5xOp9xut44fP676+npNmDBBkpSamiq32y2v16vS0lIlJia2aAcAAAAAoC1dnq58SUlJierr6zVlyhQdO3ZMd911l3JychQREaF58+Zp+/btGjJkiGw2m28bu92uqqoqnTx5skW7zWZTVVWVzpw5o/DwcFmt1hbtnTFsWHh3D61H2GwRQdnWX6ipY6ipY3pjTQAAAOjbuh1yf/e73+nBBx+UJI0cOVIbN270LZs9e7YKCwuVmJgoi8XiazcMQxaLRc3NzVdtv/Tzclfebs+pU7VqbjbaXc/fb7I9npoubWezRXR5W3+hpo6hpo7pSk0DBlh6zR+wAAAtPfXUUzpz5oxWr17d6WuunD17Vj/+8Y917NgxRUZGat26dbLZbLpw4YKysrJUXl6uQYMGKTc3V6NHjw72oQLo5bo1XfnChQsqLS3VpEmTJEnvvfeedu/e7VtuGIasVquioqLk8Xh87R6PR3a7vVV7dXW17Ha7IiMjVVNTo6amphbrAwAAoPd5++23tWPHDt/tzl5zZd26dYqJidGuXbt0//33a+XKlZKkzZs3a/Dgwdq1a5cyMzO1dOnSwB8cgD6nWyH3vffe0+c+9zkNGTJE0sVQ++STT+qTTz6R1+vVtm3bNHnyZI0fP15HjhzR0aNH1dTUpKKiIsXFxSk6OlphYWEqKyuTJLlcLsXFxSkkJEQxMTEqLi6WJBUWFiouLq6bhwoAAICe9u9//1t5eXl65JFHJKlL11zZu3evnE6nJCk5OVlvvPGGvF6v9u7dq2nTpkmS7rjjDp0+fVqVlZWBPkQAfUy3Qu6xY8cUFRXluz1mzBjNnTtXM2fOlMPh0Be/+EUlJycrLCxMq1ev1sKFCzV16lTdfPPNSkpKkiTl5uZq1apVSkpK0rlz5zRnzhxJUk5OjgoKCjR16lS98847euyxx7pTKgD4xYYNG+RwOORwOLRmzRpJF69V4HQ6lZCQoLy8PN+6hw4dUmpqqhITE5WVlaXGxkZJUmVlpdLS0pSUlKT58+errq5OknT27FnNnTtXU6ZMUVpaWouZLwDQWyxbtkyLFy/W9ddfL0lduubK5dtYrVaFh4fr9OnTV93Xxx9/HKhDA9BHdeszuVOnTtXUqVNbtKWlpSktLa3VurGxsdq5c2er9jFjxmj79u2t2qOjo7V58+bulAcAflVSUqL9+/drx44dslgsevjhh1VUVKTc3Fxt3rxZI0aM0Lx587Rv3z7Fx8crPT1dTzzxhCZMmKDMzEwVFBRo1qxZvul7DodDGzduVH5+vtLT033T95555hkVFhZq5cqVWrduXbAPGwB8fv/732vEiBGKjY3Vyy+/LEk9cs0VwzA0YMCAVttcau+M3nItB39eB6YvXsiRmgOjv9bc7QtPAUB/ZbPZlJGRodDQUEnS6NGjVVFR4fvKNEm+r0z7/Oc/32r63vr163X//fertLTUd9G+1NRUffe731V6err27t2rrVu3Sro4fW/FihXyer0KCQkJwtECQGvFxcXyeDxKSUnRJ598onPnzslisbR7zZWBAwe2uOaK3W5XdXW1oqKi1NjYqLq6Og0dOlTDhw/XyZMn9dnPfrbFvjqjoxcjlfwbCPx1AcjeeHHJ9lBzYPir5t5w4d72LkbaI9+TCwD90S233OILrRUVFdq1a5csFkuPfWXatabvAUBv8dxzz6moqEgul0uLFi3SpEmTtGrVqk5fcyU+Pl6FhYWSLgbnmJgYhYSEKD4+Xi6XS5L0zjvvKCwsTJ/5zGeCcKQA+hLO5AJANx0+fFjz5s3TkiVLNHDgQFVUVPiW9eRXpvXXaXp9capVW5iy2FKwau6tfdVb6+qs3NxcZWdnq7a2VmPHjm1xzZWMjAxt2rRJI0aM0Nq1ayVJjz76qDIyMuRwOBQREbdEuCEAACAASURBVKHc3FxJF7+OctmyZXI4HAoNDfVd+wAA2kLIBYBuKCsr06JFi5SZmSmHw6EDBw50+SvTOjp9rzP4zvCuYcpiy/36U7Ae3+48J/2pJ6bpBUtqaqpSU1Mldf6aK0OHDtXTTz/dqj0sLExPPfVUzxcLwNSYrgwAXXTixAktWLBAubm5cjgcktSjX5l2rel7AAAAuDbO5AJAFz377LNqaGjQ6tWrfW0zZszwfWVaQ0OD4uPjW3xlWk9M3wMAAMC1EXIBoIuys7OVnZ191WU98ZVp15q+BwAAgGtjujIAAAAAwDQIuQAAAAAA0yDkAgAAAABMg5ALAAAAADANQi4AAAAAwDQIuQAAAAAA0yDkAgAAAABMg5ALAAAAADANQi4AAAAAwDQIuQAAAAAA0yDkAgAAAABMg5ALAAAAADANQi4AAAAAwDQIuQAAAAAA0yDkAgAAAABMw9qdjWfPnq3Tp0/Lar24mxUrVujDDz/Upk2b1NjYqAceeEBpaWmSpJKSEq1atUoNDQ2aMmWKFi9eLEk6dOiQsrKyVFdXp5iYGC1fvlxWq1WVlZVKT0/XqVOndNNNNyk3N1fXXXddNw8XAAAAAGBmXT6TaxiGKioq5HK5fP+ioqKUl5enF198UYWFhdq2bZv+9a9/qb6+XpmZmcrPz1dxcbHKy8u1b98+SVJ6erqWLVum3bt3yzAMFRQUSJKWL1+uWbNmye12a9y4ccrPz++ZIwYAAAAAmFaXQ+4HH3wgSXrooYc0bdo0bdmyRSUlJbrrrrs0dOhQDRkyRImJiXK73Tp48KBGjRqlkSNHymq1yul0yu126/jx46qvr9eECRMkSampqXK73fJ6vSotLVViYmKLdgAAAAAA2tLlkHv27FnFxsZq48aNev755/W73/1OlZWVstlsvnXsdruqqqp08uTJDrXbbDZVVVXpzJkzCg8P902DvtQOAAAAAEBbuvyZ3C9/+cv68pe/7Lt93333adWqVZo/f76vzTAMWSwWNTc3y2KxdLj90s/LXXm7PcOGhXf2kPzCZosIyrb+Qk0dQ00d0xtrAgAAQN/W5ZD7zjvvyOv1KjY2VtLFgBodHS2Px+Nbx+PxyG63KyoqqkPt1dXVstvtioyMVE1NjZqamjRw4EDf+p1x6lStmpuNdtfz95tsj6emS9vZbBFd3tZfqKljqKljulLTgAGWXvMHLAAAAPROXZ6uXFNTozVr1qihoUG1tbXasWOHfvazn+ntt9/W6dOndf78eb366quKi4vT+PHjdeTIER09elRNTU0qKipSXFycoqOjFRYWprKyMkmSy+VSXFycQkJCFBMTo+LiYklSYWGh4uLieuaIAQAAAACm1eUzuRMnTtTf/vY33XPPPWpubtasWbP01a9+VYsXL9acOXPk9Xp133336fbbb5ckrV69WgsXLlRDQ4Pi4+OVlJQkScrNzVV2drZqa2s1duxYzZkzR5KUk5OjjIwMbdq0SSNGjNDatWt74HABAAAAAGbWre/Jfeyxx/TYY4+1aHM6nXI6na3WjY2N1c6dO1u1jxkzRtu3b2/VHh0drc2bN3enPAAAAABAP9Pl6coAAAAAAPQ2hFwAAAAAgGkQcgEAAAAApkHIBQAAAACYBiEXAAAAAGAahFwAAAAAgGkQcgEAAAAApkHIBQAAAACYBiEXAAAAAGAahFwAAAB02YYNG+RwOORwOLRmzRpJUklJiZxOpxISEpSXl+db99ChQ0pNTVViYqKysrLU2NgoSaqsrFRaWpqSkpI0f/581dXVSZLOnj2ruXPnasqUKUpLS5PH4wn8AQLocwi5AAAA6JKSkhLt379fO3bsUGFhod59910VFRUpMzNT+fn5Ki4uVnl5ufbt2ydJSk9P17Jly7R7924ZhqGCggJJ0vLlyzVr1iy53W6NGzdO+fn5kqR169YpJiZGu3bt0v3336+VK1cG7VgB9B2EXADoptraWiUnJ+ujjz6SxBkMAP2HzWZTRkaGQkNDFRISotGjR6uiokKjRo3SyJEjZbVa5XQ65Xa7dfz4cdXX12vChAmSpNTUVLndbnm9XpWWlioxMbFFuyTt3btXTqdTkpScnKw33nhDXq83OAcLoM8g5AJAN/ztb3/TzJkzVVFRIUmqr6/nDAaAfuOWW27xhdaKigrt2rVLFotFNpvNt47dbldVVZVOnjzZot1ms6mqqkpnzpxReHi4rFZri3ZJLbaxWq0KDw/X6dOnA3V4APooa7ALAIC+rKCgQDk5OVqyZIkk6eDBg74zGJJ8ZzA+//nPtzqDsX79et1///0qLS3Vxo0bfe3f/e53lZ6err1792rr1q2SLp7BWLFihbxer0JCQoJwpABwbYcPH9a8efO0ZMkSDRw40PeHP0kyDEMWi0XNzc2yWCyt2i/9vNyVty/fZsCAzp2jGTYsvFPr+4vNFtEn9+0v1BwY/bVmQi4AdMOVZ1evPFPhjzMYw4cP73B9Znhz1xdfoNvCG92WglVzb+2r3lpXW8rKyrRo0SJlZmbK4XDowIEDLT5e4fF4ZLfbFRUV1aK9urpadrtdkZGRqqmpUVNTkwYOHOhbX7o4hlZXVysqKkqNjY2qq6vT0KFDO1XfqVO1am42OrSuP/vf46nxy35ttgi/7dtfqDkw/FWzv8epjtQ8YIClzfc4hFwA6EHXOlMRrDMYHX1z1xtesK4mWG8qeKPbcr/+FKzHtzvPSX/qiTd3gXTixAktWLBAeXl5io2NlSSNHz9eR44c0dGjR3XjjTeqqKhI9957r6KjoxUWFqaysjJ99atflcvlUlxcnEJCQhQTE6Pi4mI5nU4VFhYqLi5OkhQfH6/CwkI98sgjKi4uVkxMDLNZALSLkAsAPejKMxXBPoMBAP707LPPqqGhQatXr/a1zZgxQ6tXr9bChQvV0NCg+Ph4JSUlSZJyc3OVnZ2t2tpajR07VnPmzJEk5eTkKCMjQ5s2bdKIESO0du1aSdKjjz6qjIwMORwORUREKDc3N/AHCaDPIeQCQA/iDAaA/iQ7O1vZ2dlXXbZz585WbWPGjNH27dtbtUdHR2vz5s2t2ocOHaqnn366+4UC6FcIuQDQg8LCwjiDAQAAEESEXADoAXv27PH9HhsbyxkMAACAIOF7cgEAAAAApkHIBQAAAACYBiEXAAAAAGAa3Qq5GzZskMPhkMPh0Jo1ayRJS5cuVUJCglJSUpSSkqLXXntNklRSUiKn06mEhATl5eX59nHo0CGlpqYqMTFRWVlZamxslCRVVlYqLS1NSUlJmj9/vurq6rpTKgAAAACgH+hyyC0pKdH+/fu1Y8cOFRYW6t1339Vrr72m8vJybdmyRS6XSy6XS5MnT1Z9fb0yMzOVn5+v4uJilZeXa9++fZKk9PR0LVu2TLt375ZhGCooKJAkLV++XLNmzZLb7da4ceOUn5/fM0cMAAAAADCtLodcm82mjIwMhYaGKiQkRKNHj1ZlZaUqKyuVmZkpp9Op9evXq7m5WQcPHtSoUaM0cuRIWa1WOZ1Oud1uHT9+XPX19ZowYYIkKTU1VW63W16vV6WlpUpMTGzRDgAAAABAW7r8FUK33HKL7/eKigrt2rVLW7du1YEDB5STk6OIiAjNmzdP27dv15AhQ2Sz2Xzr2+12VVVV6eTJky3abTabqqqqdObMGYWHh8tqtbZo74xhw8K7emg9ymaLCMq2/kJNHUNNHdMbawIAAEDf1u3vyT18+LDmzZunJUuW6Oabb9bGjRt9y2bPnq3CwkIlJibKYrH42g3DkMViUXNz81XbL/283JW323PqVK2am4121/P3m2yPp6ZL29lsEV3e1l+oqWOoqWO6UtOAAZZe8wcsAAAA9E7duvBUWVmZvve97+nxxx/X9OnT9d5772n37t2+5YZhyGq1KioqSh6Px9fu8Xhkt9tbtVdXV8tutysyMlI1NTVqampqsT4AAAAAAG3pcsg9ceKEFixYoNzcXDkcDkkXQ+2TTz6pTz75RF6vV9u2bdPkyZM1fvx4HTlyREePHlVTU5OKiooUFxen6OhohYWFqaysTJLkcrkUFxenkJAQxcTEqLi4WJJUWFiouLi4HjhcAAAAAICZdXm68rPPPquGhgatXr3a1zZjxgzNnTtXM2fOVGNjoxISEpScnCxJWr16tRYuXKiGhgbFx8crKSlJkpSbm6vs7GzV1tZq7NixmjNnjiQpJydHGRkZ2rRpk0aMGKG1a9d25zgBAAAAAP1Al0Nudna2srOzr7osLS2tVVtsbKx27tzZqn3MmDHavn17q/bo6Ght3ry5q+UBAAAAAPqhbn0mFwAAAACA3oSQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDWuwC0DvEnH9YA0Ku/bTwmaL6PK+6xsaVXP2fJe3BwAAAID2EHL96IK3qVuhsK1t/RUYB4VZ5Xzc1eP7laRXfp6iGr/sGQAAAAAuIuT6UWjIQALjZbob+q8l4vrBnCEOkPbO9HfWpecDZ/kBAADQUwi5CBh/hf6+GPj7Kn+d6ecxBAAAQE/p1SH3lVde0aZNm9TY2KgHHnhAaWlpwS4J/UxXz1x25Iw1Zy/RUYyFAPo7xkEAndFrQ25VVZXy8vL08ssvKzQ0VDNmzNCdd96pz3/+88EuDf0In1FGsDEWAujvGAcBdFav/QqhkpIS3XXXXRo6dKiGDBmixMREud3uYJcFAAHFWAigv2McBNBZvfZM7smTJ2Wz2Xy37Xa7Dh482OHtBwywdOr+7DcM7tT6wd6v1Plj7Ch/1uyvffurL6S++Rj6876C+RgGsr96i0COhb31uR6sx70vjld98XUhWI9vd+432P3R38ZCs7wn7Iv/9/2JmgPDrK8L7a1jMQzD6KmCetKmTZvU0NCgxx57TJJUUFCg8vJyrVixIsiVAUDgMBYC6O8YBwF0Vq+drhwVFSWPx+O77fF4ZLfbg1gRAAQeYyGA/o5xEEBn9dqQ+/Wvf11vv/22Tp8+rfPnz+vVV19VXFxcsMsCgIBiLATQ3zEOAuisXvuZ3OHDh2vx4sWaM2eOvF6v7rvvPt1+++3BLgsAAoqxEEB/xzgIoLN67WdyAQAAAADorF47XRkAAAAAgM4i5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANPo1yH3lVde0dSpU5WQkKCtW7cG9L43bNggh8Mhh8OhNWvWSJJKSkrkdDqVkJCgvLw837qHDh1SamqqEhMTlZWVpcbGRr/W9tRTTykjI6PN+66srFRaWpqSkpI0f/581dXV+aWWPXv2KDU1VVOmTNETTzwhKfj95HK5fI/dU0891eZ9+7ufamtrlZycrI8++khS5/vGH/VdWdO2bduUnJwsp9OppUuX6sKFCwGvCS1d+RhdLtDjTUdq2rBhgyZOnKiUlBSlpKQEbLy+2jh9uWD1VXt1BaO/fvGLX2jq1KlyOBx67rnnWi0PVl+1V1ewnltSy9fayzEGBkZvHAfb01bNf/zjH5WSkqJp06bphz/8oT755JMgVNhaWzVfsnfvXk2aNCmAVbWtrZo/+OADzZ49W9OmTdP3v//9PtHP7777ru69915NmzZN8+bN09mzZ4NQYWt+f401+qmPP/7YmDhxonHmzBmjrq7OcDqdxuHDhwNy32+99Zbxne98x2hoaDAuXLhgzJkzx3jllVeM+Ph448MPPzS8Xq/x0EMPGXv37jUMwzAcDofxl7/8xTAMw1i6dKmxdetWv9VWUlJi3HnnncZPfvKTNu977ty5RlFRkWEYhrFhwwZjzZo1PV7Lhx9+aHzjG98wTpw4YVy4cMGYOXOmsXfv3qD207lz54w77rjDOHXqlOH1eo377rvPeOutt4LST3/961+N5ORkY+zYscaxY8eM8+fPd7pverq+K2v64IMPjMmTJxs1NTVGc3OzsWTJEuO5554LaE1o6crH6EqBHG86WtO8efOM//3f//V7HZe72jj96quvtlgnGH3VkboC3V9//vOfjRkzZhher9c4f/68MXHiROP9999vsU4w+qojdQXjuWUYrV9rL8cY6H+9cRxsT1s119TUGHfffbfx8ccfG4ZhGOvWrTP+67/+KxhlttBePxuGYXg8HiMpKcmYOHFigKu7urZqbm5uNhISEox9+/YZhmEYP/vZz3rF/8/2+vnS+2fDMIxVq1YZa9euDXSJrQTiNbbfnsktKSnRXXfdpaFDh2rIkCFKTEyU2+0OyH3bbDZlZGQoNDRUISEhGj16tCoqKjRq1CiNHDlSVqtVTqdTbrdbx48fV319vSZMmCBJSk1N9Vud//73v5WXl6dHHnlEkq55316vV6WlpUpMTPRrTa+99pqmTp2qqKgohYSEKC8vT4MHDw5qPzU1Nam5uVnnz59XY2OjGhsbZbVag9JPBQUFysnJkd1ulyQdPHiwU33jj/qurCk0NFQ5OTkKDw+XxWLRF77wBVVWVgb9udWfXfkYXS6Q401Ha5Kk8vJy/fKXv5TT6dSKFSvU0NDg95quNk5XVlb6lgerr9qrSwp8f33ta1/TCy+8IKvVqlOnTqmpqUlDhgzxLQ9WX7VXlxSc59aVr7WXYwwMjN44DranrZq9Xq9ycnI0fPhwSdKtt96qEydOBLrEVtob2yUpOztbP/rRjwJYVdvaqvndd9/VkCFDFBcXJ0l65JFHlJaWFugSW2mvn5ubm30zQs6fP69BgwYFsryrCsRrbL8NuSdPnpTNZvPdttvtqqqqCsh933LLLb4HraKiQrt27ZLFYrlqPVfWabPZ/FbnsmXLtHjxYl1//fWSWvfRpfs+c+aMwsPDZbVa/VrT0aNH1dTUpEceeUQpKSl68cUXr/m4BaqfwsPD9eijj2rKlCmKj49XdHS0QkJCgtJPK1euVExMjO92Z/vGH/VdWVN0dLTuvvtuSdLp06e1detWfetb3wr6c6s/u/Ixulwgx5uO1lRXV6cvfvGLSk9P144dO3T27Fnl5+f7vaarjdPx8fG+5cHqq/bqClZ/hYSEaP369XI4HIqNjfW92ZaC11ft1RWsvrrytfZyjIGB0RvHwfa0VfMNN9ygyZMnS5Lq6+v1zDPP6Nvf/nYgy7uqtmqWpBdeeEFf+tKXNH78+ABW1ba2av7www/16U9/WpmZmZo+fbpycnJa/eEsGNrr54yMDGVnZ+sb3/iGSkpKNGPGjABWd3WBeI3ttyG3ublZFovFd9swjBa3A+Hw4cN66KGHtGTJEo0cOfKq9QSqzt///vcaMWKEYmNjfW3Xuu+r1eCPmpqamvT222/rySef1LZt23Tw4EEdO3YsqP30j3/8Q3/4wx/0P//zP3rzzTc1YMAAvfXWW0Htp0uu1QfBfhwlqaqqSg888IDuvfde3Xnnnb2iJrTWG8bFK1133XX61a9+pdGjR8tqteqhhx7Svn37Anb/l4/Tn/vc53ztwe6ra9UVzP5atGiR3n77bZ04cUIFBQW+9mD31bXqCkZfXe219nKMgcEX7Odrd9TU1Gju3LkaM2aMpk+fHuxy2vTPf/5Tr776qn74wx8Gu5QOa2xs1IEDBzRz5kzt2LFDI0eO1OrVq4NdVpvq6+uVlZWl559/Xvv379esWbP0k5/8JNhl+fjzNbbfhtyoqCh5PB7fbY/H0+Z0ip5WVlam733ve3r88cc1ffr0a9ZzZXt1dbVf6iwuLtZbb72llJQUrV+/Xnv27NH27duvet+RkZGqqalRU1NTi1p72qc//WnFxsYqMjJSgwYN0re//W2VlJQEtZ/279+v2NhYDRs2TKGhoUpNTdWf//znoPbTJZ19DgWqvvfff18zZszQ9OnTtWDBgqvWGqw+Q0uB+n/UGZWVldq+fbvvtmEYvrNc/nblOH25YPZVW3UFo7/ef/99HTp0SJI0ePBgJSQk6L333vMtD1ZftVdXMPrqaq+1Tz75pG85Y2Dw9cZxsCNOnjypWbNm6dZbb9XKlSuDXU673G63PB6P7r33Xs2dO9dXf29ms9k0atQo3XbbbZKk5ORkHTx4MMhVte2f//ynwsLCdPvtt0uSvvOd7+jAgQNBruoif7/G9tuQ+/Wvf11vv/22Tp8+rfPnz+vVV1/1zbH3txMnTmjBggXKzc2Vw+GQJI0fP15HjhzxTdEtKipSXFycoqOjFRYWprKyMkkXr+zrjzqfe+45FRUVyeVyadGiRZo0aZJWrVp11fsOCQlRTEyMiouLJUmFhYV+qWnixInav3+/zp49q6amJr355ptKSkoKaj+NGTNGJSUlOnfunAzD0J49e/S1r30tqP10SWefQ4Gor7a2Vt///vf16KOP6qGHHvK1B7MmXFug/h91xqBBg/Szn/1Mx44dk2EY2rp1q29anj9dbZy+XLD6qr26gtFfH330kbKzs3XhwgVduHBBr7/+ur761a/6lgerr9qrKxh9dbXX2szMTN9yxsDg643jYHsufbRrypQpysrK6hNnnhctWqTdu3fL5XLpmWeekd1u14svvhjsstr05S9/WadPn9Y//vEPSRe/AWTs2LFBrqpto0aN0scff6wPPvhAkvT666/7QnowBeI1NjB/Du+Fhg8frsWLF2vOnDnyer267777fH/l8Ldnn31WDQ0NLaY4zJgxQ6tXr9bChQvV0NCg+Ph4JSUlSZJyc3OVnZ2t2tpajR07VnPmzAlInW3dd05OjjIyMrRp0yaNGDFCa9eu7fH7Hj9+vB5++GHNmjVLXq9Xd999t2bOnKmbb745aP30jW98Q3//+9+VmpqqkJAQ3XbbbZo7d64mT54ctH66JCwsrNPPIX/Xt337dlVXV+u5557zfX3HpEmT9Oijjwb1uYWWfvCDH2jRokW67bbbgjreXKumFStWaP78+fJ6vfrKV76iBx980O/3f61xes+ePUHtq47UFej+io+P18GDB3XPPfdo4MCBSkhIkMPhCPrzqiN1BeO5dTVZWVmaNGmSvvWtbzEGBkmwn69dcanmjz/+WH//+9/V1NSk3bt3S5LGjRvXK8/oXt7PfcXlNW/cuFHZ2dk6f/68oqKirvrVN73B5TWvWrVKjz32mAzD0LBhw1rMHgmWQLzGWgzDMHq6cAAAAAAAgqHfTlcGAAAAAJgPIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJiGNdgFoP/461//qp///Of697//LcMwFBUVpZ/85Cfatm2bSktLJUnvv/++oqOjNWjQIEnStm3b9IMf/EDHjx9XRESEJKm5uVkXLlzQ/Pnzdc899/j27/V6NXHiRI0ZM0a//vWvfe1PPPFEm/u/9PvChQt14MAB7d27V4MHD/Z/hwDAZZYvX653331XL730kgYOHChJampqUlpamu688049/fTT+sIXvqABA1r+fXrjxo268cYbJV17HJSkW2+91be9xWLR+fPnFR4erp/+9Ke67bbbAnOQAAAEgMUwDCPYRcD8Lly4oG9+85v6zW9+o7Fjx0qSXC6X8vLy9Prrr/ve0E2aNEm/+MUvWrzhmj17ttLS0pSUlORr+7//+z/NnDlTf/rTnxQeHi5JKi4u1ssvv6zy8nJt3bpVo0ePblXH1fYvSVVVVUpJSdH48eP1H//xH5o5c2aP9wEAtKWhoUH33XefpkyZoh/+8IeSpPz8fL311lt64YUX9KUvfUlvv/22IiMjr7mPtsbBW2+9tdX2zz77rF599VVt27bNfwcGAECAMV0ZAXH+/HnV1NTo3LlzvrZp06bpP//zP9XU1NTp/R07dkxDhgxRaGior+2ll17St771LU2dOlW//e1vO7W/goICxcbGavr06XrhhRfE334ABFpYWJhyc3P161//WocOHdLf//53vfjii1q7dq3vD4Ht6cw42NjYqBMnTuhTn/pUT5QPAECvwXRlBMSnPvUppaen6+GHH9anP/1pfeUrX9Gdd94ph8PRIqhey5o1a7Rp0yadPXtWDQ0Nuuuuu/T888/7tv3Xv/6lv/zlL1q/fr3Gjh2r2bNna/Hixbrhhhva3XdjY6MKCgq0YsUK3X333Vq2bJneeOMNxcfHd/u4AaAzbr31Vi1evFhZWVlqbm7WypUrNXz4cN/yBx54oMV05RtvvFEbN26U1LFx8IEHHpAknTlzRmFhYZo4caJWrVoVoKMDACAwOJOLgHnwwQf11ltvKTs7WzabTb/61a90zz33qKampt1tlyxZIpfLpT/84Q8aMWKEhg8fri996Uu+5S+99JImTpyoG264QbfffrtuvPFGFRQUdKiu119/Xc3NzfrmN7+p0NBQTZ06VS+88EKXjxMAumP27NkaMmSIxo8f9dPg9gAAIABJREFU3+qPbb/97W/lcrl8/y4FXKlj4+Bvf/tbvfLKK/rlL3+p+vp63XnnnRo2bFhAjgsAgEAh5CIgysrK9Otf/1rh4eGaOHGilixZov/+7/+WxWLRW2+91eH9REZGat26dXrxxRf16quvSpLOnTsnl8ulsrIyTZo0SZMmTZLH49GWLVvk9Xrb3eeLL76o+vp6JSQkaNKkSfrjH/+o/fv36/Dhw10+XgDojhtvvFGf/exnO7x+Z8fBsWPHaunSpcrIyNBHH33Uk6UDABB0hFwERGRkpDZt2qR33nnH1+bxeFRbW6svfOELndrXyJEj9cgjj2jlypU6d+6cXnnlFQ0dOlRvvvmm9uzZoz179uiPf/yjzp07J7fb3ea+jhw5otLSUr388su+bffv36877riDs7kA+oyujIPJycm6/fbbma4MADAdPpOLgLjpppu0ceNG5eXl6eOPP1ZYWJgiIiL05JNP6uabb+70/r7//e+rsLBQmzZt0ptvvqkHH3ywxYVZrr/+es2ePVvPP/+8nE7nNffz0ksv6dvf/rZGjRrVon3BggWaN2+eFi9e3OaVTAEgkK78TK4k/b//9//00ksvdWkc/M///E9NmzZNb775pr75zW/6tXYAAAKFrxACAAAAAJgG05UBAAAAAKZByAUAAAAAmAYhFwAAAABgGoRcAAAAAIBpEHIBAAAAAKZh2q8QOnOmTs3NrS8cPWxYuE6dqg1CRV1HzYHRF2uW+mbdXa15wACLbrjhOj9UZF7XGgsDqT89R4OJmgOjN9TMWAgAbTNtyG1uNq75xi7Yb/i6gpoDoy/WLPXNuvtizX1RW2NhoOvoa6g5MKgZANDTmK4MAAAAADANQi4AAAAAwDQIuQAAAAAA0yDkAgAAAABMg5ALAAAAADANQi4AAAAAwDQIuQAAAAAA0yDkAgAAAABMg5ALAAAAADANQi4AAAAAwDSswS4AXRNx/WANCuv5h6++oVE1Z8/3+H4BAP51wdskmy2ix/fL6wIAoK8h5PZRg8Kscj7u6vH9vvLzFNX0+F4BAP4WGjKQ1wUAAMR0ZQAAAACAiRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaRByAQAAAACmQcgFAAAAAJgGIRcAAAAAYBqEXAAAAACAaViDXQD6j4jrB2tQWM8/5eobGlVz9nyP7xcAAABA30PIRcAMCrPK+birx/f7ys9TVNPjewUAAADQFzFdGQAAAABgGoRcAAAAAIBpEHIBAAAAAKZByAUAAAAAmEa3Qu4vfvELTZ06VQ6HQ88995wkqaSkRE6nUwkJCcrLy/Ote+jQIaWmpioxMVFZWVlqbGyUJFVWViotLU1JSUmaP3++6urqJElnz57V3LlzNWXKFKWlpcnj8XSnVAAAAABAP9DlkHvgwAH96U9/0s6dO/WHP/xBmzdv1j/+8Q9lZmYqPz9fxcXFKi8v1759+yRJ6enpWrZsmXbv3i3DMFRQUCBJWr58uWbNmiW3261x48YpPz9fkrRu3TrFxMRo165duv/++7Vy5coeOFwAAAAAgJl1OeR+7Wtf0wsvvCCr1apTp06pqalJZ8+e1ahRozRy5EhZrVY5nU653W4dP35c9fX1mjBhgiQpNTVVbrdbXq9XpaWlSkxMbNEuSXv37pXT6ZQkJScn64033pDX6+3u8QIAAAAATKxb35MbEhKi9evX6ze/+Y2SkpJ08uRJ2Ww233K73a6qqqpW7TabTVVVVTpz5ozCw8NltVpbtEtqsY3ValV4eLhOnz6t4cOHd6i2YcPCr7nMZovo9LEGWyBr7qn7oubA6Yt198WaAQAA0Pt1K+RK0qJFi/SDH/xAjzzyiCoqKmSxWHzLDMOQxWJRc3PzVdsv/bzclbcv32bAgI6feD51qlbNzUardpstQh5PTYf30xtcrWZ/BoSe6B+z1NwX9MW6u1rzgAGWNv+ABQAAAHR5uvL777+vQ4cOSZIGDx6shIQE/fnPf25xgSiPxyO73a6oqKgW7dXV1bLb7YqMjFRNTY2ampparC9dPAtcXV0tSWpsbFRdXZ2GDh3a1XIBAAAAAP1Al0PuRx99pOzsbF24cEEXLlzQ66+/rhkzZujIkSM6evSompqaVFRUpLi4OEVHRyssLExlZWWSJJfLpbi4OIWEhCgmJkbFxcWSpMLCQsXFxUmS4uPjVVhYKEkqLi5WTEyMQkJCunu8AAAAAAAT6/J05fj4eB08eFD33HOPBg4cqISEBDkcDkVGRmrhwoVqaGhQfHy8kpKSJEm5ubnKzs5WbW2txo4dqzlz5kiScnJylJGRoU2bNmnEiBFau3atJOnRRx9VRkaGHA6HIiIilJub2wOHCwAAAAAws259JnfhwoVauHBhi7bY2Fjt3Lmz1bpjxozR9u3bW7VHR0dr8+bNrdqHDh2qp59+ujvlAQAAAAD6mS5PVwYAAAAAoLch5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0unXhKQBdF3H9YA0K65n/gjZbhO/3+oZG1Zw93yP7xf9vw4YN2rVrl6SLV5dfsmSJSkpKtGrVKjU0NGjKlClavHixJOnQoUPKyspSXV2dYmJitHz5clmtVlVWVio9PV2nTp3STTfdpNzcXF133XU6e/asfvzjH+vYsWOKjIzUunXrZLPZdOHCBWVlZam8vFyDBg1Sbm6uRo8eHcxuAAAA6PUIuUCQDAqzyvm4q8f3+8rPU1TT43vt30pKSrR//37t2LFDFotFDz/8sIqKipSbm6vNmzdrxIgRmjdvnvbt26f4+Hilp6friSee0IQJE5SZmamCggLNmjVLy5cv16xZs+RwOLRx40bl5+crPT1d69atU0xMjJ555hkVFhZq5cqVWrdunTZv3qzBgwdr165dKi0t1dKlS1VQUBDs7gAAAOjVmK4MAO2w2WzKyMhQaGioQkJCNHr0aFVUVGjUqFEaOXKkrFarnE6n3G63jh8/rvr6ek2YMEGSlJqaKrfbLa/Xq9LSUiUmJrZol6S9e/fK6XRKkpKTk/XGG2/I6/Vq7969mjZtmiTpjjvu0OnTp1VZWRmEHgAAAOg7OJMLAO245ZZbfL9XVFRo165d+u53vyubzeZrt9vtqqqq0smTJ1u022w2VVVV6cyZMwoPD5fVam3RLqnFNlarVeHh4Tp9+vRV9/Xxxx/rM5/5TIdrHzYsvGsH3cMun1LfV/TFmv3Fn33RF/u5L9YMAP0JIRcAOujw4cOaN2+elixZooEDB6qiosK3zDAMWSwWNTc3y2KxtGq/9PNyV96+fJsBAwa02uZSe2ecOlWr5majU9v0NJstQh5P35pE31dr9hd/9UVf7edg1zxggKXX/AELAHojpisDQAeUlZXpe9/7nh5//HFNnz5dUVFR8ng8vuUej0d2u71Ve3V1tex2uyIjI1VTU6OmpqYW60sXzwJXV1dLkhobG1VXV6ehQ4dq+PDhOnnyZKt9AQAA4NoIuQDQjhMnTmjBggXKzc2Vw+GQJI0fP15HjhzR0aNH1dTUpKKiIsXFxSk6OlphYWEqKyuTJLlcLsXFxSkkJEQxMTEqLi6WJBUWFiouLk7Sxas1FxYWSpKKi4sVExOjkJAQxcfHy+W6eHGyd955R2FhYZ2aqgwAANAfMV0ZANrx7LPPqqGhQatXr/a1zZgxQ6tXr9bChQvV0NCg+Ph4JSUlSZJyc3OVnZ2t2tpajR07VnPmzJEk5eTkKCMjQ5s2bdKIESO0du1aSdKjjz6qjIwMORwORUREKDc3V5I0e/ZsLVu2TA6HQ6GhoVqzZk2AjxwAAKDvIeQCQDuys7OVnZ191WU7d+5s1TZmzBht3769VXt0dLQ2b97cqn3o0KF6+umnW7WHhYXpqaee6kLFAAAA/RfTlQEAAAAApkHIBQAAAACYBiEXAAAAAGAahFwAAAAAgGkQcgEAAAAApkHIBQAAAACYBiEXAAAAAGAahFwAAAAAgGkQcgEAAAAApkHIBQAAAACYBiEXAAAAAGAahFwAAAAAgGkQcgEAAAAApkHIBQAAAACYBiEXAAAAAGAa1mAXAHTXBW+TbLaIHtnXlfupb2hUzdnzPbJvAAAAAP5HyEWfFxoyUM7HXX7Z9ys/T1GNX/YMAAAAwB+6NV15w4YNcjgccjgcWrNmjSRp6dKlSkhIUEpKilJSUvTaa69JkkpKSuR0OpWQkKC8vDzfPg4dOqTU1FQlJiYqKytLjY2NkqTKykqlpaUpKSlJ8+fPV11dXXdKBQAAAAD0A10OuSUlJdq/f7927NihwsJCvfvuu3rttddUXl6uLVu2yOVyyeVyafLkyaqvr1dmZqby8/NVXFys8vJy7du3T5KUnp6uZcuWaffu3TIMQwUFBZKk5cuXa9asWXK73Ro3bpzy8/N75ogBAAAAAKbV5ZBrs9mUkZGh0NBQhYSEaPTo0aqsrFRlZaUyMzPldDq1fv16NTc36+DBgxo1apRGjhwpq9Uqp9Mpt9ut48ePq76+XhMmTJAkpaamyu12y+v1qrS0VImJiS3aAQAAAABoS5c/k3vLLbf4fq+oqNCuXbu0detWHThwQDk5OYqIiNC8efO0fft2DRkyRDabzbe+3W5XVVWVTp482aLdZrOpqqpKZ86cUXh4uKxWa4t2AAAAAADa0u0LTx0+fFjz5s3TkiVLdPPNN2vjxo2+ZbNnz1ZhYaESExNlsVh87YZhyGKxqLm5+artl35e7srb7Rk2LPyay3rqSryBFMia/XWl4r6qLx5HX6i5L9QIAACAvqdbIbesrEyLFi1SZmamHA6H3nvvPVVUVPimGRuGIavVqqioKHk8Ht92Ho9Hdru9VXt1dbXsdrsiIyNVU1OjpqYmDRw40Ld+Z5w6VavmZqNVu80WIY+nb10v92o1+zMg9ET/BLpmf/LX86W3P4b+1NX/hwMGWNr8AxYAAADQ5c/knjhxQgsWLFBubq4cDoeki6H2ySef1CeffCKv16tt27Zp8uTJGj9+vI4cOaKjR4+qqalJRUVFiouLU3R0tMLCwlRWViZJcrlciouLU0hIiGJiYlRcXCxJKiwsVFxcXA8cLgAAAADAzLp8JvfZZ59VQ0ODVq9e7WubMWOG5s6dq5kzZ6qxsVEJCQlKTk6WJK1evVoLFy5UQ0OD4uPjlZSUJEnKzc1Vdna2amtrNXbsWM2ZM0eSlJOTo4yMDG3atEkjRozQ2rVru3OcAAAAAIB+oMshNzs7W9nZ2VddlpaW1qotNjZWO3fubNU+ZswYbd++vVV7dHS0Nm/e3NXygB5xwdvUZ6dZAwAAAP1Rty88BZhZaMhAOR93+WXfr/w8xS/7BQAAAPqzLn8mFwAAAACA3oaQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AIAAAAATIOQCwAAAAAwDUIuAAAAAMA0CLkAAAAAANMg5AJAB9XW1io5OVkfffSRJGnp0qVKSEhQSkqKUlJS9Nprr0mSSkpK5HQ6lZCQoLy8PN/2hw4dUmpqqhITE5WVlaXGxkZJUmVlpdLS0pSUlKT58+errq5OknT27FnNnTtXU6ZMUVpamjweT4CPGAAAoO8h5AJAB/ztb3/TzJkzVVFR4WsrLy/Xli1b5HK55HK5NHnyZNXX1yszM1P5+fkqLi5WeXm59u3bJ0lKT0/XsmXLtHv3bhmGoYKCAknS8uXLNWvWLLndbo0bN075+fmSpHXr1ikmJka7du3S/fffr5UrVwb8uAEAAPoaQi4AdEBBQYFycnJkt9slSefPn1dlZaUyMzPldDq1fv16NTc36+DBgxo1apRGjhwpq9Uqp9Mpt9ut48ePq76+XhMmTJAkpaamyu12y+v1qrS0VImJiS3aJWnv3r1yOp2SpOTkZL3xxhvyer1BOHoAAIC+wxrsAgCgL7jyLGp1dbXuuusu5eTkKCIiQvPmzdP27ds1ZMgQ2Ww233p2u11VVVU6efJki3abzaaqqiqdOXNG4eHhslqtLdoltdjGarUqPDxcp0+f1vDhw/19uAAAAH0WIRcAumDkyJHauHGj7/bs2bNVWFioxMREWSwWX7thGLJYLGpubr5q+6Wfl7vy9uXbDBjQuQk4w4aFd2p9f7HZIoJdQqf1xZr9xZ990Rf7uS/WDAD9CSEXALrgvffeU0VFhW+asWEYslqtioqKanGBKI/HI7vd3qq9urpadrtdkZGRqqmpUVNTkwYOHOhbX7p4Fri6ulpRUVFqbGxUXV2dhg4d2qk6T52qVXOz0QNH3HU2W4Q8npqg1tBZfbVmf/FXX/TVfg52zQMGWHrNH7AAoDfiM7kA0AWGYejJJ5/UJ598Iq/Xq23btmny5MkaP368jhw5oqNHj6qpqUlFRUWKi4tTdHT0/9fe/QdFcR/+H3+dHtIk0PI1vRPKOCZNMyWj448JaSXTHmPb8MPjRBkzUaikta2pkxq1CRaVyJjGSghVayOmmWZiq7YNsZFT5jzTJqOZBJMo08rYsW0axTQS4RBbfgTOg9vvHxnvI6JW4PCO5fmYcWDft7f32svtZl63y65iY2NVV1cnSXK73XI4HIqJiVFqaqo8Ho8kqbq6Wg6HQ5KUnp6u6upqSZLH41FqaqpiYmIis8IAAAAjBEdyAWAQUlJStGTJEi1cuFA9PT3KyMhQTk6OJKmsrEzLli2T3+9Xenq6srKyJEkVFRUqKSlRR0eHJk+erMLCQklSaWmpiouLtX37diUlJWnTpk2SpOXLl6u4uFhOp1Px8fGqqKiIzMoCAACMIJRcABiAN954I/R7QUGBCgoK+s2Tlpamffv29RtPSUnRnj17+o0nJydr586d/cYTEhL0/PPPDzExAADA6MLpygAAAAAA0xhSyX3uuefkdDrldDpVXl4uSaqtrZXL5VJGRoY2b94cmvfkyZPKy8tTZmam1q5dq56eHklSY2OjCgoKlJWVpaVLl6qzs1OS1NbWpiVLlig7O1sFBQV9LtgCAAAAAMDVDLrk1tbW6q233tLevXtVXV2tv/3tb6qpqdGaNWtUWVkpj8ejEydO6PDhw5KkoqIirVu3TgcPHpRhGKqqqpIkrV+/Xvn5+fJ6vZoyZYoqKyslSVu2bFFqaqoOHDigBx98sN89KgEAAAAAuNKgS67NZlNxcbHGjRunmJgY3XXXXWpoaNCkSZM0ceJEWa1WuVwueb1enT17Vt3d3Zo+fbokKS8vT16vV4FAQEePHg3dguPSuCQdOnRILpdLkpSTk6M333xTgUBgqOsLAAAAADCxQZfcu+++O1RaGxoadODAAVksFtlsttA8drtdTU1Nam5u7jNus9nU1NSkCxcuKC4uTlartc+4pD7PsVqtiouLU2tr62DjAgAAAABGgSFfXfn999/XI488olWrVmns2LFqaGgIPWYYhiwWi4LBoCwWS7/xSz8vd+X05c8ZM+bGO/n1bpJus8X3mb4Y6NW4mLE3vOwbFc7lXpl5OIXrtW5mZvQ1Et77kZARAAAAI8+QSm5dXZ0ee+wxrVmzRk6nU++9916fC0T5fD7Z7XYlJib2GW9paZHdbtf48ePV3t6u3t5ejR07NjS/9OlR4JaWFiUmJqqnp0ednZ1KSEi44Wznz3coGDT6jdts8fL52vuNuR53D3T1/6f9P8/t91qDca3Mw2UkZkZf4fhvOJyu9vm4EWPGWK77BRYAAAAw6NOVP/74Yz366KOqqKiQ0+mUJE2bNk2nT5/WmTNn1Nvbq5qaGjkcDiUnJys2NlZ1dXWSJLfbLYfDoZiYGKWmpsrj8UiSqqur5XA4JEnp6emqrq6WJHk8HqWmpiomJmZIKwsAAAAAMLdBH8l98cUX5ff7VVZWFhpbsGCBysrKtGzZMvn9fqWnpysrK0uSVFFRoZKSEnV0dGjy5MkqLCyUJJWWlqq4uFjbt29XUlKSNm3aJElavny5iouL5XQ6FR8fr4qKiqGsJwAAAABgFBh0yS0pKVFJSclVH9u3b1+/sZSUFO3Zs6ffeHJysnbu3NlvPCEhQc8///xg4wEAAAAARqEhX3gK13Yx0MtFnAAAAADgJqLkDqNxMWOH5YJW0qcXtQIAAAAA9DXoC08BAAAAABBtOJKLPjjFGgAAAMBIRslFH5xiDQAAAGAk43RlAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGtZIBwAwcsR/9hZ9JjY8uw2bLT70e7e/R+1tXWFZLgAAAEY3Si6AG/aZWKtcj7vDvtz9P89Ve9iXCgAAgNFoyKcrd3R0KCcnRx999JEkafXq1crIyFBubq5yc3P1pz/9SZJUW1srl8uljIwMbd68OfT8kydPKi8vT5mZmVq7dq16enokSY2NjSooKFBWVpaWLl2qzs7OoUYFAAAAAJjckEru8ePHtXDhQjU0NITGTpw4oV27dsntdsvtduuBBx5Qd3e31qxZo8rKSnk8Hp04cUKHDx+WJBUVFWndunU6ePCgDMNQVVWVJGn9+vXKz8+X1+vVlClTVFlZOZSoAAAAAIBRYEglt6qqSqWlpbLb7ZKkrq4uNTY2as2aNXK5XNq6dauCwaDq6+s1adIkTZw4UVarVS6XS16vV2fPnlV3d7emT58uScrLy5PX61UgENDRo0eVmZnZZxwAAAAAgOsZ0t/kbtiwoc90S0uLZs6cqdLSUsXHx+uRRx7Rnj17dOutt8pms4Xms9vtampqUnNzc59xm82mpqYmXbhwQXFxcbJarX3GAQAAAAC4nrBeeGrixInatm1baHrRokWqrq5WZmamLBZLaNwwDFksFgWDwauOX/p5uSun/5fbb4+75mOXX9UVMKOR+BkfiZkBAAAQfcJacv/xj3+ooaEhdJqxYRiyWq1KTEyUz+cLzefz+WS32/uNt7S0yG63a/z48Wpvb1dvb6/Gjh0bmn8gzp/vUDBo9Bu32eLl87X3GwPM5MrPeLgM57ZyI5nHjLFc9wssAAAAYMhXV76cYRj62c9+pv/+978KBAJ6+eWX9cADD2jatGk6ffq0zpw5o97eXtXU1MjhcCg5OVmxsbGqq6uTJLndbjkcDsXExCg1NVUej0eSVF1dLYfDEc6oAAAAAAATCmvJTUlJ0ZIlS7Rw4UI5nU7dc889ysnJUWxsrMrKyrRs2TLNnj1bX/ziF5WVlSVJqqio0MaNG5WVlaVPPvlEhYWFkqTS0lJVVVVp9uzZOnbsmFasWBHOqAAwYFfeMi1ct0Zra2vTkiVLlJ2drYKCgtAZLhcvXlRRUZGys7M1b948ffDBBzd5jQEAAEaesJyu/MYbb4R+LygoUEFBQb950tLStG/fvn7jKSkp2rNnT7/x5ORk7dy5MxzxAGDIjh8/rpKSktAt0y7dGm3nzp1KSkrSI488osOHDys9PV1FRUV6+umnNX36dK1Zs0ZVVVXKz88P3RrN6XRq27ZtqqysVFFRkbZs2aLU1FS98MILqq6u1oYNG7Rlyxbt3LlTt9xyiw4cOKCjR49q9erVodusAQAA4OrCeiQXAMzqylumhfPWaIcOHZLL5ZIk5eTk6M0331QgENChQ4c0Z84cSdJ9992n1tZWNTY23uxVBwAAGFHCeuEpADCrK2+ZduUt0IZya7TLn2O1WhUXF6fW1tarLuvcuXP6whe+cMO5o+VCXSPxAn8jMfNwGc73YiS+zyMxMwCMJpRcABiEa90CLRy3RjMMQ2PGjOn3nEvjA3GtK83fTFe7qn20G6mZh8twXrF9JL7Pkc7MleYB4Po4XRkABmEot0a7fH7p06PALS0tkqSenh51dnYqISFBEyZMUHNzc79lAQAA4NoouQAwCOG8NVp6erqqq6slSR6PR6mpqYqJiVF6errcbrck6dixY4qNjR3QqcoAAACjEacrA8AgXH5rNL/fr/T09D63RispKVFHR4cmT57c59ZoxcXF2r59u5KSkrRp0yZJ0vLly1VcXCyn06n4+HhVVFRIkhYtWqR169bJ6XRq3LhxKi8vj8zKAgAAjCCUXAAYgMtvmRauW6MlJCTo+eef7zceGxurZ555ZoiJAQAARhdOVwYAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZhjXQAAOF1MdArmy0+0jEAAACAiKDkAiYzLmasXI+7h2XZ+3+eOyzLBQAAAMKF05UBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmMaQS25HR4dycnL00UcfSZJqa2vlcrmUkZGhzZs3h+Y7efKk8vLylJmZqbVr16qnp0eS1NjYqIKCAmVlZWnp0qXq7OyUJLW1tWnJkiXKzs5WQUGBfD7fUKMCAAAAAExuSCX3+PHjWrhwoRoaGiRJ3d3dWrNmjSorK+XxeHTixAkdPnxYklRUVKR169bp4MGDMgxDVVVVkqT169crPz9fXq9XU6ZMUWVlpSRpy5YtSk1N1YEDB/Tggw9qw4bpX3wyAAAUdElEQVQNQ4kKAAAAABgFhlRyq6qqVFpaKrvdLkmqr6/XpEmTNHHiRFmtVrlcLnm9Xp09e1bd3d2aPn26JCkvL09er1eBQEBHjx5VZmZmn3FJOnTokFwulyQpJydHb775pgKBwFDiAgAAAABMzjqUJ195dLW5uVk2my00bbfb1dTU1G/cZrOpqalJFy5cUFxcnKxWa5/xK5dltVoVFxen1tZWTZgwYSiRAQAAAAAmNqSSe6VgMCiLxRKaNgxDFovlmuOXfl7uyunLnzNmzI0feL799rhrPmazxd/wcgDcHGyXAAAACIewltzExMQ+F4jy+Xyy2+39xltaWmS32zV+/Hi1t7ert7dXY8eODc0vfXoUuKWlRYmJierp6VFnZ6cSEhJuOMv58x0KBo1+4zZbvHy+9n5jACLryu3yasaMsVz3CywAAAAgrLcQmjZtmk6fPq0zZ86ot7dXNTU1cjgcSk5OVmxsrOrq6iRJbrdbDodDMTExSk1NlcfjkSRVV1fL4XBIktLT01VdXS1J8ng8Sk1NVUxMTDjjAgAAAABMJqxHcmNjY1VWVqZly5bJ7/crPT1dWVlZkqSKigqVlJSoo6NDkydPVmFhoSSptLRUxcXF2r59u5KSkrRp0yZJ0vLly1VcXCyn06n4+HhVVFSEMyoAAAAAwITCUnLfeOON0O9paWnat29fv3lSUlK0Z8+efuPJycnauXNnv/GEhAQ9//zz4YgHAAAAABglwnq6MgAAAAAAkUTJBQAAAACYBiUXAAAAAGAalFwAAAAAgGlQcgEAAAAApkHJBQAAAACYBiUXAAAAAGAalFwAAAAAgGlQcgEAAAAApkHJBQAAAACYBiUXAAAAAGAalFwAAAAAgGlQcgEAAAAApkHJBQAAAACYhjXSAQBgJFu0aJFaW1tltX66O33qqaf04Ycfavv27erp6dHDDz+sgoICSVJtba02btwov9+v7OxsrVy5UpJ08uRJrV27Vp2dnUpNTdX69etltVrV2NiooqIinT9/XnfeeacqKip02223RWxdAQAARgKO5ALAIBmGoYaGBrnd7tC/xMREbd68Wb/73e9UXV2tl19+Wf/617/U3d2tNWvWqLKyUh6PRydOnNDhw4clSUVFRVq3bp0OHjwowzBUVVUlSVq/fr3y8/Pl9Xo1ZcoUVVZWRnJ1AQAARgRKLgAM0qlTpyRJixcv1pw5c7Rr1y7V1tZq5syZSkhI0K233qrMzEx5vV7V19dr0qRJmjhxoqxWq1wul7xer86ePavu7m5Nnz5dkpSXlyev16tAIKCjR48qMzOzzzgAAACuj5ILAIPU1tamtLQ0bdu2TTt27NAf/vAHNTY2ymazheax2+1qampSc3PzDY3bbDY1NTXpwoULiouLC50GfWkcAAAA18ff5ALAIM2YMUMzZswITc+fP18bN27U0qVLQ2OGYchisSgYDMpisdzw+KWfl7ty+kbcfnvcgJ8zHGy2+EhHGLCRmHm4DOd7MRLf55GYGQBGE0ouAAzSsWPHFAgElJaWJunTgpqcnCyfzxeax+fzyW63KzEx8YbGW1paZLfbNX78eLW3t6u3t1djx44NzT9Q5893KBg0hrCWQ2ezxcvna49ohoEaqZmHy3C9FyP1fY505jFjLFHzBRYARCNOVwaAQWpvb1d5ebn8fr86Ojq0d+9ePfvsszpy5IhaW1vV1dWl1157TQ6HQ9OmTdPp06d15swZ9fb2qqamRg6HQ8nJyYqNjVVdXZ0kye12y+FwKCYmRqmpqfJ4PJKk6upqORyOSK4uAADAiMCRXAAYpFmzZun48eOaO3eugsGg8vPzde+992rlypUqLCxUIBDQ/PnzNXXqVElSWVmZli1bJr/fr/T0dGVlZUmSKioqVFJSoo6ODk2ePFmFhYWSpNLSUhUXF2v79u1KSkrSpk2bIrauAAAAIwUlFwCGYMWKFVqxYkWfMZfLJZfL1W/etLQ07du3r994SkqK9uzZ0288OTlZO3fuDF9YAACAUYDTlQEAAAAApkHJBQAAAACYBiUXAAAAAGAalFwAAAAAgGlQcgEAAAAApkHJBQAAAACYBiUXAAAAAGAalFwAAAAAgGlYh2OhixYtUmtrq6zWTxf/1FNP6cMPP9T27dvV09Ojhx9+WAUFBZKk2tpabdy4UX6/X9nZ2Vq5cqUk6eTJk1q7dq06OzuVmpqq9evXh5YHAAAAAMDVhP1IrmEYamhokNvtDv1LTEzU5s2b9bvf/U7V1dV6+eWX9a9//Uvd3d1as2aNKisr5fF4dOLECR0+fFiSVFRUpHXr1ungwYMyDENVVVXhjgoAAAAAMJmwl9xTp05JkhYvXqw5c+Zo165dqq2t1cyZM5WQkKBbb71VmZmZ8nq9qq+v16RJkzRx4kRZrVa5XC55vV6dPXtW3d3dmj59uiQpLy9PXq833FEBAAAAACYT9vN/29ralJaWpieffFKBQECFhYXKzs6WzWYLzWO321VfX6/m5uZ+401NTf3GbTabmpqaBpTj9tvjrvmYzRY/oGUBGH5slwAAAAiHsJfcGTNmaMaMGaHp+fPna+PGjVq6dGlozDAMWSwWBYNBWSyWGx4fiPPnOxQMGv3GbbZ4+Xzt/cYARNaV2+XVjBljue4XWAAAAEDYT1c+duyYjhw5Epo2DEPJycny+XyhMZ/PJ7vdrsTExBsab2lpkd1uD3dUAAAAAIDJhL3ktre3q7y8XH6/Xx0dHdq7d6+effZZHTlyRK2trerq6tJrr70mh8OhadOm6fTp0zpz5ox6e3tVU1Mjh8Oh5ORkxcbGqq6uTpLkdrvlcDjCHRUAAAAAYDJhP1151qxZOn78uObOnatgMKj8/Hzde++9WrlypQoLCxUIBDR//nxNnTpVklRWVqZly5bJ7/crPT1dWVlZkqSKigqVlJSoo6NDkydPVmFhYbijAgAAAABMZlhuPLtixQqtWLGiz5jL5ZLL5eo3b1pamvbt29dvPCUlRXv27BmOeAAAAAAAkwr76coAAAAAAEQKJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaVByAQAAAACmQckFAAAAAJgGJRcAAAAAYBqUXAAAAACAaUR1yd2/f79mz56tjIwM7d69O9JxACAi2BcCAADcOGukA1xLU1OTNm/erFdffVXjxo3TggUL9NWvflVf+tKXIh0NAG4a9oUAAAADE7Ult7a2VjNnzlRCQoIkKTMzU16vVz/60Y9u6PljxlgG9Jj9/90yuKD/w3AtdziXTeaRv+yRmPl62+xA5jGb4dwX3kzRkmMgRmLmSG6f0bjs4RLpzJF+fQCIdhbDMIxIh7iaX/3qV/rkk0+0cuVKSdIrr7yi+vp6/fSnP41wMgC4edgXAgAADEzU/k1uMBiUxfJ/31QahtFnGgBGA/aFAAAAAxO1JTcxMVE+ny807fP5ZLfbI5gIAG4+9oUAAAADE7Ul9/7779eRI0fU2tqqrq4uvfbaa3I4HJGOBQA3FftCAACAgYnaC09NmDBBK1euVGFhoQKBgObPn6+pU6dGOhYA3FTsCwEAAAYmai88BQAAAADAQEXt6coAAAAAAAwUJRcAAAAAYBqUXAAAAACAaVByAQAAAACmMapK7v79+zV79mxlZGRo9+7dkY5zTR0dHcrJydFHH30kSaqtrZXL5VJGRoY2b94c4XRX99xzz8npdMrpdKq8vFxS9Of+xS9+odmzZ8vpdOqll16SFP2ZL3nmmWdUXFwsSTp58qTy8vKUmZmptWvXqqenJ8Lp+lq0aJGcTqdyc3OVm5ur48ePj5htEZ8azPa9atUqvfrqq6HpxsZGFRQUKCsrS0uXLlVnZ2e/51y8eFFPP/205s6dK6fTqbfeemtEZH788cflcrmUm5ur2traiGa+ZMuWLfrlL3951de5ePGiioqKlJ2drXnz5umDDz6I+szNzc363ve+p9zcXM2bN09HjhyJ+syXdHR06Fvf+pbefffdQWcGAAyQMUqcO3fOmDVrlnHhwgWjs7PTcLlcxvvvvx/pWP389a9/NXJycozJkycb//73v42uri4jPT3d+PDDD41AIGAsXrzYOHToUKRj9vH2228bDz30kOH3+42LFy8ahYWFxv79+6M697vvvmssWLDACAQCRldXlzFr1izj5MmTUZ35ktraWuOrX/2q8ZOf/MQwDMNwOp3GX/7yF8MwDGP16tXG7t27Ixmvj2AwaHzta18zAoFAaGykbIv41EC373PnzhmPPPKIMXXqVOOPf/xjaDlLliwxampqDMMwjOeee84oLy/v91rbtm0zfvzjHxvBYND45z//aXzta18zgsFgVGeuqqoyVqxYYRiGYfz97383vv71rw84bzgzt7W1GatXrzamTp1qbN269aqv9etf/9p48sknDcMwjPfee8948MEHoz7z448/buzatcswDMP44IMPjPvvv9/o6emJ6syXrFq1yrjvvvuMd955Z8B5AQCDM2qO5NbW1mrmzJlKSEjQrbfeqszMTHm93kjH6qeqqkqlpaWy2+2SpPr6ek2aNEkTJ06U1WqVy+WKutw2m03FxcUaN26cYmJidNddd6mhoSGqc3/lK1/Rb3/7W1mtVp0/f169vb1qa2uL6syS9J///EebN2/WD3/4Q0nS2bNn1d3drenTp0uS8vLyoirzqVOnJEmLFy/WnDlztGvXrhGzLeJTA92+9+/fr29+85vKzs4OLSMQCOjo0aPKzMyUdO3P6YEDB/SDH/xAFotFd999t1566SUZg7jL3c3MHAwG1dXVpd7eXnV1dekzn/nMgPOGK7Mkvf7667rjjjv03e9+95qvdejQIc2ZM0eSdN9996m1tVWNjY1RnfmBBx5QTk6OJGnSpEny+/365JNPojqzJHk8Ht1222368pe/POCsAIDBGzUlt7m5WTabLTRtt9vV1NQUwURXt2HDBqWmpoamR0Luu+++O1SyGhoadODAAVkslqjPHRMTo61bt8rpdCotLW1EvNfr1q3TypUr9dnPflZS/8+HzWaLqsxtbW1KS0vTtm3btGPHDv3hD39QY2Nj1L/P+D8D3b6///3v68EHH+yzjAsXLiguLk5Wq1XStT+nZ86c0dGjR5Wfn6+HHnpILS0tGjNm4P+bupmZ582bp//85z/6+te/rm9/+9t64oknBpw3XJklae7cuVqyZInGjh17zde62n7j3LlzUZ05MzNTn/vc5yRJL774ou655x7Fx8dHdebGxkb95je/0apVqwacEwAwNKOm5AaDQVksltC0YRh9pqPVSMr9/vvva/HixVq1apUmTpw4InI/9thjOnLkiD7++GM1NDREdeZXXnlFSUlJSktLC41F++djxowZKi8vV3x8vMaPH6/58+dr69atUZ0ZVzeU7ftqj19t/t7eXp07d067d+/W+vXr9cQTT6i9vT2qMz/33HOaPn263n77be3fv18bNmzQ2bNnI5L5Rl25HMMwBvVlwiU3c9+/Y8cOvfzyy6G/pR2s4c4cDAa1du1aPfnkk4M+ug8AGLxRU3ITExPl8/lC0z6fL3RKcDQbKbnr6ur0ne98R48//rjmzZsX9bk/+OADnTx5UpJ0yy23KCMjQ++++25UZ/Z4PHr77beVm5urrVu36o033tCePXv6ZG5paYmqzMeOHetzgRjDMJScnBzV7zP6G+r2PX78eLW3t6u3t/e683/+85+X0+mUxWJRSkqKEhMTdfr06ajO/PrrrysvL08Wi0V33nmnpk2bpvr6+ohkvlETJkxQc3NzaHoo+42bue8vLy/XK6+8ot27dyspKWnQy7kZmU+dOqVTp05p7dq1ys3N1YkTJ1RSUqJ33nlnSMsFANyYUVNy77//fh05ckStra3q6urSa6+9JofDEelY/9O0adN0+vRpnTlzRr29vaqpqYm63B9//LEeffRRVVRUyOl0Sor+3B999JFKSkp08eJFXbx4Ua+//roWLFgQ1Zlfeukl1dTUyO1267HHHtM3vvENbdy4UbGxsaqrq5Mkud3uqMrc3t6u8vJy+f1+dXR0aO/evXr22WdH5LY4WoVj+46JiVFqaqo8Ho8kqbq6+qrzz5o1KzTPv//9b3388ce68847ozpzSkqK/vznP0uSWltbdeLECd1zzz0RyXyj0tPT5Xa7JX36RVRsbKy+8IUvRHXmHTt26N1339Xvf/97JSYmDno5Nyvzl770JR0+fFhut1tut1tTpkzR008/rZkzZw5puQCAG2ONdICbZcKECVq5cqUKCwsVCAQ0f/58TZ06NdKx/qfY2FiVlZVp2bJl8vv9Sk9PV1ZWVqRj9fHiiy/K7/errKwsNLZgwYKozp2enq76+nrNnTtXY8eOVUZGhpxOp8aPHx+1ma+loqJCJSUl6ujo0OTJk1VYWBjpSCGzZs3S8ePHNXfuXAWDQeXn5+vee+8dkdviaBWu7bu0tFTFxcXavn27kpKStGnTJknS73//ezU3N2v58uV64okn9NRTT4XKx9NPPz2ov7u8mZlXr16tJ598Uk6nU2PGjNGPf/xj3XHHHRHLfC2XZ160aJHWrVsnp9OpcePGDfrU35uV+bHHHtO2bdsUFxenRYsWhR5/4YUXNGHChKjMvHz58kE9HwAQHhZjMJeuBAAAAAAgCo2a05UBAAAAAOZHyQUAAAAAmAYlFwAAAABgGpRcAAAAAIBpUHIBAAAAAKZByQUAAAAAmAYlFwAAAABgGpRcAAAAAIBp/H/EqKvDRzsuegAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<Figure size 1152x1296 with 9 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df.hist(figsize = (16,18))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Check for missing values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "True\n",
      "\n",
      "\n",
      "METRO           0\n",
      "STRATA          0\n",
      "PSU             0\n",
      "REPLICATE       0\n",
      "CASEWGT         0\n",
      "               ..\n",
      "ALCOHOL         0\n",
      "NONALCILL       0\n",
      "PHARMA          0\n",
      "NONMEDPHARMA    0\n",
      "ALLABUSE        0\n",
      "Length: 86, dtype: int64\n",
      "\n",
      "\n",
      "4679548\n"
     ]
    }
   ],
   "source": [
    "# Any missing values?\n",
    "print (df.isnull().values.any())\n",
    "print('\\n')\n",
    "\n",
    "# Total missing values for each feature\n",
    "print (df.isnull().sum())\n",
    "print('\\n')\n",
    "\n",
    "# Total number of missing values\n",
    "print (df.isnull().sum().sum())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "df.to_csv(r\"C:\\Users\\Laura-Black\\Documents\\PhD\\Data Scientist\\Springboard\\Capstone Projects\\Drug Abuse ED Visits\\Output files\\Capstone1DataWrangling.csv\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This data set has 86 columns and 229,211 rows. Most of the variables are categorical. In the original data set, the categorical variables were represented by numbers. Steps were taken to replace the numbers with their corresponding names. Since the dataframe is very large and somewhat unwieldy the decision was made to remove  the 'sdled' and 'CATID' columns. These columns won't be used in the analysis because their inclusion is beyond the scope of this project. Additionally, the number of distinct values for each varible was plotted, subplot histograms of the quantitative variables were plotted, and it was determined that the data set did not include any missing values."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
